| NCT06881823 | Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC | NOT_YET_RECRUITING | PHASE1, PHASE2 | 2026-06-29 | 2033-06-01 | 2030-03-31 |
| NCT05776927 | A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. | NOT_YET_RECRUITING | PHASE3 | 2026-02-01 | 2029-02-01 | 2026-03-18 |
| NCT07174063 | A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer | NOT_YET_RECRUITING | PHASE1 | 2025-12-26 | 2027-06-18 | 2027-06-18 |
| NCT07006727 | Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors | NOT_YET_RECRUITING | PHASE1 | 2025-12-17 | 2031-08-18 | 2031-08-18 |
| NCT06994845 | Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN | NOT_YET_RECRUITING | PHASE3 | 2025-12-08 | 2030-06-30 | 2030-06-28 |
| NCT07206056 | An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01) | RECRUITING | PHASE1, PHASE2 | 2025-11-28 | 2030-12-17 | 2029-10-29 |
| NCT07146906 | A Study to Assess the Effects of Zigakibart on IgA Nephropathy. | NOT_YET_RECRUITING | PHASE2 | 2025-11-18 | 2030-07-16 | 2030-04-09 |
| NCT07190300 | TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | NOT_YET_RECRUITING | PHASE1, PHASE2 | 2025-11-03 | 2032-05-14 | 2032-05-14 |
| NCT06751238 | Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA). | RECRUITING | PHASE1 | 2025-10-31 | 2032-12-01 | 2032-11-30 |
| NCT06997588 | EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS) | NOT_YET_RECRUITING | PHASE2 | 2025-10-21 | 2030-09-30 | 2028-08-02 |
| NCT07203001 | A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease | NOT_YET_RECRUITING | PHASE2 | 2025-10-11 | 2029-05-02 | 2029-05-02 |
| NCT07039422 | Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab | NOT_YET_RECRUITING | PHASE2 | 2025-10-03 | 2030-08-30 | 2030-08-30 |
| NCT07140614 | A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A. | RECRUITING | PHASE1 | 2025-09-30 | 2028-02-26 | 2028-02-25 |
| NCT07102628 | Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes | NOT_YET_RECRUITING | PHASE3 | 2025-09-30 | 2027-03-06 | 2027-03-06 |
| NCT07094516 | A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease | NOT_YET_RECRUITING | PHASE2 | 2025-09-18 | 2030-12-31 | 2028-09-14 |
| NCT06894511 | An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC | RECRUITING | PHASE2 | 2025-09-11 | 2029-04-09 | 2029-04-09 |
| NCT06824103 | Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease | RECRUITING | PHASE4 | 2025-09-09 | 2032-01-11 | 2029-11-29 |
| NCT07117214 | A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers | NOT_YET_RECRUITING | PHASE1 | 2025-08-20 | 2027-01-26 | 2027-01-26 |
| NCT06858319 | Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. | RECRUITING | PHASE3 | 2025-07-28 | 2031-06-25 | 2031-06-25 |
| NCT06934967 | Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients | NOT_YET_RECRUITING | PHASE3 | 2025-07-28 | 2031-10-31 | 2031-10-01 |
| NCT06846281 | Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. | RECRUITING | PHASE3 | 2025-07-23 | 2032-01-08 | 2030-02-07 |
| NCT07032272 | A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants. | RECRUITING | PHASE1 | 2025-07-23 | 2025-11-24 | 2025-11-21 |
| NCT06868212 | A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines | RECRUITING | PHASE3 | 2025-07-11 | 2027-08-03 | 2027-05-11 |
| NCT06991556 | An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | RECRUITING | PHASE2 | 2025-07-07 | 2035-09-08 | 2032-02-17 |
| NCT07047118 | A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) | RECRUITING | PHASE2 | 2025-07-03 | 2028-12-11 | 2028-02-14 |
| NCT06855277 | Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC | RECRUITING | PHASE3 | 2025-07-01 | 2032-11-04 | 2028-02-29 |
| NCT07034690 | Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia | NOT_YET_RECRUITING | PHASE4 | 2025-06-30 | 2027-06-30 | 2026-06-23 |
| NCT07048197 | A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease | RECRUITING | PHASE1, PHASE2 | 2025-06-20 | 2028-09-15 | 2028-09-15 |
| NCT06941792 | Inclisiran Effectiveness in China: a Pragmatic Randomized Trial | RECRUITING | PHASE4 | 2025-06-17 | 2026-01-30 | 2026-01-30 |
| NCT07029555 | An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis | RECRUITING | PHASE1 | 2025-06-12 | 2028-05-16 | 2028-05-15 |
| NCT06910813 | DFT383 in Pediatric Participants With Nephropathic Cystinosis | RECRUITING | PHASE1, PHASE2 | 2025-06-02 | 2030-08-26 | 2030-08-26 |
| NCT06784752 | Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET | RECRUITING | PHASE3 | 2025-05-30 | 2034-01-05 | 2030-09-27 |
| NCT06865651 | Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria | RECRUITING | PHASE2 | 2025-05-22 | 2027-10-07 | 2027-09-01 |
| NCT06711887 | Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) | RECRUITING | PHASE3 | 2025-05-19 | 2032-07-28 | 2030-07-18 |
| NCT06875973 | Pelacarsen Roll-over Extension Program | RECRUITING | PHASE3 | 2025-05-19 | 2028-01-03 | 2027-12-31 |
| NCT06947993 | Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis | RECRUITING | PHASE2 | 2025-05-16 | 2028-11-27 | 2028-11-27 |
| NCT06813911 | Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD | RECRUITING | PHASE3 | 2025-04-30 | 2027-12-01 | 2027-11-05 |
| NCT06632600 | A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. | RECRUITING | PHASE2 | 2025-04-28 | 2027-09-22 | 2027-03-22 |
| NCT06704269 | Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis | RECRUITING | PHASE1, PHASE2 | 2025-04-22 | 2029-10-26 | 2029-08-02 |
| NCT06726148 | Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors | RECRUITING | PHASE1, PHASE2 | 2025-04-03 | 2028-09-25 | 2028-09-25 |
| NCT06857955 | A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients | RECRUITING | PHASE2 | 2025-03-26 | 2028-04-05 | 2026-12-31 |
| NCT06840392 | Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa | RECRUITING | PHASE3 | 2025-03-20 | 2028-10-20 | 2028-06-02 |
| NCT05541159 | Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants | WITHDRAWN | PHASE1 | 2025-03-19 | 2025-07-15 | 2025-07-15 |
| NCT06869785 | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab | RECRUITING | PHASE3 | 2025-03-13 | 2031-05-26 | 2026-12-24 |
| NCT06868290 | Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA | RECRUITING | PHASE2 | 2025-03-13 | 2030-05-24 | 2029-06-07 |
| NCT05490030 | Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants | WITHDRAWN | PHASE1 | 2025-03-06 | 2025-06-26 | 2025-06-26 |
| NCT06597006 | Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia | RECRUITING | PHASE3 | 2025-02-28 | 2029-04-15 | 2028-03-21 |
| NCT06780670 | Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy | RECRUITING | PHASE2, PHASE3 | 2025-02-27 | 2033-04-11 | 2028-03-20 |
| NCT06617793 | An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis | RECRUITING | PHASE1, PHASE2 | 2025-02-24 | 2030-10-22 | 2030-10-22 |
| NCT06797518 | Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN | RECRUITING | PHASE2 | 2025-02-21 | 2027-11-27 | 2027-11-27 |
| NCT06514534 | Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib. | RECRUITING | PHASE2 | 2025-02-18 | 2028-12-01 | 2028-12-01 |
| NCT06501443 | LATAM LOWERS LDL-C | RECRUITING | PHASE4 | 2025-02-11 | 2026-11-29 | 2026-11-27 |
| NCT06744920 | A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis | RECRUITING | PHASE3 | 2025-02-07 | 2033-02-26 | 2028-02-27 |
| NCT06799000 | A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa | RECRUITING | PHASE3 | 2025-01-31 | 2028-10-20 | 2028-09-21 |
| NCT06382051 | Modifying PEST for Psoriatic Arthritis Screening | RECRUITING | NA | 2025-01-23 | 2025-08-31 | 2025-08-31 |
| NCT05367401 | A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants | WITHDRAWN | PHASE1, PHASE2 | 2024-12-20 | 2029-10-26 | 2029-10-26 |
| NCT06665256 | Phase 2 Study of Rapcabtagene Autoleucel in Myositis | RECRUITING | PHASE2 | 2024-12-17 | 2030-07-17 | 2029-07-17 |
| NCT06675864 | Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS) | RECRUITING | PHASE1, PHASE2 | 2024-12-12 | 2030-06-13 | 2030-06-13 |
| NCT06597019 | Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia | RECRUITING | PHASE3 | 2024-12-09 | 2029-04-15 | 2028-03-21 |
| NCT06427811 | Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation | ACTIVE_NOT_RECRUITING | PHASE4 | 2024-11-28 | 2026-11-01 | 2026-11-01 |
| NCT06733922 | ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS | RECRUITING | PHASE4 | 2024-11-27 | 2027-11-30 | 2027-11-22 |
| NCT06444113 | Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis | RECRUITING | PHASE4 | 2024-11-25 | 2027-02-23 | 2026-05-18 |
| NCT06411639 | Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases | WITHDRAWN | PHASE1 | 2024-11-25 | 2028-06-24 | 2025-12-17 |
| NCT06386419 | A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia | ACTIVE_NOT_RECRUITING | PHASE4 | 2024-11-12 | 2026-02-27 | 2026-02-27 |
| NCT06531499 | A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study | RECRUITING | PHASE1 | 2024-11-11 | 2028-11-24 | 2028-11-24 |
| NCT06655896 | Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis | RECRUITING | PHASE2 | 2024-10-29 | 2032-08-30 | 2028-11-30 |
| NCT06439082 | A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) | RECRUITING | PHASE3 | 2024-10-24 | 2030-04-19 | 2029-03-23 |
| NCT06649110 | A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) | RECRUITING | PHASE1, PHASE2 | 2024-10-24 | 2028-12-31 | 2028-11-29 |
| NCT06643481 | A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) | RECRUITING | PHASE2 | 2024-10-17 | 2028-06-20 | 2027-01-29 |
| NCT06562192 | Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers | RECRUITING | PHASE1 | 2024-10-15 | 2030-06-26 | 2030-06-25 |
| NCT06470048 | A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis | RECRUITING | PHASE2 | 2024-10-09 | 2030-07-15 | 2028-07-10 |
| NCT06335979 | An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). | RECRUITING | PHASE1 | 2024-10-08 | 2027-07-09 | 2027-07-09 |
| NCT06376253 | A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers | TERMINATED | PHASE1 | 2024-09-08 | 2025-07-10 | 2025-07-10 |
| NCT06581198 | A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN) | RECRUITING | PHASE2 | 2024-09-04 | 2033-06-07 | 2029-06-13 |
| NCT06546670 | A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease | RECRUITING | PHASE1, PHASE2 | 2024-08-15 | 2029-12-19 | 2028-07-12 |
| NCT06247995 | A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. | RECRUITING | PHASE1, PHASE2 | 2024-08-14 | 2031-09-09 | 2031-09-09 |
| NCT06401356 | An Extension Study for Patients Previously Enrolled in Studies With Pelabresib | RECRUITING | PHASE3 | 2024-08-13 | 2027-06-30 | 2027-06-02 |
| NCT06388941 | Iptacopan in Patients With ANCA Associated Vasculitis | RECRUITING | PHASE2 | 2024-08-05 | 2027-10-05 | 2027-09-09 |
| NCT06517758 | A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG. | RECRUITING | PHASE3 | 2024-07-31 | 2032-05-27 | 2026-12-28 |
| NCT06379217 | NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. | RECRUITING | PHASE1 | 2024-07-29 | 2027-06-22 | 2027-06-22 |
| NCT06372925 | Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction | RECRUITING | PHASE4 | 2024-07-12 | 2026-06-24 | 2026-06-24 |
| NCT06462469 | Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease | RECRUITING | PHASE4 | 2024-07-04 | 2028-02-17 | 2027-01-04 |
| NCT06293365 | Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease | RECRUITING | PHASE2 | 2024-07-02 | 2029-03-16 | 2025-08-29 |
| NCT06331312 | Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) | RECRUITING | PHASE3 | 2024-06-28 | 2028-02-10 | 2028-02-10 |
| NCT06431763 | A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease. | ACTIVE_NOT_RECRUITING | PHASE4 | 2024-06-21 | 2025-12-15 | 2025-09-01 |
| NCT06133972 | Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). | RECRUITING | PHASE3 | 2024-05-21 | 2032-04-16 | 2030-04-19 |
| NCT05739942 | Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma | RECRUITING | PHASE1 | 2024-05-15 | 2031-08-28 | 2026-02-05 |
| NCT05795140 | Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS | RECRUITING | PHASE3 | 2024-05-08 | 2033-01-03 | 2032-12-23 |
| NCT06267560 | Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-04-24 | 2026-03-31 | 2026-03-31 |
| NCT06155500 | Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC) | ACTIVE_NOT_RECRUITING | PHASE1 | 2024-04-16 | 2039-01-11 | 2039-01-11 |
| NCT06236061 | Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-04-08 | 2025-12-25 | 2025-05-28 |
| NCT06004661 | Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function | RECRUITING | PHASE2 | 2024-04-04 | 2026-08-04 | 2026-06-05 |
| NCT06130540 | Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR | COMPLETED | PHASE1 | 2024-03-27 | 2025-04-02 | 2025-03-12 |
| NCT06240741 | A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan | COMPLETED | PHASE3 | 2024-03-21 | 2024-12-27 | 2024-12-27 |
| NCT05939414 | An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. | RECRUITING | PHASE3 | 2024-03-12 | 2031-10-03 | 2026-03-31 |
| NCT05842954 | Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-03-07 | 2027-08-08 | 2025-06-27 |
| NCT05646381 | A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis | RECRUITING | PHASE2 | 2024-03-07 | 2030-03-12 | 2030-03-12 |
| NCT05827081 | Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | RECRUITING | PHASE3 | 2024-02-28 | 2030-09-20 | 2029-09-07 |
| NCT05935215 | Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) | RECRUITING | PHASE3 | 2024-02-28 | 2029-07-19 | 2028-07-21 |
| NCT06006559 | A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever | RECRUITING | PHASE2 | 2024-02-20 | 2026-09-07 | 2026-09-07 |
| NCT06097663 | A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) | COMPLETED | PHASE2 | 2024-02-15 | 2024-11-04 | 2024-10-27 |
| NCT05750628 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria | RECRUITING | PHASE2 | 2024-01-23 | 2026-06-23 | 2026-06-09 |
| NCT05996835 | Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) | RECRUITING | PHASE2 | 2024-01-18 | 2026-02-20 | 2025-12-04 |
| NCT05849298 | A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC | RECRUITING | PHASE2 | 2024-01-03 | 2030-05-18 | 2028-04-07 |
| NCT06142383 | A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure | TERMINATED | PHASE2 | 2023-12-12 | 2024-11-01 | 2024-11-01 |
| NCT05976243 | A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines | RECRUITING | PHASE3 | 2023-12-07 | 2028-12-31 | 2026-03-30 |
| NCT06149104 | A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study | COMPLETED | PHASE3 | 2023-12-04 | 2024-08-14 | 2024-08-14 |
| NCT05948943 | Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. | RECRUITING | PHASE2, PHASE3 | 2023-11-24 | 2033-05-02 | 2028-09-22 |
| NCT06042478 | Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-11-15 | 2027-07-20 | 2025-08-18 |
| NCT05870579 | [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer | RECRUITING | PHASE1 | 2023-11-13 | 2032-01-26 | 2026-12-30 |
| NCT05983198 | Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT | RECRUITING | PHASE1, PHASE2 | 2023-11-07 | 2029-11-05 | 2026-11-19 |
| NCT05985915 | A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-10-27 | 2030-07-18 | 2028-08-21 |
| NCT06031844 | A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP | COMPLETED | PHASE2 | 2023-10-16 | 2024-12-23 | 2024-12-17 |
| NCT05977322 | A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. | TERMINATED | PHASE1 | 2023-10-06 | 2024-12-13 | 2024-12-13 |
| NCT05888493 | A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma | RECRUITING | PHASE3 | 2023-10-02 | 2031-01-18 | 2028-07-25 |
| NCT05755386 | Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN | RECRUITING | PHASE3 | 2023-10-02 | 2029-05-31 | 2028-10-27 |
| NCT05900141 | An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-09-29 | 2028-08-24 | 2028-08-24 |
| NCT05809895 | Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer | WITHDRAWN | PHASE2 | 2023-09-15 | 2029-07-18 | 2029-07-17 |
| NCT05272059 | Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus | WITHDRAWN | PHASE1 | 2023-09-01 | 2025-04-14 | 2025-04-14 |
| NCT05885555 | A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-08-16 | 2029-03-19 | 2025-02-05 |
| NCT05803941 | Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer | RECRUITING | PHASE4 | 2023-08-14 | 2033-07-21 | 2033-07-20 |
| NCT05722522 | Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy | TERMINATED | PHASE3 | 2023-08-10 | 2024-12-13 | 2024-10-18 |
| NCT05758415 | Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy | TERMINATED | PHASE3 | 2023-08-02 | 2024-12-11 | 2024-10-18 |
| NCT05853458 | Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors | ACTIVE_NOT_RECRUITING | PHASE4 | 2023-07-28 | 2027-01-27 | 2026-06-01 |
| NCT05791097 | Study of Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Platinum-based Doublet Chemotherapy as First-line Treatment for Participants With Locally Advanced or Metastatic NSCLC. | WITHDRAWN | PHASE3 | 2023-07-28 | 2027-12-26 | 2027-12-24 |
| NCT05834738 | Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-07-20 | 2026-08-19 | 2025-10-22 |
| NCT05677451 | 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up | RECRUITING | PHASE3 | 2023-07-11 | 2032-03-30 | 2026-04-02 |
| NCT05888103 | Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol. | COMPLETED | PHASE3 | 2023-07-11 | 2024-10-24 | 2024-04-02 |
| NCT05852938 | A Study of Zigakibart in Adults With IgA Nephropathy | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-07-06 | 2028-06-07 | 2026-02-19 |
| NCT05838768 | Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. | RECRUITING | PHASE1 | 2023-06-27 | 2029-05-30 | 2029-05-30 |
| NCT05592990 | A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy | RECRUITING | PHASE2 | 2023-06-14 | 2026-02-24 | 2026-02-24 |
| NCT05816395 | Safety and Efficacy of RHH646 for Knee Osteoarthritis | COMPLETED | PHASE2 | 2023-05-31 | 2025-02-24 | 2025-02-24 |
| NCT05670106 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-05-16 | 2025-11-14 | 2024-05-17 |
| NCT05562466 | A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma | RECRUITING | PHASE3 | 2023-05-11 | 2028-05-30 | 2028-02-01 |
| NCT05552469 | Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases | RECRUITING | PHASE1 | 2023-05-08 | 2027-02-01 | 2027-01-29 |
| NCT05658003 | A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-05-05 | 2027-01-13 | 2024-12-02 |
| NCT05252585 | A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) | RECRUITING | PHASE4 | 2023-05-01 | 2026-12-31 | 2026-12-31 |
| NCT05678959 | Long-term Extension Study of Ligelizumab in Food Allergy | TERMINATED | PHASE3 | 2023-04-27 | 2025-03-06 | 2025-03-06 |
| NCT05630001 | Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan. | COMPLETED | PHASE3 | 2023-04-24 | 2024-10-17 | 2024-10-17 |
| NCT05624749 | Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) | RECRUITING | PHASE3 | 2023-04-21 | 2029-04-20 | 2027-04-23 |
| NCT05795153 | A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks. | COMPLETED | PHASE3 | 2023-04-05 | 2024-04-25 | 2024-04-25 |
| NCT05462873 | A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 | 2023-04-04 | 2026-01-20 | 2026-01-20 |
| NCT05622708 | A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission | RECRUITING | PHASE4 | 2023-03-28 | 2030-06-21 | 2030-04-26 |
| NCT05764265 | Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants | TERMINATED | PHASE2 | 2023-03-27 | 2024-05-14 | 2024-04-26 |
| NCT05767034 | Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-03-22 | 2026-02-17 | 2025-09-10 |
| NCT05763875 | Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy. | COMPLETED | PHASE3 | 2023-03-15 | 2024-06-20 | 2024-06-20 |
| NCT05454410 | Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD) | COMPLETED | PHASE2 | 2023-03-13 | 2023-11-28 | 2023-11-28 |
| NCT05739383 | A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-03-09 | 2029-04-16 | 2029-04-16 |
| NCT06905327 | A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects | COMPLETED | PHASE1 | 2023-03-08 | 2025-07-01 | 2024-09-25 |
| NCT05653349 | Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-03-06 | 2028-12-18 | 2026-04-24 |
| NCT05524051 | A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery. | TERMINATED | PHASE2 | 2023-03-03 | 2025-06-23 | 2025-03-26 |
| NCT05639114 | Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) | RECRUITING | PHASE3 | 2023-03-02 | 2029-04-20 | 2027-04-23 |
| NCT05798117 | An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2023-02-28 | 2026-09-09 | 2026-09-09 |
| NCT05469360 | Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants | RECRUITING | PHASE1 | 2023-02-23 | 2028-01-02 | 2026-09-11 |
| NCT05447663 | A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant | TERMINATED | PHASE1, PHASE2 | 2023-02-23 | 2023-10-26 | 2023-10-26 |
| NCT05201066 | Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-02-13 | 2028-02-14 | 2028-02-14 |
| NCT05682378 | Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-02-10 | 2028-03-02 | 2028-03-02 |
| NCT05666804 | Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-02-06 | 2025-10-31 | 2025-10-31 |
| NCT05653219 | A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-02-02 | 2028-04-10 | 2025-06-19 |
| NCT05168748 | CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia | WITHDRAWN | PHASE1 | 2023-01-24 | 2026-08-13 | 2026-08-13 |
| NCT05386680 | Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam | COMPLETED | PHASE3 | 2023-01-12 | 2024-11-29 | 2024-11-29 |
| NCT05666687 | An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain | COMPLETED | PHASE1 | 2023-01-11 | 2023-11-07 | 2023-11-07 |
| NCT05648968 | A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia | RECRUITING | PHASE3 | 2022-12-30 | 2029-05-02 | 2026-03-02 |
| NCT05429502 | Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors | TERMINATED | PHASE1 | 2022-12-27 | 2025-02-26 | 2025-02-26 |
| NCT05335876 | Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials | RECRUITING | PHASE3 | 2022-12-19 | 2030-06-26 | 2030-06-26 |
| NCT05513001 | An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-12-09 | 2027-08-02 | 2024-08-26 |
| NCT05445843 | Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation. | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-12-06 | 2027-11-30 | 2024-11-04 |
| NCT05599932 | Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment | COMPLETED | PHASE1 | 2022-12-02 | 2023-09-18 | 2023-09-18 |
| NCT05569174 | Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy | COMPLETED | PHASE3 | 2022-12-02 | 2024-12-18 | 2024-12-18 |
| NCT05507437 | Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney Injury | COMPLETED | PHASE2 | 2022-11-22 | 2024-04-25 | 2024-04-25 |
| NCT05456191 | A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-11-21 | 2031-07-07 | 2025-05-15 |
| NCT05384587 | Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-11-11 | 2027-10-17 | 2025-08-13 |
| NCT05497284 | To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF | TERMINATED | PHASE2 | 2022-11-10 | 2024-09-26 | 2024-08-26 |
| NCT05462990 | A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA | TERMINATED | PHASE2 | 2022-11-09 | 2025-04-08 | 2024-08-02 |
| NCT05562934 | An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients. | COMPLETED | PHASE2 | 2022-11-08 | 2024-08-27 | 2024-07-02 |
| NCT05753592 | A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Hepatic Impairment Compared With Matched Healthy Participants | COMPLETED | PHASE1 | 2022-10-31 | 2023-12-17 | 2023-12-14 |
| NCT05544929 | A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers | RECRUITING | PHASE1 | 2022-10-26 | 2027-09-01 | 2027-09-01 |
| NCT05358249 | Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-10-24 | 2026-05-18 | 2026-04-03 |
| NCT05758402 | A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study) | COMPLETED | NA | 2022-10-20 | 2023-06-30 | 2023-06-30 |
| NCT05432388 | Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts | COMPLETED | PHASE2 | 2022-10-12 | 2025-03-11 | 2025-03-11 |
| NCT05275868 | Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer | RECRUITING | PHASE1 | 2022-10-05 | 2027-07-28 | 2027-07-28 |
| NCT05397496 | Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies | RECRUITING | PHASE1 | 2022-10-03 | 2028-06-05 | 2027-06-07 |
| NCT05380453 | Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-09-21 | 2026-11-30 | 2026-11-30 |
| NCT05110196 | Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC. | COMPLETED | PHASE4 | 2022-09-03 | 2025-08-04 | 2025-08-04 |
| NCT04877522 | Asciminib Roll-over Study | RECRUITING | PHASE4 | 2022-08-30 | 2030-08-30 | 2030-08-30 |
| NCT05222529 | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma | RECRUITING | PHASE2 | 2022-08-29 | 2027-08-30 | 2027-07-30 |
| NCT05232864 | Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus Nephritis | TERMINATED | PHASE3 | 2022-08-22 | 2023-08-23 | 2023-08-23 |
| NCT05305664 | A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany | COMPLETED | PHASE3 | 2022-08-19 | 2025-01-28 | 2025-01-28 |
| NCT05206591 | Study to Demonstrate the Efficacy and Safety of Secukinumab up to 224 Weeks in Subjects With Active Peripheral Spondyloarthritis (pSpA). | WITHDRAWN | PHASE3 | 2022-08-16 | 2028-06-12 | 2028-03-20 |
| NCT05268289 | Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V | RECRUITING | PHASE2 | 2022-08-10 | 2028-09-28 | 2025-09-30 |
| NCT04926831 | Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC | TERMINATED | PHASE2 | 2022-08-10 | 2024-03-13 | 2024-03-13 |
| NCT05631795 | Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment | COMPLETED | PHASE4 | 2022-08-09 | 2025-06-12 | 2025-06-12 |
| NCT05349214 | Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-08-04 | 2027-05-12 | 2025-05-13 |
| NCT05350072 | Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-07-28 | 2027-05-06 | 2025-05-07 |
| NCT05124925 | Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments. | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-07-27 | 2026-06-16 | 2024-06-26 |
| NCT05199571 | Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China | COMPLETED | PHASE4 | 2022-07-22 | 2025-02-13 | 2025-02-13 |
| NCT05126277 | Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis | RECRUITING | PHASE3 | 2022-07-14 | 2030-11-05 | 2027-06-22 |
| NCT05142696 | A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab | RECRUITING | PHASE1, PHASE2 | 2022-07-13 | 2029-03-23 | 2029-03-09 |
| NCT05360446 | Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-07-08 | 2026-10-26 | 2026-10-26 |
| NCT05161195 | Roll-over Study to Allow Continued Access to Ribociclib | ACTIVE_NOT_RECRUITING | PHASE4 | 2022-07-07 | 2030-08-14 | 2030-06-28 |
| NCT05415072 | A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-07-04 | 2027-10-01 | 2027-10-01 |
| NCT05135000 | Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension | TERMINATED | PHASE2 | 2022-06-30 | 2024-04-25 | 2024-03-20 |
| NCT05132075 | Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-06-15 | 2026-03-30 | 2026-02-28 |
| NCT05328752 | Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF) | COMPLETED | PHASE1 | 2022-05-17 | 2024-01-18 | 2024-01-18 |
| NCT05155709 | A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy. | TERMINATED | PHASE1 | 2022-05-17 | 2024-04-17 | 2024-04-17 |
| NCT05109728 | A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. | RECRUITING | PHASE1 | 2022-05-10 | 2026-02-25 | 2025-12-31 |
| NCT05329623 | A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants. | COMPLETED | PHASE1 | 2022-05-03 | 2024-04-07 | 2024-04-07 |
| NCT05275855 | First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers | COMPLETED | PHASE1 | 2022-04-29 | 2024-12-18 | 2024-12-18 |
| NCT05330273 | Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz | COMPLETED | PHASE1 | 2022-04-28 | 2022-11-22 | 2022-11-22 |
| NCT05330286 | Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter. | TERMINATED | PHASE1 | 2022-04-13 | 2022-08-19 | 2022-08-19 |
| NCT05192941 | Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia | COMPLETED | PHASE4 | 2022-04-08 | 2025-03-19 | 2024-06-11 |
| NCT05036668 | Study of Efficacy and Safety of ABO809 in Healthy Participants | COMPLETED | PHASE1 | 2022-04-07 | 2022-12-27 | 2022-11-07 |
| NCT04899349 | Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | TERMINATED | PHASE2 | 2022-04-06 | 2023-05-10 | 2023-05-10 |
| NCT04878432 | STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS | TERMINATED | PHASE2 | 2022-03-17 | 2024-09-01 | 2023-10-26 |
| NCT05203419 | Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) | TERMINATED | PHASE1 | 2022-03-15 | 2023-06-04 | 2023-06-04 |
| NCT05269966 | Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) | COMPLETED | PHASE4 | 2022-03-09 | 2023-08-29 | 2023-08-29 |
| NCT05236530 | Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir | COMPLETED | PHASE1 | 2022-03-09 | 2022-10-17 | 2022-10-17 |
| NCT04862143 | Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant | TERMINATED | PHASE2 | 2022-03-08 | 2022-09-19 | 2022-09-19 |
| NCT04675931 | To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria | COMPLETED | PHASE2 | 2022-03-07 | 2025-08-20 | 2025-07-24 |
| NCT05172596 | PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma | TERMINATED | PHASE2 | 2022-03-03 | 2025-05-21 | 2025-05-21 |
| NCT05090371 | A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation | RECRUITING | PHASE4 | 2022-03-02 | 2026-12-31 | 2026-12-31 |
| NCT05230537 | A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-02-17 | 2026-10-02 | 2026-10-01 |
| NCT04230148 | Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). | RECRUITING | PHASE4 | 2022-02-11 | 2026-12-10 | 2026-12-10 |
| NCT05199090 | Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM | TERMINATED | PHASE2 | 2022-02-10 | 2023-05-11 | 2023-05-11 |
| NCT05195892 | Investigate Bioequivalence of Alpelisib Granule and Film-coated Tablet Formulation and the Food Effect of Alpelisib Granule Formulation in Adult Healthy Volunteers | COMPLETED | PHASE1 | 2022-02-03 | 2022-11-09 | 2022-11-09 |
| NCT05089656 | Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA) | COMPLETED | PHASE3 | 2022-02-01 | 2025-04-29 | 2024-11-12 |
| NCT04456023 | Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL) | WITHDRAWN | PHASE2 | 2022-01-31 | 2027-09-27 | 2022-10-31 |
| NCT04980833 | Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1) | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-01-27 | 2027-07-22 | 2027-07-22 |
| NCT05114746 | Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan | RECRUITING | PHASE2 | 2022-01-25 | 2028-01-31 | 2023-12-08 |
| NCT05084638 | Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls. | ACTIVE_NOT_RECRUITING | PHASE4 | 2022-01-25 | 2026-02-16 | 2025-02-04 |
| NCT04903197 | Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma | TERMINATED | PHASE1 | 2022-01-24 | 2025-02-24 | 2025-02-24 |
| NCT04889430 | Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy | RECRUITING | PHASE3 | 2022-01-17 | 2029-03-29 | 2028-09-19 |
| NCT05048342 | A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines | COMPLETED | PHASE3 | 2022-01-15 | 2023-12-09 | 2023-12-08 |
| NCT04925479 | Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia | RECRUITING | PHASE1, PHASE2 | 2021-12-27 | 2031-11-01 | 2026-06-30 |
| NCT05086744 | Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders | TERMINATED | PHASE2 | 2021-12-21 | 2024-05-17 | 2023-09-20 |
| NCT05038735 | Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor. | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-12-17 | 2026-10-15 | 2026-09-15 |
| NCT05147220 | Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) | RECRUITING | PHASE3 | 2021-12-16 | 2030-10-30 | 2026-04-30 |
| NCT05156281 | Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) | RECRUITING | PHASE3 | 2021-12-13 | 2030-10-30 | 2026-04-30 |
| NCT04993157 | Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment | COMPLETED | PHASE1 | 2021-12-10 | 2022-06-28 | 2022-06-28 |
| NCT05111249 | A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam in Early Manifest Huntington's Disease | TERMINATED | PHASE2 | 2021-12-08 | 2023-10-27 | 2023-10-27 |
| NCT04984876 | Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy | TERMINATED | PHASE3 | 2021-12-07 | 2023-11-27 | 2023-11-27 |
| NCT04795427 | Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors | COMPLETED | PHASE2 | 2021-12-06 | 2024-11-18 | 2023-05-29 |
| NCT05032157 | A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines | COMPLETED | PHASE3 | 2021-12-01 | 2024-01-05 | 2023-12-18 |
| NCT04895748 | DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies | ACTIVE_NOT_RECRUITING | PHASE1 | 2021-11-30 | 2026-03-06 | 2026-03-06 |
| NCT05030311 | A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines | COMPLETED | PHASE3 | 2021-11-30 | 2024-01-19 | 2023-12-27 |
| NCT04988087 | A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD) | TERMINATED | PHASE2 | 2021-11-30 | 2023-03-07 | 2023-02-07 |
| NCT04156659 | Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL | WITHDRAWN | PHASE2 | 2021-11-30 | 2027-11-30 | 2022-11-30 |
| NCT04737330 | A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED) | TERMINATED | PHASE3 | 2021-11-29 | 2023-05-16 | 2023-05-16 |
| NCT05030428 | Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-11-23 | 2027-10-13 | 2027-10-13 |
| NCT05026996 | Study to Assess the Pharmacokinetics of Pelacarsen (TQJ230) in Participants With Mild Hepatic Impairment Compared to Matched Healthy Participants | COMPLETED | PHASE1 | 2021-11-23 | 2022-10-19 | 2022-10-19 |
| NCT05084651 | Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazole | COMPLETED | PHASE1 | 2021-11-18 | 2022-05-14 | 2022-05-13 |
| NCT05024058 | Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines | TERMINATED | PHASE3 | 2021-11-16 | 2022-08-09 | 2022-08-09 |
| NCT04940052 | Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-11-15 | 2027-06-04 | 2025-01-22 |
| NCT04952753 | Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC | TERMINATED | PHASE2 | 2021-11-15 | 2025-01-20 | 2025-01-20 |
| NCT05078580 | Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function. | COMPLETED | PHASE1 | 2021-11-10 | 2022-06-20 | 2022-06-20 |
| NCT05073133 | Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (OFELIA) | COMPLETED | PHASE4 | 2021-11-04 | 2023-08-08 | 2023-08-08 |
| NCT04795466 | Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease | TERMINATED | PHASE2 | 2021-10-28 | 2024-03-07 | 2024-03-07 |
| NCT04857372 | A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 | 2021-10-21 | 2026-09-04 | 2026-09-04 |
| NCT04774926 | Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab. | COMPLETED | PHASE4 | 2021-10-15 | 2023-10-04 | 2023-10-04 |
| NCT04712721 | Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. | TERMINATED | EARLY_PHASE1 | 2021-10-14 | 2024-07-01 | 2024-06-18 |
| NCT04948333 | Asciminib Treatment Optimization in ≥ 3rd Line CML-CP | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-10-13 | 2026-02-03 | 2024-03-12 |
| NCT04930094 | Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-10-06 | 2027-07-05 | 2025-04-11 |
| NCT04971226 | A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-10-06 | 2031-01-18 | 2023-11-28 |
| NCT04926818 | Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-10-05 | 2031-11-19 | 2027-03-02 |
| NCT04838613 | Study of Diagnostic Performance of [18F]CTT1057 in BCR | COMPLETED | PHASE3 | 2021-09-30 | 2023-11-23 | 2023-11-23 |
| NCT04935359 | Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2 | COMPLETED | PHASE3 | 2021-09-30 | 2024-08-13 | 2024-08-13 |
| NCT04882124 | Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD | COMPLETED | PHASE2 | 2021-09-24 | 2022-09-15 | 2022-09-15 |
| NCT04816214 | Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy | TERMINATED | PHASE3 | 2021-09-22 | 2022-12-27 | 2022-12-27 |
| NCT04557462 | A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy | RECRUITING | PHASE3 | 2021-09-20 | 2032-11-11 | 2032-11-11 |
| NCT04886258 | Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis | COMPLETED | PHASE2 | 2021-09-20 | 2024-12-23 | 2024-12-14 |
| NCT04868968 | Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS) | COMPLETED | PHASE2 | 2021-09-20 | 2023-05-05 | 2022-12-13 |
| NCT04623216 | Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation. | TERMINATED | PHASE1, PHASE2 | 2021-09-14 | 2024-08-22 | 2024-08-22 |
| NCT04851873 | Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) | COMPLETED | PHASE3 | 2021-09-08 | 2023-06-13 | 2023-06-13 |
| NCT04946318 | Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma | TERMINATED | PHASE2 | 2021-09-08 | 2022-09-08 | 2022-09-08 |
| NCT04838626 | Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection | COMPLETED | PHASE2, PHASE3 | 2021-09-07 | 2023-11-24 | 2023-11-24 |
| NCT05067140 | A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2021-09-02 | 2027-05-25 | 2027-05-25 |
| NCT04814368 | A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA) | TERMINATED | PHASE2 | 2021-08-27 | 2024-06-24 | 2024-06-24 |
| NCT04939610 | A Study of 177Lu-FAP-2286 in Advanced Solid Tumors | RECRUITING | PHASE1, PHASE2 | 2021-07-30 | 2028-06-30 | 2026-06-30 |
| NCT04817618 | Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. | RECRUITING | PHASE3 | 2021-07-28 | 2026-07-04 | 2026-03-27 |
| NCT04747613 | Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-07-27 | 2027-10-19 | 2027-10-19 |
| NCT04788615 | Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-07-23 | 2026-02-13 | 2025-11-11 |
| NCT04729387 | Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-07-22 | 2025-12-06 | 2023-04-21 |
| NCT04732117 | Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis | COMPLETED | PHASE3 | 2021-07-21 | 2025-02-14 | 2024-04-03 |
| NCT04771143 | Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056 | WITHDRAWN | PHASE1 | 2021-07-21 | 2022-01-03 | 2022-01-03 |
| NCT04722666 | Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent | TERMINATED | PHASE2 | 2021-07-20 | 2023-09-26 | 2023-09-26 |
| NCT04820530 | Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy | COMPLETED | PHASE3 | 2021-07-19 | 2023-04-18 | 2022-11-02 |
| NCT04662931 | An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients | COMPLETED | PHASE4 | 2021-07-14 | 2024-02-14 | 2024-02-14 |
| NCT04679935 | Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration | COMPLETED | PHASE4 | 2021-07-13 | 2024-01-31 | 2024-01-31 |
| NCT04807400 | Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support | COMPLETED | PHASE3 | 2021-07-07 | 2023-01-13 | 2023-01-13 |
| NCT04806503 | A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia. | TERMINATED | PHASE2 | 2021-06-30 | 2022-10-14 | 2022-07-27 |
| NCT04784390 | Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia | TERMINATED | PHASE1 | 2021-06-30 | 2022-08-03 | 2022-08-03 |
| NCT04929249 | A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) | COMPLETED | PHASE3 | 2021-06-25 | 2023-09-15 | 2023-09-15 |
| NCT04873934 | Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome | COMPLETED | PHASE3 | 2021-06-24 | 2024-08-07 | 2024-08-07 |
| NCT04711902 | Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo. | COMPLETED | PHASE3 | 2021-06-24 | 2023-03-10 | 2022-06-02 |
| NCT04702425 | VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) | TERMINATED | PHASE1 | 2021-06-23 | 2024-07-23 | 2024-07-23 |
| NCT04810611 | Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS | TERMINATED | PHASE1 | 2021-06-18 | 2024-04-19 | 2024-04-19 |
| NCT04689828 | 177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-06-15 | 2026-09-30 | 2022-10-02 |
| NCT04657822 | Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study | RECRUITING | PHASE4 | 2021-06-10 | 2031-06-10 | 2031-06-10 |
| NCT04878211 | A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab | TERMINATED | PHASE4 | 2021-06-10 | 2023-04-14 | 2023-04-14 |
| NCT04720157 | An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-06-09 | 2027-02-11 | 2025-01-13 |
| NCT04589663 | Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma | COMPLETED | PHASE2 | 2021-06-07 | 2022-04-11 | 2022-04-11 |
| NCT04812548 | A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants | TERMINATED | PHASE2 | 2021-05-31 | 2023-05-08 | 2023-05-08 |
| NCT04864392 | Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis | TERMINATED | PHASE2 | 2021-05-31 | 2025-05-29 | 2024-09-29 |
| NCT04697953 | Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE) | WITHDRAWN | PHASE3 | 2021-05-31 | 2025-05-31 | 2021-06-21 |
| NCT04869358 | Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab | COMPLETED | PHASE4 | 2021-05-27 | 2023-06-13 | 2022-05-10 |
| NCT04637555 | Open-label Extension Study for CLCZ696G2301 (PARADISE-MI) | WITHDRAWN | PHASE3 | 2021-05-26 | 2023-06-01 | 2023-06-01 |
| NCT04797000 | Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence | ACTIVE_NOT_RECRUITING | PHASE2 | 2021-05-25 | 2026-12-09 | 2025-04-26 |
| NCT04666259 | Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation | COMPLETED | PHASE3 | 2021-05-25 | 2024-06-26 | 2023-06-20 |
| NCT04677595 | Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation | COMPLETED | PHASE2 | 2021-05-17 | 2025-05-22 | 2023-10-12 |
| NCT04896632 | Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants | TERMINATED | PHASE1 | 2021-05-13 | 2022-11-24 | 2022-11-24 |
| NCT04828161 | A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 | TERMINATED | PHASE2, PHASE3 | 2021-05-10 | 2022-01-27 | 2021-11-18 |
| NCT04630158 | Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP) | COMPLETED | PHASE2 | 2021-04-21 | 2023-06-08 | 2023-06-07 |
| NCT04836858 | A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis. | COMPLETED | PHASE2 | 2021-04-20 | 2022-12-13 | 2022-07-14 |
| NCT04589650 | Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum | ACTIVE_NOT_RECRUITING | PHASE2 | 2021-04-19 | 2031-02-28 | 2024-03-20 |
| NCT04792567 | Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) | COMPLETED | PHASE4 | 2021-04-19 | 2022-08-15 | 2021-09-06 |
| NCT04717635 | Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD | COMPLETED | PHASE3 | 2021-03-30 | 2025-04-16 | 2025-04-16 |
| NCT04573920 | Atrasentan in Patients With Proteinuric Glomerular Diseases | ACTIVE_NOT_RECRUITING | PHASE2 | 2021-03-15 | 2026-10-27 | 2024-07-02 |
| NCT04765657 | Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C) | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-03-01 | 2026-12-28 | 2022-06-09 |
| NCT04774003 | Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C | COMPLETED | PHASE1 | 2021-02-26 | 2021-10-18 | 2021-10-18 |
| NCT04699188 | Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2021-02-24 | 2026-08-26 | 2026-08-26 |
| NCT04667949 | Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients | COMPLETED | PHASE4 | 2021-02-20 | 2025-03-25 | 2025-03-25 |
| NCT04539041 | Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy | COMPLETED | PHASE1 | 2021-02-16 | 2024-10-17 | 2024-10-17 |
| NCT04659863 | Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia | COMPLETED | PHASE3 | 2021-02-16 | 2024-11-18 | 2023-10-30 |
| NCT04546633 | Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria | COMPLETED | PHASE2 | 2021-02-16 | 2024-08-28 | 2024-08-13 |
| NCT04396366 | Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis | TERMINATED | PHASE2 | 2021-02-02 | 2023-06-21 | 2023-06-15 |
| NCT04079231 | Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema | WITHDRAWN | PHASE3 | 2021-02-01 | 2023-01-31 | 2023-01-31 |
| NCT04666298 | Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C | COMPLETED | PHASE2 | 2021-01-29 | 2022-10-19 | 2022-04-18 |
| NCT04652726 | Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia | COMPLETED | PHASE3 | 2021-01-27 | 2024-11-27 | 2023-11-09 |
| NCT04239027 | A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration | COMPLETED | PHASE3 | 2021-01-26 | 2023-02-02 | 2022-05-23 |
| NCT04578834 | Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients | COMPLETED | PHASE3 | 2021-01-25 | 2025-09-19 | 2025-09-19 |
| NCT04558918 | Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment | COMPLETED | PHASE3 | 2021-01-25 | 2023-03-06 | 2022-09-26 |
| NCT04544189 | Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE2 | 2021-01-20 | 2026-03-02 | 2026-03-02 |
| NCT04667117 | A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab | COMPLETED | PHASE4 | 2021-01-14 | 2023-07-06 | 2023-07-06 |
| NCT04524000 | Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE2 | 2021-01-08 | 2026-07-31 | 2026-06-30 |
| NCT04541589 | Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome | COMPLETED | PHASE2 | 2021-01-05 | 2024-08-19 | 2024-08-19 |
| NCT04638647 | Secukinumab Open Label Roll-over Extension Protocol | RECRUITING | PHASE4 | 2020-12-22 | 2030-04-04 | 2030-01-29 |
| NCT04300309 | Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria | TERMINATED | PHASE2, PHASE3 | 2020-12-21 | 2024-05-10 | 2023-07-02 |
| NCT04632927 | Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment | COMPLETED | PHASE3 | 2020-12-21 | 2024-10-22 | 2024-10-22 |
| NCT04641442 | Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations | ACTIVE_NOT_RECRUITING | PHASE2 | 2020-12-18 | 2027-11-14 | 2025-10-03 |
| NCT04597632 | An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study | COMPLETED | PHASE3 | 2020-12-16 | 2023-03-28 | 2023-03-28 |
| NCT04264819 | Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration | COMPLETED | PHASE3 | 2020-12-14 | 2023-05-10 | 2022-10-05 |
| NCT04635800 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients | COMPLETED | PHASE1 | 2020-12-10 | 2022-05-24 | 2022-05-24 |
| NCT04582409 | A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation | TERMINATED | PHASE2 | 2020-11-30 | 2022-07-11 | 2022-07-11 |
| NCT04283526 | Study of Select Combinations in Adults With Myelofibrosis | WITHDRAWN | PHASE1 | 2020-11-30 | 2024-04-11 | 2024-04-11 |
| NCT04516369 | Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-11-24 | 2026-06-22 | 2022-04-05 |
| NCT04278417 | Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy | COMPLETED | PHASE3 | 2020-11-19 | 2024-08-19 | 2023-10-30 |
| NCT04491136 | Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM) | TERMINATED | PHASE4 | 2020-11-11 | 2023-06-08 | 2023-06-08 |
| NCT04460729 | A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases | WITHDRAWN | PHASE2 | 2020-11-11 | 2023-11-17 | 2023-11-17 |
| NCT04328727 | Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia | COMPLETED | PHASE2 | 2020-11-04 | 2024-12-06 | 2022-06-10 |
| NCT04488185 | An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound | WITHDRAWN | PHASE4 | 2020-11-02 | 2021-03-24 | 2021-03-24 |
| NCT04417621 | Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma | ACTIVE_NOT_RECRUITING | PHASE2 | 2020-10-30 | 2025-10-30 | 2025-10-29 |
| NCT04587622 | Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment | COMPLETED | PHASE1 | 2020-10-30 | 2022-09-15 | 2022-09-15 |
| NCT04486716 | A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 | 2020-10-19 | 2024-10-21 | 2023-11-20 |
| NCT04225676 | Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL) | TERMINATED | PHASE2 | 2020-10-19 | 2021-10-19 | 2021-10-19 |
| NCT04390763 | Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | TERMINATED | PHASE2 | 2020-10-16 | 2024-05-02 | 2024-04-26 |
| NCT04480853 | Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis | RECRUITING | PHASE4 | 2020-10-12 | 2026-01-27 | 2026-01-27 |
| NCT04346654 | A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP | COMPLETED | PHASE2 | 2020-10-09 | 2023-09-22 | 2023-09-22 |
| NCT04391894 | A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease | COMPLETED | PHASE2 | 2020-10-06 | 2021-05-13 | 2021-05-13 |
| NCT04427072 | Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation | TERMINATED | PHASE3 | 2020-09-25 | 2023-11-06 | 2023-02-15 |
| NCT04064242 | Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis | COMPLETED | PHASE2 | 2020-09-23 | 2023-12-12 | 2023-09-19 |
| NCT04564053 | Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants | COMPLETED | PHASE1 | 2020-09-23 | 2020-12-10 | 2020-12-10 |
| NCT04268823 | Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | TERMINATED | PHASE2 | 2020-09-10 | 2022-09-20 | 2022-09-13 |
| NCT04410523 | Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma | TERMINATED | PHASE2 | 2020-09-09 | 2022-09-06 | 2022-07-12 |
| NCT04240704 | Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL | TERMINATED | PHASE1 | 2020-09-07 | 2024-09-05 | 2024-09-05 |
| NCT04150029 | A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy | TERMINATED | PHASE2 | 2020-09-01 | 2024-10-25 | 2024-10-25 |
| NCT04443907 | Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD) | TERMINATED | PHASE1 | 2020-08-25 | 2025-01-06 | 2025-01-06 |
| NCT04452877 | A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC | COMPLETED | PHASE2 | 2020-08-19 | 2024-11-07 | 2024-11-07 |
| NCT04323436 | Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations | TERMINATED | PHASE2 | 2020-08-19 | 2023-01-26 | 2022-12-14 |
| NCT04513548 | Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria | TERMINATED | PHASE1 | 2020-08-05 | 2022-07-19 | 2022-07-19 |
| NCT06558097 | Safety, Tolerability, and Pharmacokinetics of XXB750 in Healthy Participants | COMPLETED | PHASE1 | 2020-07-29 | 2023-03-31 | 2023-03-02 |
| NCT04300296 | PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus | COMPLETED | PHASE2 | 2020-07-27 | 2022-05-03 | 2021-11-16 |
| NCT04318327 | BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma | TERMINATED | PHASE1 | 2020-07-23 | 2025-04-29 | 2025-04-29 |
| NCT04294160 | A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer | TERMINATED | PHASE1 | 2020-07-22 | 2024-09-25 | 2024-09-25 |
| NCT04321252 | Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects | COMPLETED | PHASE1 | 2020-07-22 | 2020-11-10 | 2020-11-10 |
| NCT04097379 | Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA | COMPLETED | PHASE2 | 2020-07-20 | 2025-01-17 | 2024-08-08 |
| NCT04208178 | Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-07-16 | 2026-06-16 | 2026-06-16 |
| NCT04353492 | An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab | COMPLETED | PHASE3 | 2020-07-14 | 2025-03-11 | 2024-10-09 |
| NCT04181762 | Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis | TERMINATED | PHASE3 | 2020-07-07 | 2023-09-13 | 2023-09-13 |
| NCT04382651 | Study of Efficacy and Safety of MAS825 in Patients With COVID-19 | COMPLETED | PHASE2 | 2020-06-11 | 2021-04-21 | 2021-01-06 |
| NCT04251533 | Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-06-08 | 2025-10-14 | 2023-05-31 |
| NCT04266301 | Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) | TERMINATED | PHASE3 | 2020-06-08 | 2024-10-02 | 2024-10-02 |
| NCT03628053 | Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia | WITHDRAWN | PHASE3 | 2020-06-05 | 2026-01-07 | 2025-10-08 |
| NCT04147195 | Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) | TERMINATED | PHASE2 | 2020-06-04 | 2022-01-06 | 2022-01-06 |
| NCT04408937 | The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor. | COMPLETED | PHASE1 | 2020-05-29 | 2020-11-04 | 2020-11-04 |
| NCT04382053 | Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia | COMPLETED | PHASE2 | 2020-05-27 | 2020-12-24 | 2020-12-10 |
| NCT03774082 | Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant | COMPLETED | PHASE2 | 2020-05-20 | 2024-08-26 | 2022-02-25 |
| NCT04362137 | Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm | COMPLETED | PHASE3 | 2020-05-02 | 2020-10-17 | 2020-10-17 |
| NCT04358081 | Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease | COMPLETED | PHASE3 | 2020-05-01 | 2020-07-27 | 2020-07-27 |
| NCT04362813 | Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia | COMPLETED | PHASE3 | 2020-04-30 | 2020-12-22 | 2020-09-16 |
| NCT04210843 | Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab | TERMINATED | PHASE3 | 2020-04-08 | 2022-09-01 | 2022-09-01 |
| NCT04179175 | Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-03-18 | 2026-07-15 | 2023-05-26 |
| NCT04261439 | A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab | TERMINATED | PHASE1 | 2020-02-27 | 2023-12-27 | 2023-12-27 |
| NCT04612062 | A First-in-Human Study of CEE321 in Adult Subjects | COMPLETED | PHASE1 | 2020-02-27 | 2021-05-16 | 2021-05-16 |
| NCT04237649 | KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors | TERMINATED | EARLY_PHASE1 | 2020-02-20 | 2023-09-15 | 2023-09-15 |
| NCT04237116 | A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD) | TERMINATED | PHASE3 | 2020-02-19 | 2021-07-23 | 2021-06-29 |
| NCT04042025 | Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi | ACTIVE_NOT_RECRUITING | PHASE3 | 2020-02-10 | 2035-12-31 | 2035-12-31 |
| NCT04074590 | Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis | TERMINATED | PHASE2 | 2020-02-03 | 2022-11-07 | 2022-11-07 |
| NCT04143919 | Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE) | COMPLETED | NA | 2020-01-31 | 2021-06-11 | 2021-06-07 |
| NCT04209205 | Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis | COMPLETED | PHASE3 | 2020-01-29 | 2022-05-17 | 2022-05-17 |
| NCT04139317 | Safety and Efficacy of Capmatinib (INC280) Plus Pembrolizumab vs Pembrolizumab Alone in NSCLC With PD-L1≥ 50% | TERMINATED | PHASE2 | 2020-01-22 | 2023-02-07 | 2022-01-14 |
| NCT04164732 | Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy | COMPLETED | PHASE2 | 2020-01-08 | 2023-08-22 | 2023-08-22 |
| NCT04066244 | Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients | TERMINATED | PHASE2 | 2019-12-30 | 2024-02-01 | 2024-02-01 |
| NCT04065841 | Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. | TERMINATED | PHASE2 | 2019-12-30 | 2022-10-27 | 2022-10-27 |
| NCT04023552 | Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD | ACTIVE_NOT_RECRUITING | PHASE3 | 2019-12-12 | 2026-02-26 | 2026-02-26 |
| NCT04156620 | Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA | COMPLETED | PHASE3 | 2019-12-11 | 2022-12-20 | 2022-02-17 |
| NCT04023227 | Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC | COMPLETED | PHASE4 | 2019-12-10 | 2025-03-31 | 2025-03-16 |
| NCT04053764 | Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease | COMPLETED | PHASE2 | 2019-12-10 | 2023-03-20 | 2023-03-20 |
| NCT03988608 | Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects. | COMPLETED | PHASE2 | 2019-12-09 | 2023-05-17 | 2021-07-16 |
| NCT04123418 | A Study of WVT078 in Patients With Multiple Myeloma (MM) | TERMINATED | PHASE1 | 2019-12-05 | 2024-12-02 | 2024-12-02 |
| NCT04047472 | Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration | COMPLETED | PHASE3 | 2019-11-29 | 2024-02-28 | 2024-02-28 |
| NCT04154787 | Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy | TERMINATED | PHASE2 | 2019-11-23 | 2023-01-20 | 2023-01-20 |
| NCT04094311 | Study of Out of Specification for Tisagenlecleucel | RECRUITING | PHASE3 | 2019-11-21 | 2026-03-31 | 2026-03-31 |
| NCT03760445 | HDM201 Added to CT in R/R or Newly Diagnosed AML | WITHDRAWN | PHASE1, PHASE2 | 2019-11-15 | 2023-06-13 | 2021-07-22 |
| NCT04129528 | Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects | COMPLETED | PHASE2 | 2019-11-08 | 2024-06-04 | 2024-01-15 |
| NCT03968419 | This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. | TERMINATED | PHASE2 | 2019-11-05 | 2022-08-15 | 2022-04-20 |
| NCT03975829 | Pediatric Long-Term Follow-up and Rollover Study | ACTIVE_NOT_RECRUITING | PHASE4 | 2019-11-04 | 2026-07-23 | 2026-06-23 |
| NCT04058756 | Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments | ACTIVE_NOT_RECRUITING | PHASE1 | 2019-10-30 | 2030-04-30 | 2030-04-30 |
| NCT04114630 | Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab | WITHDRAWN | PHASE3 | 2019-10-30 | 2022-01-07 | 2021-12-06 |
| NCT04109313 | An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU | COMPLETED | PHASE2 | 2019-10-24 | 2022-09-09 | 2022-09-09 |
| NCT03938454 | A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism | COMPLETED | PHASE2 | 2019-10-16 | 2023-11-29 | 2023-03-28 |
| NCT03989635 | Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. | WITHDRAWN | PHASE2 | 2019-10-15 | 2021-06-14 | 2021-06-14 |
| NCT03781414 | Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension | TERMINATED | PHASE2 | 2019-10-07 | 2023-04-20 | 2023-04-20 |
| NCT03955445 | Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN | RECRUITING | PHASE3 | 2019-10-03 | 2036-05-30 | 2036-05-30 |
| NCT03905525 | Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome | COMPLETED | PHASE2 | 2019-10-01 | 2023-06-06 | 2022-09-28 |
| NCT04084314 | Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study | COMPLETED | PHASE4 | 2019-09-30 | 2023-03-13 | 2023-02-23 |
| NCT04097821 | Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients | TERMINATED | PHASE1, PHASE2 | 2019-09-26 | 2024-08-28 | 2023-05-03 |
| NCT04005352 | Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) | COMPLETED | PHASE3 | 2019-09-25 | 2022-09-09 | 2022-09-09 |
| NCT04104776 | A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas | RECRUITING | PHASE1, PHASE2 | 2019-09-18 | 2030-02-27 | 2030-02-27 |
| NCT04072887 | Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients | COMPLETED | PHASE2 | 2019-09-12 | 2022-02-01 | 2021-10-08 |
| NCT03867201 | Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients | COMPLETED | PHASE3 | 2019-08-26 | 2024-04-30 | 2021-08-11 |
| NCT04058067 | To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema | COMPLETED | PHASE3 | 2019-08-23 | 2023-01-31 | 2023-01-31 |
| NCT04000529 | Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies | TERMINATED | PHASE1 | 2019-07-30 | 2024-01-15 | 2024-01-15 |
| NCT03977649 | A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients | COMPLETED | PHASE4 | 2019-07-30 | 2021-07-05 | 2021-07-05 |
| NCT03814746 | Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients | ACTIVE_NOT_RECRUITING | PHASE3 | 2019-07-26 | 2026-12-14 | 2022-08-31 |
| NCT03944707 | Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients | TERMINATED | PHASE2 | 2019-07-18 | 2020-04-27 | 2020-04-27 |
| NCT03917472 | Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema | COMPLETED | PHASE3 | 2019-07-17 | 2021-03-24 | 2021-03-24 |
| NCT04035668 | A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome | TERMINATED | PHASE2 | 2019-07-12 | 2021-11-23 | 2021-11-23 |
| NCT03810313 | Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion | TERMINATED | PHASE3 | 2019-07-03 | 2021-07-26 | 2021-07-26 |
| NCT03802630 | Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion | TERMINATED | PHASE3 | 2019-07-02 | 2021-07-26 | 2021-07-26 |
| NCT03988634 | Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) | COMPLETED | PHASE3 | 2019-06-29 | 2022-12-14 | 2022-12-14 |
| NCT03960840 | Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2019-06-26 | 2028-05-31 | 2027-06-30 |
| NCT03876769 | Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-06-24 | 2027-10-19 | 2025-08-20 |
| NCT03940352 | HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) | TERMINATED | PHASE1 | 2019-06-24 | 2024-08-20 | 2024-08-20 |
| NCT03822468 | Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer | COMPLETED | PHASE2 | 2019-06-11 | 2024-08-30 | 2021-06-11 |
| NCT03876028 | Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients | TERMINATED | PHASE1 | 2019-06-11 | 2021-11-01 | 2021-11-01 |
| NCT03769168 | An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA) | COMPLETED | PHASE3 | 2019-06-07 | 2024-11-07 | 2024-11-07 |
| NCT04665154 | A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers | COMPLETED | PHASE1 | 2019-06-07 | 2022-08-03 | 2022-08-03 |
| NCT03954626 | Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD | COMPLETED | PHASE3 | 2019-06-07 | 2019-07-31 | 2019-07-09 |
| NCT03926611 | This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines | COMPLETED | PHASE2 | 2019-06-06 | 2021-04-15 | 2021-01-14 |
| NCT03906136 | AScalate: Treat-to-target in Axial Spondyloarthritis | COMPLETED | PHASE3 | 2019-06-04 | 2022-09-22 | 2022-02-04 |
| NCT03946670 | A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS). | TERMINATED | PHASE2 | 2019-06-04 | 2024-07-15 | 2022-04-26 |
| NCT03837184 | Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies | COMPLETED | PHASE3 | 2019-05-31 | 2021-06-29 | 2021-06-29 |
| NCT03927690 | Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema | COMPLETED | PHASE2 | 2019-05-24 | 2022-08-31 | 2022-06-17 |
| NCT03930641 | Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration | COMPLETED | PHASE3 | 2019-05-23 | 2019-07-02 | 2019-07-02 |
| NCT03798626 | Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers | COMPLETED | PHASE1 | 2019-05-22 | 2025-02-05 | 2023-03-01 |
| NCT03810183 | A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With Eosinophilia | TERMINATED | PHASE2 | 2019-05-21 | 2020-01-16 | 2020-01-16 |
| NCT03570892 | Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma | ACTIVE_NOT_RECRUITING | PHASE3 | 2019-05-07 | 2026-02-11 | 2021-05-06 |
| NCT03891953 | Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. | ACTIVE_NOT_RECRUITING | PHASE1 | 2019-05-07 | 2025-12-31 | 2025-12-31 |
| NCT03909295 | An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan. | TERMINATED | PHASE3 | 2019-05-07 | 2019-11-19 | 2019-11-19 |
| NCT03785405 | Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF | COMPLETED | PHASE3 | 2019-05-02 | 2023-12-29 | 2023-12-29 |
| NCT03650400 | Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma | TERMINATED | PHASE2 | 2019-05-01 | 2020-01-22 | 2019-12-16 |
| NCT03809611 | A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia. | COMPLETED | PHASE2 | 2019-04-26 | 2019-12-16 | 2019-12-16 |
| NCT03917459 | COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure | COMPLETED | PHASE3 | 2019-04-16 | 2021-05-25 | 2021-05-25 |
| NCT03814187 | Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C | COMPLETED | PHASE3 | 2019-04-16 | 2023-02-13 | 2023-02-13 |
| NCT03907878 | A Safety and Efficacy Study of Ligelizumab in the Treatment of CSU in Japanese Patients Inadequately Controlled With H1- Antihistamines | COMPLETED | PHASE3 | 2019-04-13 | 2022-01-26 | 2022-01-26 |
| NCT03945318 | Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN) | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2019-04-08 | 2026-04-13 | 2025-10-01 |
| NCT03896152 | Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Study, Assessing Multiple LNP023 Doses in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria | COMPLETED | PHASE2 | 2019-04-05 | 2022-02-09 | 2020-04-07 |
| NCT03948334 | A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients | TERMINATED | PHASE2 | 2019-04-04 | 2020-08-25 | 2020-07-23 |
| NCT03681093 | Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma | COMPLETED | PHASE3 | 2019-03-26 | 2020-06-10 | 2020-05-29 |
| NCT03874858 | De-escalation and TFR Study in CML Patients Treated With Nilotinib Followed by a Second Attempt After Nilotinib and Asciminib Combination | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-03-22 | 2026-12-31 | 2026-11-30 |
| NCT03591510 | A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-03-13 | 2030-10-31 | 2027-05-03 |
| NCT03827798 | Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-02-27 | 2026-12-11 | 2024-12-04 |
| NCT03839823 | Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer | COMPLETED | PHASE2 | 2019-02-25 | 2023-05-10 | 2022-04-12 |
| NCT03713632 | Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) | COMPLETED | PHASE3 | 2019-02-25 | 2022-07-19 | 2021-09-23 |
| NCT03828539 | Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine | COMPLETED | PHASE4 | 2019-02-22 | 2020-07-29 | 2020-07-29 |
| NCT03491215 | Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease | COMPLETED | PHASE1, PHASE2 | 2019-02-21 | 2023-02-02 | 2021-03-11 |
| NCT03832114 | Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted | COMPLETED | PHASE2 | 2019-02-20 | 2021-04-23 | 2021-04-23 |
| NCT03610724 | Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients | COMPLETED | PHASE2 | 2019-02-15 | 2023-04-26 | 2021-07-27 |
| NCT03623243 | Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients | COMPLETED | PHASE3 | 2019-02-14 | 2022-07-06 | 2022-07-06 |
| NCT03756129 | Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression | COMPLETED | PHASE2 | 2019-02-08 | 2020-03-23 | 2020-03-23 |
| NCT03851705 | A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) | COMPLETED | PHASE3 | 2019-02-06 | 2021-09-09 | 2020-03-02 |
| NCT03742349 | Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC). | TERMINATED | PHASE1 | 2019-01-31 | 2023-02-06 | 2023-02-06 |
| NCT03713619 | This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). | COMPLETED | PHASE3 | 2019-01-31 | 2022-07-26 | 2021-10-01 |
| NCT03765788 | A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis | COMPLETED | PHASE2 | 2019-01-30 | 2021-06-08 | 2021-06-08 |
| NCT03626545 | Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy | TERMINATED | PHASE3 | 2019-01-23 | 2021-12-20 | 2021-01-08 |
| NCT03553823 | Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab | COMPLETED | PHASE2 | 2019-01-14 | 2020-01-28 | 2020-01-28 |
| NCT02989402 | A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type. | COMPLETED | PHASE4 | 2018-12-31 | 2022-12-08 | 2022-12-07 |
| NCT03650114 | Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS | ACTIVE_NOT_RECRUITING | PHASE3 | 2018-12-28 | 2028-09-30 | 2027-12-30 |
| NCT03696771 | Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced Cancer | COMPLETED | PHASE1 | 2018-12-27 | 2020-10-19 | 2020-10-19 |
| NCT03647488 | Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer | COMPLETED | PHASE2 | 2018-12-26 | 2020-09-07 | 2020-09-07 |
| NCT03631199 | Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects | ACTIVE_NOT_RECRUITING | PHASE3 | 2018-12-21 | 2027-06-07 | 2021-08-09 |
| NCT03656562 | Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients | COMPLETED | PHASE2 | 2018-12-19 | 2025-04-28 | 2022-07-27 |
| NCT03574545 | Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis | COMPLETED | PHASE1 | 2018-12-19 | 2024-07-18 | 2024-07-18 |
| NCT03589885 | Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis | COMPLETED | PHASE3 | 2018-12-19 | 2020-08-05 | 2019-11-19 |
| NCT03718533 | Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function | TERMINATED | PHASE2 | 2018-12-17 | 2020-11-03 | 2020-11-03 |
| NCT03804879 | Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy | COMPLETED | PHASE2 | 2018-12-17 | 2021-05-03 | 2021-05-03 |
| NCT03629249 | Systemic Corticosteroids Avoidance Study in Severe Asthma Patients | TERMINATED | PHASE3 | 2018-12-13 | 2020-02-06 | 2020-02-06 |
| NCT03751280 | Study of Efficacy of PEAR-004 in Schizophrenia | COMPLETED | PHASE2 | 2018-12-10 | 2019-09-26 | 2019-09-26 |
| NCT03701334 | A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 | 2018-12-07 | 2026-05-29 | 2026-05-29 |
| NCT03663335 | Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients | COMPLETED | PHASE2 | 2018-11-28 | 2021-10-29 | 2021-10-29 |
| NCT03887520 | Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) | COMPLETED | NA | 2018-11-27 | 2021-07-30 | 2021-07-30 |
| NCT03578367 | Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) | COMPLETED | PHASE2 | 2018-11-22 | 2025-02-28 | 2021-11-08 |
| NCT03605277 | Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers | COMPLETED | PHASE1 | 2018-11-16 | 2019-04-14 | 2019-03-18 |
| NCT03517566 | A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis | TERMINATED | PHASE2 | 2018-11-14 | 2020-08-06 | 2020-07-15 |
| NCT03568461 | Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma | COMPLETED | PHASE2 | 2018-11-12 | 2025-05-28 | 2020-11-24 |
| NCT03525834 | Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. | COMPLETED | PHASE4 | 2018-11-09 | 2020-09-25 | 2020-09-25 |
| NCT03524612 | A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP | COMPLETED | PHASE2 | 2018-11-02 | 2022-10-03 | 2021-10-22 |
| NCT03710564 | Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections | TERMINATED | PHASE3 | 2018-10-30 | 2021-07-01 | 2020-12-21 |
| NCT03369912 | A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection | WITHDRAWN | PHASE2 | 2018-10-23 | 2022-11-15 | 2022-11-15 |
| NCT03580356 | A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. | COMPLETED | PHASE3 | 2018-10-20 | 2022-06-14 | 2021-06-22 |
| NCT03377426 | LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI) | WITHDRAWN | PHASE2 | 2018-10-19 | 2019-10-28 | 2019-10-28 |
| NCT03580369 | A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines | COMPLETED | PHASE3 | 2018-10-17 | 2022-06-14 | 2021-07-16 |
| NCT03398434 | Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation | WITHDRAWN | PHASE2 | 2018-10-16 | 2020-01-30 | 2019-11-28 |
| NCT03456999 | Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients | WITHDRAWN | PHASE2 | 2018-10-15 | 2020-11-16 | 2020-07-13 |
| NCT03630159 | Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients | COMPLETED | PHASE1 | 2018-10-09 | 2021-07-20 | 2021-07-20 |
| NCT03393481 | Prevention of Thromboembolic Events in Total Knee Replacement Patients | WITHDRAWN | PHASE2 | 2018-10-03 | 2020-04-17 | 2020-01-08 |
| NCT03474965 | Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients | COMPLETED | PHASE2 | 2018-10-01 | 2024-11-06 | 2024-11-06 |
| NCT03681457 | Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects | COMPLETED | PHASE1 | 2018-09-24 | 2019-09-25 | 2019-09-25 |
| NCT03610516 | Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis. | COMPLETED | PHASE2 | 2018-09-12 | 2023-06-29 | 2023-06-29 |
| NCT03517540 | Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis | COMPLETED | PHASE2 | 2018-09-11 | 2020-10-15 | 2020-09-15 |
| NCT03560739 | A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients | COMPLETED | PHASE2 | 2018-09-11 | 2020-05-05 | 2019-08-26 |
| NCT03484923 | Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma | COMPLETED | PHASE2 | 2018-09-10 | 2022-12-30 | 2022-12-30 |
| NCT03497897 | Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne | COMPLETED | PHASE2 | 2018-09-10 | 2022-03-09 | 2022-02-24 |
| NCT02672358 | Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC | WITHDRAWN | PHASE2 | 2018-09-03 | 2020-12-07 | 2019-09-02 |
| NCT03668613 | Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis | COMPLETED | PHASE3 | 2018-08-29 | 2023-09-12 | 2019-09-19 |
| NCT03671330 | Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. | COMPLETED | PHASE2 | 2018-08-29 | 2025-05-09 | 2022-04-25 |
| NCT03551626 | Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes | COMPLETED | PHASE3 | 2018-08-29 | 2021-09-16 | 2020-10-05 |
| NCT03374657 | A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2018-08-22 | 2026-05-11 | 2026-05-11 |
| NCT03461289 | Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 | COMPLETED | PHASE3 | 2018-08-16 | 2020-09-11 | 2020-09-11 |
| NCT03437278 | Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU) | COMPLETED | PHASE2 | 2018-08-01 | 2021-02-03 | 2020-10-23 |
| NCT03240393 | Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC) | WITHDRAWN | PHASE2 | 2018-07-31 | 2021-10-26 | 2021-10-26 |
| NCT03481660 | A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema | COMPLETED | PHASE3 | 2018-07-27 | 2021-06-08 | 2020-06-29 |
| NCT03529084 | Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations | WITHDRAWN | PHASE3 | 2018-07-24 | 2024-06-03 | 2020-08-13 |
| NCT03481634 | Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema | COMPLETED | PHASE3 | 2018-07-23 | 2021-10-18 | 2020-11-11 |
| NCT03512197 | A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML) | COMPLETED | PHASE3 | 2018-07-20 | 2021-02-12 | 2021-02-12 |
| NCT03549000 | A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. | TERMINATED | PHASE1 | 2018-07-18 | 2022-10-17 | 2022-10-17 |
| NCT03379233 | A Randomized Study to Evaluate the Effect of Reminder Notifications and Motivational/Adaptive Messaging on Treatment Adherence | TERMINATED | PHASE3 | 2018-07-11 | 2019-01-22 | 2019-01-22 |
| NCT03300427 | The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients | COMPLETED | PHASE4 | 2018-07-05 | 2022-03-23 | 2022-03-23 |
| NCT03499899 | A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer | COMPLETED | PHASE2 | 2018-07-02 | 2021-11-24 | 2020-02-27 |
| NCT03504852 | Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis | COMPLETED | PHASE3 | 2018-06-25 | 2020-07-15 | 2019-09-13 |
| NCT03354754 | LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI) | TERMINATED | PHASE2 | 2018-05-15 | 2018-09-24 | 2018-09-24 |
| NCT03400176 | VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib | TERMINATED | PHASE1 | 2018-04-09 | 2023-09-29 | 2023-09-29 |
| NCT03439839 | Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) | COMPLETED | PHASE2 | 2018-04-09 | 2022-02-28 | 2020-04-22 |
| NCT03280030 | A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML | COMPLETED | PHASE2 | 2018-04-06 | 2022-11-14 | 2022-11-14 |
| NCT03505099 | Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2 | COMPLETED | PHASE3 | 2018-04-02 | 2021-06-15 | 2021-06-15 |
| NCT03081234 | Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer | WITHDRAWN | PHASE3 | 2018-03-31 | 2025-11-17 | 2025-11-17 |
| NCT03447769 | Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A | TERMINATED | PHASE3 | 2018-03-16 | 2023-02-07 | 2022-03-17 |
| NCT03249714 | Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab | COMPLETED | PHASE2 | 2018-03-15 | 2020-07-29 | 2019-12-26 |
| NCT03297294 | Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN) | TERMINATED | PHASE2 | 2018-03-14 | 2019-03-25 | 2019-03-25 |
| NCT03350815 | Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis | COMPLETED | PHASE4 | 2018-03-13 | 2021-05-29 | 2021-03-11 |
| NCT03440736 | Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome | COMPLETED | PHASE4 | 2018-02-28 | 2022-06-03 | 2021-11-30 |
| NCT03466203 | Safety Study of LLF580 in Obese Volunteers | COMPLETED | PHASE1 | 2018-02-26 | 2019-11-13 | 2019-11-13 |
| NCT03217422 | ADCC Mediated B-Cell dEpletion and BAFF-R Blockade | ACTIVE_NOT_RECRUITING | PHASE2, PHASE3 | 2018-02-15 | 2025-12-25 | 2023-12-28 |
| NCT03379727 | Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia. | COMPLETED | PHASE3 | 2018-02-13 | 2021-07-09 | 2021-07-09 |
| NCT03333109 | Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients | COMPLETED | PHASE3 | 2018-02-08 | 2020-01-13 | 2020-01-13 |
| NCT03373461 | Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation | COMPLETED | PHASE2 | 2018-02-07 | 2021-06-22 | 2020-12-29 |
| NCT03158311 | Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium | COMPLETED | PHASE3 | 2018-02-05 | 2019-07-19 | 2019-07-12 |
| NCT03439046 | Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant | COMPLETED | PHASE3 | 2018-02-02 | 2023-12-11 | 2023-12-11 |
| NCT02939599 | Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients | TERMINATED | PHASE2 | 2018-02-01 | 2018-11-06 | 2018-11-06 |
| NCT03301896 | Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies | TERMINATED | PHASE1 | 2018-01-31 | 2022-06-30 | 2022-06-30 |
| NCT03333343 | Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC | ACTIVE_NOT_RECRUITING | PHASE1 | 2018-01-29 | 2026-03-09 | 2026-03-09 |
| NCT03365791 | PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies | COMPLETED | PHASE2 | 2018-01-24 | 2020-09-17 | 2019-02-21 |
| NCT03372083 | Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis | COMPLETED | PHASE4 | 2018-01-16 | 2019-12-05 | 2019-12-05 |
| NCT03386474 | Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD | COMPLETED | PHASE3 | 2018-01-15 | 2018-09-06 | 2018-09-06 |
| NCT03203850 | Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH) | TERMINATED | PHASE2 | 2018-01-11 | 2023-04-17 | 2023-04-17 |
| NCT03340506 | Dabrafenib and/or Trametinib Rollover Study | RECRUITING | PHASE4 | 2017-12-28 | 2027-12-21 | 2027-12-20 |
| NCT02684058 | Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors | COMPLETED | PHASE2 | 2017-12-28 | 2023-04-28 | 2021-08-23 |
| NCT03338998 | Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH). | COMPLETED | PHASE2 | 2017-12-24 | 2020-05-13 | 2020-05-13 |
| NCT03287414 | Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis | TERMINATED | PHASE2 | 2017-12-20 | 2022-02-14 | 2020-11-25 |
| NCT03264989 | Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC) | COMPLETED | PHASE2 | 2017-12-19 | 2023-06-26 | 2023-06-26 |
| NCT03111992 | Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma | COMPLETED | PHASE1 | 2017-12-18 | 2020-03-02 | 2020-03-02 |
| NCT03138811 | A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma | COMPLETED | PHASE1 | 2017-12-18 | 2019-07-16 | 2019-07-16 |
| NCT03344640 | Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy | COMPLETED | PHASE2 | 2017-12-15 | 2019-10-17 | 2019-08-02 |
| NCT03333694 | Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis) | TERMINATED | PHASE1 | 2017-12-15 | 2018-11-01 | 2018-11-01 |
| NCT03369704 | Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients | COMPLETED | PHASE3 | 2017-12-15 | 2018-10-20 | 2018-05-11 |
| NCT03381729 | Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy | TERMINATED | PHASE1 | 2017-12-14 | 2021-11-18 | 2021-11-18 |
| NCT03320941 | A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity | COMPLETED | PHASE2 | 2017-12-07 | 2018-07-25 | 2018-07-25 |
| NCT03242928 | Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD) | COMPLETED | PHASE2 | 2017-12-04 | 2019-12-16 | 2019-12-16 |
| NCT03259074 | Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) | COMPLETED | PHASE3 | 2017-11-30 | 2021-11-29 | 2021-11-12 |
| NCT03355196 | First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients | COMPLETED | PHASE1 | 2017-11-20 | 2019-03-26 | 2019-03-26 |
| NCT03334747 | Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria. | COMPLETED | PHASE2 | 2017-11-16 | 2019-11-23 | 2019-11-23 |
| NCT03200717 | Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment | COMPLETED | PHASE2 | 2017-11-14 | 2021-08-10 | 2021-08-10 |
| NCT03299686 | Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma | COMPLETED | PHASE2 | 2017-11-06 | 2019-07-08 | 2019-04-08 |
| NCT03215758 | Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma | COMPLETED | PHASE3 | 2017-11-01 | 2019-07-30 | 2019-07-02 |
| NCT03226392 | Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma | COMPLETED | PHASE3 | 2017-10-31 | 2019-08-01 | 2019-07-05 |
| NCT03106779 | Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs | COMPLETED | PHASE3 | 2017-10-26 | 2024-12-04 | 2020-05-25 |
| NCT03306277 | Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 | COMPLETED | PHASE3 | 2017-10-24 | 2019-11-12 | 2019-11-12 |
| NCT03334812 | Study on Safety, Tolerability and Prelimenary Efficacy of LNA043 in Patients Undergoing Autologous Chondrocyte Implantation | TERMINATED | PHASE2 | 2017-10-18 | 2019-04-05 | 2019-04-05 |
| NCT02715505 | Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD) | WITHDRAWN | PHASE1, PHASE2 | 2017-10-10 | 2020-05-18 | 2020-05-18 |
| NCT03205150 | Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients | COMPLETED | PHASE2 | 2017-10-04 | 2019-11-14 | 2019-11-11 |
| NCT03025698 | A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia | COMPLETED | PHASE2 | 2017-09-30 | 2025-01-27 | 2022-04-22 |
| NCT02566044 | Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis | COMPLETED | PHASE1, PHASE2 | 2017-09-27 | 2018-04-24 | 2018-04-24 |
| NCT03176264 | PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer | TERMINATED | PHASE1 | 2017-09-25 | 2018-01-30 | 2018-01-30 |
| NCT03150160 | Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma | COMPLETED | PHASE4 | 2017-09-21 | 2017-12-04 | 2017-12-04 |
| NCT03194776 | Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication | COMPLETED | PHASE2 | 2017-09-20 | 2018-12-27 | 2018-09-07 |
| NCT03257358 | A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod | COMPLETED | PHASE4 | 2017-09-19 | 2019-06-28 | 2019-03-05 |
| NCT02927366 | Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients | TERMINATED | PHASE2 | 2017-09-19 | 2018-06-07 | 2018-06-07 |
| NCT03312738 | A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor | COMPLETED | PHASE2 | 2017-09-15 | 2022-04-25 | 2022-04-25 |
| NCT03275064 | Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis. | COMPLETED | PHASE2 | 2017-09-12 | 2022-09-06 | 2022-09-06 |
| NCT03172936 | Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas | TERMINATED | PHASE1 | 2017-09-08 | 2020-12-18 | 2020-12-18 |
| NCT03257995 | Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. | COMPLETED | PHASE2 | 2017-09-05 | 2018-01-18 | 2018-01-17 |
| NCT03056755 | Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments | COMPLETED | PHASE2 | 2017-08-29 | 2024-11-12 | 2021-06-14 |
| NCT03207867 | A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma | TERMINATED | PHASE2 | 2017-08-28 | 2023-02-14 | 2023-02-13 |
| NCT03066804 | A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients | COMPLETED | PHASE3 | 2017-08-22 | 2019-10-28 | 2019-10-28 |
| NCT03131453 | A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease | TERMINATED | PHASE2, PHASE3 | 2017-08-03 | 2020-03-26 | 2020-03-26 |
| NCT03167242 | Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria | COMPLETED | PHASE2 | 2017-08-02 | 2021-06-28 | 2021-06-14 |
| NCT02993224 | Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet | COMPLETED | PHASE2 | 2017-07-27 | 2021-03-11 | 2020-01-29 |
| NCT03141086 | A Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and Pharmacokinetics (PK) of LML134 in Shift Work Disorder | TERMINATED | PHASE2 | 2017-07-26 | 2018-09-12 | 2018-08-30 |
| NCT03152552 | A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure | TERMINATED | PHASE2 | 2017-07-25 | 2018-06-06 | 2018-06-06 |
| NCT03152591 | Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome | COMPLETED | PHASE2 | 2017-07-24 | 2018-06-25 | 2018-06-25 |
| NCT02992483 | Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma | COMPLETED | PHASE1 | 2017-07-12 | 2019-06-07 | 2019-06-07 |
| NCT03066648 | Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS | COMPLETED | PHASE1 | 2017-07-06 | 2023-09-08 | 2023-09-08 |
| NCT03087942 | Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects | COMPLETED | PHASE1 | 2017-07-05 | 2018-08-07 | 2018-08-07 |
| NCT03040973 | Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone | ACTIVE_NOT_RECRUITING | PHASE2 | 2017-07-04 | 2027-07-30 | 2027-07-30 |
| NCT03136861 | SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis | COMPLETED | PHASE3 | 2017-06-30 | 2019-02-15 | 2019-02-15 |
| NCT02962895 | Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) | COMPLETED | PHASE2 | 2017-06-27 | 2021-09-23 | 2020-06-30 |
| NCT03094195 | Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN) | TERMINATED | PHASE2 | 2017-06-27 | 2019-03-07 | 2019-03-07 |
| NCT03108027 | Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma | COMPLETED | PHASE2 | 2017-06-26 | 2018-02-24 | 2018-02-24 |
| NCT03198767 | Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066 | COMPLETED | PHASE2 | 2017-06-21 | 2017-09-04 | 2017-09-04 |
| NCT03078751 | Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer | COMPLETED | PHASE2 | 2017-06-20 | 2020-03-09 | 2020-03-09 |
| NCT03081494 | Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer | COMPLETED | PHASE1 | 2017-06-09 | 2019-05-07 | 2019-05-07 |
| NCT02962414 | Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment | ACTIVE_NOT_RECRUITING | PHASE3 | 2017-06-08 | 2027-08-13 | 2027-08-04 |
| NCT03050398 | A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib | TERMINATED | PHASE3 | 2017-06-07 | 2019-03-08 | 2019-03-08 |
| NCT03048448 | Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects | COMPLETED | PHASE1 | 2017-05-31 | 2019-04-22 | 2019-04-22 |
| NCT03114319 | Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors | TERMINATED | PHASE1 | 2017-05-26 | 2025-07-04 | 2025-07-04 |
| NCT03064854 | PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients | TERMINATED | PHASE1 | 2017-05-24 | 2021-07-28 | 2021-07-28 |
| NCT03031782 | Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA) | COMPLETED | PHASE3 | 2017-05-23 | 2020-11-09 | 2020-10-07 |
| NCT02998645 | Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia | COMPLETED | PHASE2 | 2017-05-11 | 2022-05-30 | 2020-11-03 |
| NCT02452268 | A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers | TERMINATED | PHASE1 | 2017-05-08 | 2022-03-07 | 2022-03-07 |
| NCT03100058 | A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults | COMPLETED | PHASE2 | 2017-05-06 | 2018-08-02 | 2018-03-02 |
| NCT03137784 | Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma | COMPLETED | PHASE2, PHASE3 | 2017-05-04 | 2017-12-29 | 2017-12-29 |
| NCT03100825 | A Long-term Safety Study of QVM149 in Japanese Patients With Asthma | COMPLETED | PHASE3 | 2017-04-28 | 2019-04-08 | 2018-09-18 |
| NCT03131479 | Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function. | COMPLETED | PHASE2 | 2017-04-28 | 2018-01-16 | 2018-01-16 |
| NCT03060577 | An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol | COMPLETED | PHASE2 | 2017-04-27 | 2021-12-17 | 2021-12-17 |
| NCT03328897 | Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria | COMPLETED | PHASE3 | 2017-04-26 | 2019-09-24 | 2019-07-23 |
| NCT02947165 | Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. | COMPLETED | PHASE1 | 2017-04-25 | 2021-06-18 | 2021-06-18 |
| NCT03100500 | A Long-term Safety Study of QMF149 in Japanese Participants With Asthma | COMPLETED | PHASE3 | 2017-04-25 | 2019-02-12 | 2018-07-19 |
| NCT03123939 | Phase III B in Acute Lymphoblastic Leukemia | COMPLETED | PHASE3 | 2017-04-24 | 2020-10-13 | 2020-10-13 |
| NCT02988440 | Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients | COMPLETED | PHASE1 | 2017-04-20 | 2020-02-27 | 2020-02-27 |
| NCT03055494 | Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients | COMPLETED | PHASE4 | 2017-04-18 | 2019-02-26 | 2018-04-25 |
| NCT02892019 | Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma | COMPLETED | PHASE2 | 2017-04-18 | 2019-07-17 | 2019-06-19 |
| NCT02961218 | Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia | COMPLETED | PHASE2 | 2017-04-05 | 2020-04-27 | 2019-06-27 |
| NCT02745080 | Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis | COMPLETED | PHASE3 | 2017-04-03 | 2019-12-30 | 2019-12-30 |
| NCT02966353 | Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients. | COMPLETED | PHASE2 | 2017-03-31 | 2019-02-15 | 2018-07-24 |
| NCT03020199 | Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis | COMPLETED | PHASE4 | 2017-03-27 | 2023-06-16 | 2021-11-30 |
| NCT03052517 | Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment | TERMINATED | PHASE3 | 2017-03-21 | 2020-03-16 | 2020-02-19 |
| NCT03096834 | A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies | COMPLETED | PHASE3 | 2017-03-20 | 2021-01-28 | 2018-01-18 |
| NCT02913261 | Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation | COMPLETED | PHASE3 | 2017-03-10 | 2021-04-23 | 2019-06-24 |
| NCT02678000 | Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function | COMPLETED | PHASE2 | 2017-03-10 | 2018-10-11 | 2018-10-11 |
| NCT02987660 | Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax | TERMINATED | NA | 2017-03-03 | 2017-07-26 | 2017-07-26 |
| NCT02974140 | Cataract Refractive Suite Study | TERMINATED | NA | 2017-03-02 | 2017-07-25 | 2017-07-25 |
| NCT03066609 | Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis | COMPLETED | PHASE3 | 2017-02-28 | 2018-11-20 | 2017-12-21 |
| NCT02974725 | A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma | TERMINATED | PHASE1 | 2017-02-24 | 2024-04-24 | 2024-04-24 |
| NCT02967692 | A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma | TERMINATED | PHASE3 | 2017-02-17 | 2024-08-21 | 2020-08-11 |
| NCT02955069 | Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) | COMPLETED | PHASE2 | 2017-02-14 | 2020-05-13 | 2018-08-10 |
| NCT03026257 | Clinical Assessment of a HYDRAGLYDE® Regimen | COMPLETED | NA | 2017-02-13 | 2017-08-18 | 2017-08-18 |
| NCT02712983 | Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection | COMPLETED | PHASE2 | 2017-02-08 | 2019-03-20 | 2019-03-20 |
| NCT03005288 | Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes | COMPLETED | PHASE2 | 2017-02-01 | 2019-05-08 | 2019-03-21 |
| NCT03063086 | Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma. | COMPLETED | PHASE2 | 2017-01-21 | 2018-08-02 | 2018-08-02 |
| NCT02892344 | Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma | COMPLETED | PHASE3 | 2017-01-16 | 2018-11-30 | 2018-11-05 |
| NCT02998671 | Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne | COMPLETED | PHASE2 | 2016-12-22 | 2018-08-01 | 2018-08-01 |
| NCT02900378 | randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure | COMPLETED | PHASE3 | 2016-12-20 | 2018-04-11 | 2018-04-11 |
| NCT02873650 | Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment | TERMINATED | PHASE1 | 2016-12-20 | 2019-04-08 | 2018-10-12 |
| NCT02888080 | Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis | COMPLETED | PHASE2 | 2016-12-19 | 2019-03-04 | 2019-03-04 |
| NCT02852239 | Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment | COMPLETED | PHASE1 | 2016-12-19 | 2019-09-27 | 2019-09-27 |
| NCT02970669 | Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients. | COMPLETED | PHASE4 | 2016-12-16 | 2018-03-19 | 2018-03-19 |
| NCT02965820 | OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers | COMPLETED | NA | 2016-12-16 | 2017-04-01 | 2017-04-01 |
| NCT02934568 | Ribociclib (LEE011) Rollover Study for Continued Access | RECRUITING | PHASE2 | 2016-12-15 | 2026-09-01 | 2026-08-31 |
| NCT02953938 | Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety | COMPLETED | PHASE4 | 2016-12-15 | 2018-12-28 | 2018-12-28 |
| NCT02925104 | A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors. | COMPLETED | PHASE1 | 2016-12-14 | 2018-05-16 | 2018-05-16 |
| NCT02965833 | CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers | COMPLETED | NA | 2016-12-13 | 2017-03-24 | 2017-03-24 |
| NCT02748863 | Study of Secukinumab With 2 mL Pre-filled Syringes | COMPLETED | PHASE3 | 2016-12-12 | 2018-06-08 | 2017-08-08 |
| NCT02924727 | Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI | COMPLETED | PHASE3 | 2016-12-09 | 2021-02-26 | 2021-02-26 |
| NCT02961062 | Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery | COMPLETED | PHASE2 | 2016-12-01 | 2018-02-21 | 2018-01-15 |
| NCT02947152 | HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma | TERMINATED | PHASE1 | 2016-12-01 | 2017-09-14 | 2017-09-14 |
| NCT02756663 | Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma | WITHDRAWN | PHASE2 | 2016-12 | 2021-02 | 2021-02 |
| NCT01964235 | Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma | WITHDRAWN | PHASE2 | 2016-12 | 2019-07 | 2019-07 |
| NCT02941926 | Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC | COMPLETED | PHASE3 | 2016-11-30 | 2022-11-09 | 2019-11-08 |
| NCT02884206 | Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction | COMPLETED | PHASE3 | 2016-11-23 | 2022-05-16 | 2022-05-16 |
| NCT02980263 | Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease | WITHDRAWN | PHASE2 | 2016-11-15 | 2017-11-30 | 2017-11-30 |
| NCT02939170 | Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks | COMPLETED | NA | 2016-11-14 | 2016-12-02 | 2016-12-02 |
| NCT02678312 | Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure | COMPLETED | PHASE2, PHASE3 | 2016-11-03 | 2022-01-03 | 2022-01-03 |
| NCT02619617 | Safety and Efficacy Study of SOM230 s.c. in Cluster Headache | TERMINATED | PHASE2 | 2016-10-31 | 2018-09-25 | 2018-09-25 |
| NCT02887183 | Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes. | COMPLETED | PHASE4 | 2016-10-25 | 2018-10-22 | 2018-10-22 |
| NCT03096847 | Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer | COMPLETED | PHASE3 | 2016-10-24 | 2020-02-06 | 2018-12-11 |
| NCT02913105 | Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH | TERMINATED | PHASE2 | 2016-10-24 | 2018-09-19 | 2018-09-19 |
| NCT02829723 | A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors | TERMINATED | PHASE1, PHASE2 | 2016-10-21 | 2022-12-01 | 2022-12-01 |
| NCT02936102 | A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. | TERMINATED | PHASE1 | 2016-10-20 | 2024-11-22 | 2024-11-22 |
| NCT02705963 | A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors | COMPLETED | PHASE1 | 2016-10-20 | 2019-08-29 | 2019-08-29 |
| NCT02896127 | Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis | COMPLETED | PHASE3 | 2016-10-18 | 2019-03-19 | 2018-05-14 |
| NCT02890069 | A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat | COMPLETED | PHASE1 | 2016-10-14 | 2022-02-22 | 2022-02-22 |
| NCT02900651 | Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies | TERMINATED | PHASE1 | 2016-10-03 | 2024-10-09 | 2024-10-09 |
| NCT02697734 | Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease | COMPLETED | PHASE3 | 2016-10-03 | 2020-12-31 | 2019-06-19 |
| NCT02721966 | Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement | COMPLETED | PHASE3 | 2016-10-03 | 2019-06-26 | 2019-06-26 |
| NCT02911857 | An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes | COMPLETED | PHASE3 | 2016-10-03 | 2017-01-27 | 2017-01-27 |
| NCT01649050 | Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis | WITHDRAWN | PHASE2 | 2016-10 | 2018-03 | 2018-03 |
| NCT02867735 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema | COMPLETED | PHASE1 | 2016-09-21 | 2018-02-15 | 2018-02-15 |
| NCT02792218 | Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 | 2016-09-20 | 2020-07-20 | 2019-07-05 |
| NCT02878681 | 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME. | WITHDRAWN | PHASE4 | 2016-09 | 2017-09 | 2017-09 |
| NCT02771210 | Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site | COMPLETED | PHASE3 | 2016-08-30 | 2019-12-11 | 2019-12-11 |
| NCT02871375 | Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal | COMPLETED | NA | 2016-08-30 | 2016-11-14 | 2016-11-14 |
| NCT02792231 | Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. | COMPLETED | PHASE3 | 2016-08-26 | 2020-10-22 | 2019-07-10 |
| NCT02826642 | A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia | WITHDRAWN | PHASE1 | 2016-08-26 | 2016-11-29 | 2016-11-29 |
| NCT02878616 | Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316 | COMPLETED | PHASE1 | 2016-08-26 | 2017-07-19 | 2017-07-19 |
| NCT02900664 | A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib) | COMPLETED | PHASE1 | 2016-08-23 | 2021-03-17 | 2021-03-17 |
| NCT02662985 | Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) | COMPLETED | PHASE3 | 2016-08-22 | 2020-11-10 | 2020-11-10 |
| NCT03918980 | Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064 | COMPLETED | PHASE1 | 2016-08-18 | 2020-01-27 | 2020-01-27 |
| NCT02874794 | Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction | COMPLETED | PHASE4 | 2016-08-17 | 2019-01-26 | 2018-12-13 |
| NCT02720536 | Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation | COMPLETED | PHASE3 | 2016-08-16 | 2019-07-23 | 2019-07-23 |
| NCT02855164 | Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) | TERMINATED | PHASE2 | 2016-08-01 | 2020-04-06 | 2020-04-06 |
| NCT02740270 | Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas | COMPLETED | PHASE1 | 2016-07-22 | 2020-03-03 | 2020-03-03 |
| NCT02768298 | Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction. | COMPLETED | PHASE4 | 2016-07-12 | 2019-11-25 | 2019-11-25 |
| NCT02807857 | A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care | COMPLETED | NA | 2016-07-07 | 2018-03-23 | 2018-03-23 |
| NCT02807844 | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | COMPLETED | PHASE1, PHASE2 | 2016-06-29 | 2020-06-04 | 2020-06-04 |
| NCT02703571 | Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors | TERMINATED | PHASE1 | 2016-06-29 | 2019-09-24 | 2019-09-24 |
| NCT02798211 | Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo | COMPLETED | PHASE4 | 2016-06-27 | 2018-12-05 | 2018-12-05 |
| NCT02756650 | 1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement | COMPLETED | PHASE2 | 2016-06-23 | 2019-01-31 | 2019-01-31 |
| NCT02826603 | Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis | COMPLETED | PHASE3 | 2016-06-22 | 2018-07-09 | 2018-07-09 |
| NCT02640664 | Rainbow Extension Study | COMPLETED | PHASE3 | 2016-06-16 | 2022-04-21 | 2022-04-21 |
| NCT02795429 | Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC | COMPLETED | PHASE1, PHASE2 | 2016-06-15 | 2021-06-24 | 2021-06-01 |
| NCT02734615 | Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers | TERMINATED | PHASE1 | 2016-06-14 | 2021-09-13 | 2021-09-13 |
| NCT02732119 | Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. | COMPLETED | PHASE1, PHASE2 | 2016-06-14 | 2020-02-25 | 2020-02-25 |
| NCT02720510 | A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM) | TERMINATED | PHASE2 | 2016-06-14 | 2017-05-22 | 2017-05-22 |
| NCT02634983 | QVA Mechanistic Efficacy Study (Receptor Effects, Etc) | COMPLETED | PHASE4 | 2016-06-03 | 2017-09-26 | 2017-09-26 |
| NCT02775916 | Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome | COMPLETED | PHASE2 | 2016-06-01 | 2017-05-17 | 2017-05-17 |
| NCT02795416 | Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population | WITHDRAWN | PHASE3 | 2016-06 | 2017-03 | 2017-03 |
| NCT02763046 | Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis | COMPLETED | PHASE4 | 2016-05-31 | 2019-09-24 | 2019-09-24 |
| NCT02663752 | A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy. | TERMINATED | PHASE2 | 2016-05-30 | 2016-07-01 | 2016-07-01 |
| NCT02649218 | A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients | COMPLETED | PHASE2 | 2016-05-24 | 2019-05-02 | 2019-05-02 |
| NCT02696967 | A Study of CLR325 in Chronic Stable Heart Failure Patients. | COMPLETED | PHASE2 | 2016-05-17 | 2019-01-14 | 2019-01-14 |
| NCT02720107 | Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01) | COMPLETED | PHASE4 | 2016-05-12 | 2016-11-14 | 2016-11-14 |
| NCT02703636 | NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. | COMPLETED | PHASE4 | 2016-05-09 | 2018-05-07 | 2018-05-07 |
| NCT02465528 | Ceritinib Rare Indications Study in ALK+ Tumors | TERMINATED | PHASE2 | 2016-05-06 | 2018-08-20 | 2018-08-20 |
| NCT02857868 | A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects | COMPLETED | PHASE1 | 2016-05-03 | 2017-07-20 | 2017-07-20 |
| NCT01617941 | A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention | WITHDRAWN | PHASE2 | 2016-05 | 2016-11 | 2016-11 |
| NCT02696031 | Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis | COMPLETED | PHASE3 | 2016-04-29 | 2021-03-11 | 2019-07-01 |
| NCT02554890 | Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode. | COMPLETED | PHASE4 | 2016-04-29 | 2018-07-24 | 2018-06-29 |
| NCT02750813 | ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1® | COMPLETED | NA | 2016-04-27 | 2016-08-17 | 2016-08-17 |
| NCT02763644 | Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients | TERMINATED | PHASE2 | 2016-04-22 | 2017-06-30 | 2017-02-10 |
| NCT02605967 | Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma | COMPLETED | PHASE2 | 2016-04-20 | 2021-02-19 | 2019-11-05 |
| NCT02713256 | A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease | COMPLETED | PHASE2 | 2016-04-19 | 2017-04-24 | 2017-04-24 |
| NCT02711345 | A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. | TERMINATED | PHASE1 | 2016-04-15 | 2018-11-21 | 2018-11-21 |
| NCT02750592 | Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis | COMPLETED | PHASE3 | 2016-03-22 | 2018-05-16 | 2017-07-05 |
| NCT02752776 | A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis. | COMPLETED | PHASE4 | 2016-03-17 | 2018-03-28 | 2018-03-28 |
| NCT02842749 | Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China | COMPLETED | PHASE4 | 2016-03-14 | 2024-02-22 | 2024-02-22 |
| NCT02690974 | Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting | COMPLETED | PHASE4 | 2016-03-08 | 2017-11-29 | 2017-06-07 |
| NCT02634970 | CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab | WITHDRAWN | PHASE4 | 2016-03 | 2017-12 | 2017-12 |
| NCT02758548 | Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects | COMPLETED | PHASE2 | 2016-03 | 2016-05 | 2016-05 |
| NCT02678260 | Phase I Study of PDR001 in Patients With Advanced Malignancies. | COMPLETED | PHASE1 | 2016-02-19 | 2017-09-01 | 2017-09-01 |
| NCT02546674 | Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline. | COMPLETED | PHASE4 | 2016-02-18 | 2021-03-25 | 2021-02-23 |
| NCT02575365 | Effect of Fingolimod on Neurodegeneration | TERMINATED | PHASE4 | 2016-02-16 | 2017-01-27 | 2017-01-27 |
| NCT02661217 | Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event | COMPLETED | PHASE4 | 2016-02-12 | 2018-06-20 | 2018-02-20 |
| NCT02690701 | Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis | COMPLETED | PHASE4 | 2016-02-10 | 2018-02-19 | 2017-04-26 |
| NCT02625922 | Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure | TERMINATED | PHASE2 | 2016-02-05 | 2017-01-11 | 2017-01-11 |
| NCT02598297 | Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations. | TERMINATED | PHASE3 | 2016-02-03 | 2017-10-23 | 2017-10-23 |
| NCT02601378 | A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma. | TERMINATED | PHASE1 | 2016-02-01 | 2022-01-07 | 2022-01-07 |
| NCT02607813 | Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations | TERMINATED | PHASE1 | 2016-01-18 | 2022-02-19 | 2022-02-18 |
| NCT02864706 | SCHEDULE Follow Up Visit 5-7 yr | COMPLETED | PHASE4 | 2016-01-18 | 2017-09-25 | 2017-09-25 |
| NCT02713243 | To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea. | COMPLETED | PHASE2 | 2016-01-16 | 2018-01-25 | 2018-01-25 |
| NCT02577107 | Head to Head Study of Anti-VEGF Treatment. | COMPLETED | PHASE4 | 2016-01-13 | 2016-07-09 | 2016-07-09 |
| NCT02375971 | RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity | COMPLETED | PHASE3 | 2015-12-30 | 2017-12-14 | 2017-12-14 |
| NCT02554786 | A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma | COMPLETED | PHASE3 | 2015-12-29 | 2019-06-28 | 2018-11-21 |
| NCT02624557 | Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment. | COMPLETED | PHASE1 | 2015-12-21 | 2017-10-01 | 2017-10-01 |
| NCT02115386 | Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib | TERMINATED | PHASE3 | 2015-12-17 | 2016-10-31 | 2016-10-31 |
| NCT02607774 | Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis | COMPLETED | PHASE1 | 2015-12-17 | 2016-12-20 | 2016-12-20 |
| NCT02596009 | Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices | COMPLETED | PHASE4 | 2015-12-16 | 2016-04-29 | 2016-04-29 |
| NCT02584933 | Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study | ACTIVE_NOT_RECRUITING | PHASE4 | 2015-12-11 | 2027-06-09 | 2027-06-09 |
| NCT02555683 | Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. | COMPLETED | PHASE3 | 2015-12-11 | 2019-11-04 | 2019-10-21 |
| NCT02520752 | A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors | COMPLETED | PHASE1 | 2015-12-10 | 2017-09-12 | 2017-01-30 |
| NCT02626234 | A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors | COMPLETED | PHASE1 | 2015-12-08 | 2017-04-28 | 2017-02-28 |
| NCT02571777 | Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma | COMPLETED | PHASE3 | 2015-12-08 | 2019-06-14 | 2019-06-14 |
| NCT02563067 | Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. | COMPLETED | PHASE3 | 2015-12-03 | 2019-08-02 | 2019-07-04 |
| NCT02495129 | Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome | WITHDRAWN | PHASE1, PHASE2 | 2015-12 | 2017-09 | 2017-09 |
| NCT02565511 | A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease | TERMINATED | PHASE2, PHASE3 | 2015-11-30 | 2020-04-30 | 2020-04-30 |
| NCT02608268 | Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies | TERMINATED | PHASE1, PHASE2 | 2015-11-23 | 2022-08-30 | 2022-08-30 |
| NCT02603393 | Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD | COMPLETED | PHASE4 | 2015-11-20 | 2017-07-18 | 2017-07-18 |
| NCT02603445 | Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL | COMPLETED | PHASE1 | 2015-11-16 | 2018-07-10 | 2018-07-10 |
| NCT02491281 | First-in-human Single Ascending Dose Study of LNA043 in Patients Scheduled for Total Knee Replacement | COMPLETED | PHASE1 | 2015-11-16 | 2018-03-06 | 2018-02-07 |
| NCT02399202 | A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function | COMPLETED | PHASE1 | 2015-11-06 | 2016-03-21 | 2016-03-21 |
| NCT02515331 | Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients | COMPLETED | PHASE2 | 2015-11-04 | 2017-08-17 | 2017-08-17 |
| NCT02445222 | CAR-T Long Term Follow Up (LTFU) Study | RECRUITING | PHASE3 | 2015-11-02 | 2036-02-22 | 2036-02-22 |
| NCT02573467 | An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 | COMPLETED | PHASE3 | 2015-11-02 | 2017-02-13 | 2016-08-17 |
| NCT01613677 | Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer | WITHDRAWN | PHASE2 | 2015-11 | 2017-09 | 2017-09 |
| NCT01824264 | Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes | WITHDRAWN | PHASE2 | 2015-11 | 2016-11 | 2016-11 |
| NCT02422589 | A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors | COMPLETED | PHASE1 | 2015-10-23 | 2017-12-12 | 2017-12-12 |
| NCT02431481 | Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011 | COMPLETED | PHASE1 | 2015-10-23 | 2018-05-11 | 2017-09-14 |
| NCT02435212 | Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload | COMPLETED | PHASE2 | 2015-10-21 | 2024-01-15 | 2018-05-31 |
| NCT02516592 | Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort | COMPLETED | PHASE4 | 2015-10-13 | 2017-05-04 | 2017-05-04 |
| NCT02258009 | Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema | WITHDRAWN | PHASE4 | 2015-10 | 2016-10 | 2016-10 |
| NCT02471144 | Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis | COMPLETED | PHASE3 | 2015-09-29 | 2023-03-30 | 2018-12-13 |
| NCT02565576 | Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis | COMPLETED | PHASE2 | 2015-09-29 | 2017-12-19 | 2017-07-31 |
| NCT02468193 | Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome | COMPLETED | PHASE2 | 2015-09-24 | 2018-10-29 | 2018-06-07 |
| NCT02468661 | A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification | TERMINATED | PHASE1 | 2015-09-23 | 2018-12-05 | 2017-11-15 |
| NCT02570854 | A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients | COMPLETED | PHASE1 | 2015-09-22 | 2020-05-13 | 2020-05-13 |
| NCT02534909 | Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria | COMPLETED | PHASE2 | 2015-09-09 | 2022-05-24 | 2022-05-24 |
| NCT02516605 | A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients | COMPLETED | PHASE2 | 2015-09-09 | 2018-08-02 | 2018-08-02 |
| NCT03596970 | Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients. | WITHDRAWN | PHASE3 | 2015-09 | 2020-12 | 2020-12 |
| NCT02551224 | Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | NA | 2015-09 | 2016-03 | 2016-03 |
| NCT02336425 | Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma | TERMINATED | PHASE2 | 2015-09 | 2016-03 | 2016-03 |
| NCT02404350 | Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis | COMPLETED | PHASE3 | 2015-08-31 | 2019-01-24 | 2017-08-16 |
| NCT02435173 | Study of Efficacy of CDZ173 in Patients With APDS/PASLI | COMPLETED | PHASE2, PHASE3 | 2015-08-24 | 2021-08-16 | 2021-08-16 |
| NCT02450903 | LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib. | COMPLETED | PHASE2 | 2015-08-21 | 2018-05-24 | 2017-07-31 |
| NCT02435680 | Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC) | COMPLETED | PHASE2 | 2015-08-10 | 2020-03-23 | 2020-01-04 |
| NCT02576639 | Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age | COMPLETED | PHASE2 | 2015-08-10 | 2016-03-11 | 2016-03-11 |
| NCT02333344 | The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA | WITHDRAWN | PHASE4 | 2015-07-30 | 2020-01-28 | 2020-01-28 |
| NCT02445248 | Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients | COMPLETED | PHASE2 | 2015-07-29 | 2022-12-22 | 2022-12-22 |
| NCT02487446 | Efficacy and Safety Study of QVA149 in COPD Patients | COMPLETED | PHASE3 | 2015-07-28 | 2016-09-12 | 2016-09-12 |
| NCT02487498 | Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients. | COMPLETED | PHASE3 | 2015-07-27 | 2016-09-06 | 2016-09-06 |
| NCT02437318 | Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. | COMPLETED | PHASE3 | 2015-07-23 | 2023-06-09 | 2018-06-12 |
| NCT02468674 | A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study | COMPLETED | PHASE2 | 2015-07-22 | 2018-12-03 | 2018-12-03 |
| NCT02670928 | Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months. | COMPLETED | PHASE4 | 2015-07-20 | 2017-04-06 | 2017-04-06 |
| NCT02477332 | Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU | COMPLETED | PHASE2 | 2015-07-15 | 2017-06-12 | 2016-11-02 |
| NCT02543086 | Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos | TERMINATED | PHASE1 | 2015-07 | 2015-09 | 2015-09 |
| NCT02371629 | A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD | COMPLETED | PHASE4 | 2015-06-24 | 2016-11-16 | 2016-11-16 |
| NCT02460224 | Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. | COMPLETED | PHASE1, PHASE2 | 2015-06-17 | 2020-12-31 | 2020-12-31 |
| NCT02547714 | Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A | COMPLETED | PHASE4 | 2015-06-16 | 2016-05-02 | 2016-05-02 |
| NCT02468232 | Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction | COMPLETED | PHASE3 | 2015-06-15 | 2021-02-18 | 2019-02-08 |
| NCT02474537 | INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function | COMPLETED | PHASE1 | 2015-06-12 | 2017-09-12 | 2017-08-14 |
| NCT02414139 | Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1) | COMPLETED | PHASE2 | 2015-06-11 | 2023-05-16 | 2023-04-12 |
| NCT02422615 | Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. | COMPLETED | PHASE3 | 2015-06-09 | 2023-01-11 | 2017-11-03 |
| NCT02470403 | Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index | COMPLETED | PHASE2 | 2015-06-05 | 2016-04-04 | 2016-04-04 |
| NCT02268526 | Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients | COMPLETED | PHASE2 | 2015-06-02 | 2016-12-07 | 2016-12-07 |
| NCT02450799 | Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation | COMPLETED | NA | 2015-06 | 2016-05 | 2016-05 |
| NCT02294227 | 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis | COMPLETED | PHASE3 | 2015-05-29 | 2017-12-19 | 2016-02-16 |
| NCT02393625 | Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE1 | 2015-05-27 | 2026-04-09 | 2026-04-09 |
| NCT02370706 | Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis | COMPLETED | PHASE1 | 2015-05-21 | 2020-11-09 | 2020-11-09 |
| NCT02595970 | Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis | COMPLETED | PHASE3 | 2015-05-20 | 2017-02-09 | 2017-02-09 |
| NCT02442206 | Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients | COMPLETED | PHASE4 | 2015-05-18 | 2017-05-15 | 2017-04-20 |
| NCT02159053 | 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis | COMPLETED | PHASE3 | 2015-05-18 | 2018-01-02 | 2016-02-23 |
| NCT02292550 | Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer. | COMPLETED | PHASE1 | 2015-05-14 | 2018-09-26 | 2018-09-26 |
| NCT02404025 | Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects | COMPLETED | PHASE2 | 2015-05-12 | 2017-09-06 | 2016-07-05 |
| NCT02482428 | Efficacy and Tolerability of Topical LFX453 for External Genital Warts | COMPLETED | PHASE2 | 2015-05-12 | 2016-05-31 | 2016-05-31 |
| NCT02396212 | Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA | COMPLETED | PHASE3 | 2015-05-07 | 2018-08-01 | 2017-03-07 |
| NCT02409667 | Plaque Psoriasis Efficacy and Safety With Secukinumab | COMPLETED | PHASE3 | 2015-05-07 | 2017-05-08 | 2017-03-14 |
| NCT01922141 | Aliskiren Study of Safety and Efficacy in Senior Hypertensives | WITHDRAWN | PHASE4 | 2015-05 | 2018-06 | 2018-06 |
| NCT02449018 | A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251 | COMPLETED | PHASE2 | 2015-04-30 | 2017-01-23 | 2016-12-27 |
| NCT02418468 | Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations | COMPLETED | PHASE4 | 2015-04-28 | 2016-04-19 | 2016-04-19 |
| NCT02404441 | Phase I/II Study of PDR001 in Patients With Advanced Malignancies | COMPLETED | PHASE1, PHASE2 | 2015-04-27 | 2020-07-21 | 2020-07-21 |
| NCT02140411 | Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. | COMPLETED | PHASE4 | 2015-04-25 | 2016-12-21 | 2016-12-21 |
| NCT02550106 | Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment | COMPLETED | PHASE4 | 2015-04-22 | 2016-01-11 | 2016-01-11 |
| NCT02372084 | A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function | COMPLETED | PHASE1 | 2015-04-21 | 2016-05-19 | 2016-05-19 |
| NCT02375958 | PCA062 in pCAD-positive Tumors. | COMPLETED | PHASE1 | 2015-04-15 | 2018-07-17 | 2018-07-17 |
| NCT02421172 | Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients | COMPLETED | PHASE2 | 2015-04-13 | 2016-11-23 | 2016-11-23 |
| NCT02394561 | A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME) | COMPLETED | PHASE3 | 2015-04-10 | 2017-06-08 | 2017-06-08 |
| NCT02299505 | Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) | COMPLETED | PHASE1 | 2015-04-09 | 2020-03-06 | 2016-06-16 |
| NCT02435849 | Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients | COMPLETED | PHASE2 | 2015-04-08 | 2022-11-17 | 2020-01-21 |
| NCT02257632 | Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration | COMPLETED | PHASE4 | 2015-04-08 | 2017-06-08 | 2017-03-20 |
| NCT02268552 | An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA) | COMPLETED | PHASE1, PHASE2 | 2015-04-02 | 2022-12-29 | 2022-12-29 |
| NCT02336451 | A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges | COMPLETED | PHASE2 | 2015-04-01 | 2019-02-06 | 2019-02-06 |
| NCT02474082 | Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis. | COMPLETED | PHASE3 | 2015-04 | 2016-06 | 2016-06 |
| NCT02476422 | A Study to Assess the Efficacy and Tolerability of Diclofenac Potassium Soft Gelatin Capsules Compared With Ibuprofen Tablets in Patients With Moderate to Severe Postoperative Dental Pain | COMPLETED | PHASE3 | 2015-04 | 2015-08 | 2015-08 |
| NCT02382913 | Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) | COMPLETED | PHASE1 | 2015-04 | 2015-06 | 2015-06 |
| NCT02427750 | A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects. | COMPLETED | PHASE2 | 2015-04 | 2015-05 | 2015-05 |
| NCT02354508 | Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues | COMPLETED | PHASE3 | 2015-03-31 | 2018-09-27 | 2018-01-08 |
| NCT02373098 | Fingolimod Effect on Cytokine and Chemokine Levels | COMPLETED | PHASE4 | 2015-03-31 | 2017-01-18 | 2017-01-18 |
| NCT02403206 | Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts | COMPLETED | NA | 2015-03-26 | 2016-08-24 | 2016-07-12 |
| NCT02388620 | Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011 | COMPLETED | PHASE1 | 2015-03-25 | 2017-01-09 | 2017-01-09 |
| NCT02343172 | Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma | COMPLETED | PHASE1 | 2015-03-13 | 2019-10-16 | 2019-10-16 |
| NCT02365519 | LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease | COMPLETED | PHASE2 | 2015-03-09 | 2015-10-16 | 2015-10-16 |
| NCT02381886 | A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations | ACTIVE_NOT_RECRUITING | PHASE1 | 2015-03-06 | 2026-02-03 | 2016-12-07 |
| NCT02386800 | CINC424A2X01B Rollover Protocol | ACTIVE_NOT_RECRUITING | PHASE4 | 2015-03-05 | 2027-09-16 | 2027-09-16 |
| NCT02404389 | Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients | COMPLETED | PHASE2 | 2015-03-05 | 2016-01-27 | 2016-01-27 |
| NCT02355028 | LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration | COMPLETED | PHASE2 | 2015-03-03 | 2016-10-18 | 2016-09-15 |
| NCT02143622 | Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients | WITHDRAWN | PHASE1, PHASE2 | 2015-03 | 2018-08 | 2018-08 |
| NCT02127697 | Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma | WITHDRAWN | PHASE3 | 2015-03 | 2017-05 | 2017-05 |
| NCT02300987 | A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression | COMPLETED | PHASE2 | 2015-02-26 | 2018-02-21 | 2018-02-21 |
| NCT02366468 | Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema | COMPLETED | PHASE4 | 2015-02-23 | 2017-06-08 | 2017-06-08 |
| NCT02253277 | Safety and Tolerability of Combined Treatment With Nilotinib and Ruxolitinib in CML and Ph+ ALL Patients | COMPLETED | PHASE1 | 2015-02-18 | 2018-04-03 | 2018-03-06 |
| NCT02323126 | Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer | TERMINATED | PHASE2 | 2015-02-09 | 2021-02-05 | 2019-09-23 |
| NCT02474069 | Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis | COMPLETED | PHASE3 | 2015-02-08 | 2016-09-15 | 2016-09-15 |
| NCT02217410 | CCFZ533X2201 - PoC Study in de Novo Renal Transplantation | COMPLETED | PHASE1, PHASE2 | 2015-02-05 | 2017-11-29 | 2017-11-29 |
| NCT02333370 | A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer | COMPLETED | PHASE1 | 2015-02-04 | 2022-09-29 | 2022-09-29 |
| NCT02334449 | First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers | COMPLETED | PHASE1 | 2015-02 | 2016-02 | 2016-02 |
| NCT02248922 | Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa | TERMINATED | PHASE4 | 2015-01-27 | 2017-04-10 | 2017-04-10 |
| NCT02276027 | A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer | COMPLETED | PHASE2 | 2015-01-20 | 2019-10-15 | 2019-10-15 |
| NCT02124772 | Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations | COMPLETED | PHASE1, PHASE2 | 2015-01-15 | 2020-12-29 | 2020-12-29 |
| NCT02335944 | Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer. | TERMINATED | PHASE1, PHASE2 | 2015-01-13 | 2020-11-10 | 2020-11-10 |
| NCT02362789 | Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers | COMPLETED | PHASE3 | 2015-01-04 | 2016-07-15 | 2016-07-15 |
| NCT02379637 | Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough | COMPLETED | PHASE2 | 2015-01 | 2015-04 | 2015-04 |
| NCT02325739 | FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression | COMPLETED | PHASE1, PHASE2 | 2014-12-29 | 2019-05-30 | 2019-05-30 |
| NCT02338609 | Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus | COMPLETED | PHASE4 | 2014-12-17 | 2023-12-18 | 2023-12-18 |
| NCT02294786 | Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer | TERMINATED | PHASE2 | 2014-12-17 | 2017-10-19 | 2017-10-19 |
| NCT02290431 | Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma | COMPLETED | PHASE2 | 2014-12-16 | 2018-12-25 | 2017-12-29 |
| NCT02262260 | Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME | COMPLETED | PHASE3 | 2014-12-12 | 2017-09-12 | 2017-09-12 |
| NCT02333331 | Dose Range Finding Study of Bimagrumab in Sarcopenia | COMPLETED | PHASE2 | 2014-12-09 | 2018-06-28 | 2018-06-26 |
| NCT02290821 | Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries | COMPLETED | PHASE3 | 2014-12 | 2015-09 | 2015-09 |
| NCT02325518 | Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution | COMPLETED | PHASE4 | 2014-12 | 2015-12 | 2015-12 |
| NCT02329223 | Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients | COMPLETED | PHASE3 | 2014-12 | 2015-12 | 2015-12 |
| NCT02221505 | Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia | TERMINATED | PHASE1 | 2014-12 | 2015-03 | 2015-03 |
| NCT02305446 | Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ. | COMPLETED | PHASE3 | 2014-12 | 2015-04 | 2015-04 |
| NCT02069886 | Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia | WITHDRAWN | PHASE4 | 2014-12 | 2018-12 | 2018-12 |
| NCT02233543 | A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2014-11-30 | 2016-06-26 | 2016-06-26 |
| NCT02292446 | Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available. | COMPLETED | PHASE3 | 2014-11-21 | 2017-12-29 | 2017-12-29 |
| NCT02278120 | Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer | COMPLETED | PHASE3 | 2014-11-20 | 2023-04-20 | 2017-08-21 |
| NCT02296424 | ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab | COMPLETED | PHASE3 | 2014-11-17 | 2017-09-25 | 2016-10-14 |
| NCT02259088 | A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients | COMPLETED | PHASE3 | 2014-11-05 | 2017-01-17 | 2017-01-17 |
| NCT02334748 | A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies | COMPLETED | PHASE3 | 2014-11-03 | 2018-08-31 | 2018-08-31 |
| NCT02235740 | A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2) | TERMINATED | PHASE1 | 2014-11 | 2015-10 | 2015-10 |
| NCT02139228 | Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children | COMPLETED | PHASE3 | 2014-11 | 2015-01 | 2014-12 |
| NCT02058108 | Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection | TERMINATED | PHASE3 | 2014-10-31 | 2019-01-09 | 2019-01-09 |
| NCT02213042 | Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer | TERMINATED | PHASE2 | 2014-10-24 | 2020-06-04 | 2020-06-04 |
| NCT02291029 | Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome | COMPLETED | PHASE2 | 2014-10-22 | 2018-06-29 | 2018-06-29 |
| NCT02226120 | Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction | COMPLETED | PHASE3 | 2014-10-16 | 2017-12-28 | 2017-12-28 |
| NCT01956669 | Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors | COMPLETED | PHASE2 | 2014-10-08 | 2019-11-05 | 2019-11-05 |
| NCT01930162 | Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant | COMPLETED | PHASE2 | 2014-10-07 | 2016-08-29 | 2016-08-29 |
| NCT02180217 | Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease | COMPLETED | PHASE3 | 2014-10-06 | 2019-12-04 | 2018-02-21 |
| NCT02240212 | Study of Afuresertib Combined With Paclitaxel in Gastric Cancer | COMPLETED | PHASE1 | 2014-10 | 2017-02-07 | 2017-02-07 |
| NCT02271854 | A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness | COMPLETED | PHASE3 | 2014-10 | 2014-12 | 2014-12 |
| NCT02255279 | Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico. | COMPLETED | PHASE3 | 2014-10 | 2015-05 | 2015-05 |
| NCT02232061 | Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks | COMPLETED | PHASE4 | 2014-09-29 | 2020-01-24 | 2020-01-24 |
| NCT02267135 | Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis | COMPLETED | PHASE3 | 2014-09-29 | 2015-12-07 | 2015-12-07 |
| NCT02186821 | Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) | TERMINATED | PHASE2 | 2014-09-17 | 2017-12-13 | 2017-12-13 |
| NCT02152761 | Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery | COMPLETED | PHASE2 | 2014-09-16 | 2018-10-25 | 2018-05-14 |
| NCT04072302 | Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model | COMPLETED | PHASE1 | 2014-09-15 | 2017-11-29 | 2017-11-29 |
| NCT02159040 | Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. | TERMINATED | PHASE2 | 2014-09-11 | 2015-06-26 | 2015-06-26 |
| NCT02151383 | Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure | TERMINATED | PHASE2 | 2014-09-05 | 2017-04-03 | 2017-04-03 |
| NCT02256488 | Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects | COMPLETED | PHASE3 | 2014-09 | 2014-12 | 2014-12 |
| NCT02160951 | Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies | COMPLETED | PHASE1 | 2014-09 | 2016-05 | 2016-05 |
| NCT02091752 | A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial) | TERMINATED | PHASE2 | 2014-09 | 2015-02 | 2015-02 |
| NCT02161575 | Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD | COMPLETED | PHASE4 | 2014-08-28 | 2017-09-14 | 2017-09-14 |
| NCT02202616 | Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study) | COMPLETED | PHASE4 | 2014-08-27 | 2017-04-05 | 2017-04-05 |
| NCT02187783 | LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) | COMPLETED | PHASE2 | 2014-08-25 | 2018-01-17 | 2018-01-17 |
| NCT02228096 | Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients | COMPLETED | PHASE2 | 2014-08-14 | 2019-05-24 | 2018-05-29 |
| NCT02177682 | Study of Afuresertib Monotherapy in Japanese Relapsed Multiple Myeloma Patients | TERMINATED | PHASE1 | 2014-08-13 | 2019-08-14 | 2017-02-09 |
| NCT02189174 | Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies | TERMINATED | PHASE1 | 2014-08-07 | 2015-11-12 | 2015-11-12 |
| NCT02161562 | OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients | COMPLETED | PHASE3 | 2014-08-01 | 2016-11-03 | 2016-11-03 |
| NCT01948791 | 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients | COMPLETED | PHASE4 | 2014-08 | 2015-09 | 2015-09 |
| NCT02150213 | Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 | COMPLETED | PHASE2 | 2014-08 | 2015-09 | 2015-09 |
| NCT02178540 | Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients | COMPLETED | PHASE4 | 2014-08 | 2015-02 | 2015-02 |
| NCT02205398 | Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy | TERMINATED | PHASE1 | 2014-07-28 | 2017-01-20 | 2017-01-20 |
| NCT02160041 | BGJ398 for Patients With Tumors With FGFR Genetic Alterations | TERMINATED | PHASE2 | 2014-07-24 | 2018-04-30 | 2018-04-30 |
| NCT02148133 | A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia | COMPLETED | PHASE2 | 2014-07-23 | 2017-09-05 | 2015-09-10 |
| NCT02144038 | Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma | COMPLETED | PHASE1 | 2014-07-23 | 2015-10-28 | 2015-10-28 |
| NCT01920711 | Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction | COMPLETED | PHASE3 | 2014-07-18 | 2019-06-07 | 2019-06-07 |
| NCT02272777 | A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase | COMPLETED | PHASE3 | 2014-07-17 | 2017-01-30 | 2017-01-30 |
| NCT02125877 | Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) | COMPLETED | PHASE2 | 2014-07-08 | 2016-02-24 | 2016-02-24 |
| NCT02143635 | Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt | COMPLETED | PHASE1 | 2014-07-07 | 2020-06-09 | 2017-06-20 |
| NCT02108951 | Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase Inhibitors. | TERMINATED | PHASE3 | 2014-07-07 | 2016-08-10 | 2016-08-10 |
| NCT02245828 | A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374 | COMPLETED | PHASE1 | 2014-07 | 2015-12 | 2015-12 |
| NCT02154776 | Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. | COMPLETED | PHASE1 | 2014-06-27 | 2016-10-26 | 2016-10-26 |
| NCT02059291 | Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers | COMPLETED | PHASE3 | 2014-06-27 | 2017-07-04 | 2017-07-04 |
| NCT02132130 | Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss | COMPLETED | PHASE1, PHASE2 | 2014-06-23 | 2019-12-09 | 2019-12-09 |
| NCT01818726 | Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients | TERMINATED | PHASE4 | 2014-06-23 | 2016-10-17 | 2016-10-17 |
| NCT02034006 | A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. | COMPLETED | PHASE3 | 2014-06-10 | 2016-07-15 | 2016-07-15 |
| NCT02158936 | A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) | TERMINATED | PHASE3 | 2014-06-10 | 2016-04-30 | 2016-04-30 |
| NCT02108964 | A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies | COMPLETED | PHASE1, PHASE2 | 2014-06-06 | 2023-08-15 | 2018-03-22 |
| NCT01941004 | Safety and Efficacy of Fingolimod in MS Patients in China | WITHDRAWN | PHASE3 | 2014-06 | 2017-05 | 2017-05 |
| NCT02177032 | Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age | COMPLETED | PHASE3 | 2014-06 | 2015-08 | 2014-10 |
| NCT02307838 | Long-term Follow-up of Fingolimod Phase II Study Patients | COMPLETED | PHASE4 | 2014-06 | 2015-12 | 2015-12 |
| NCT02055352 | Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD | COMPLETED | PHASE4 | 2014-05-30 | 2016-01-26 | 2016-01-26 |
| NCT02116803 | An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective | COMPLETED | PHASE2, PHASE3 | 2014-05-28 | 2016-11-28 | 2016-11-28 |
| NCT02049450 | Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia. | COMPLETED | PHASE2 | 2014-05-28 | 2016-04-12 | 2016-04-12 |
| NCT02149420 | PD of VAY736 in Patients With Primary Sjögren's Syndrome | COMPLETED | PHASE2 | 2014-05-23 | 2018-02-07 | 2018-02-07 |
| NCT02060383 | Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | COMPLETED | PHASE4 | 2014-05-23 | 2018-03-26 | 2018-02-05 |
| NCT02032173 | Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase | TERMINATED | PHASE3 | 2014-05-19 | 2015-04-29 | 2015-04-29 |
| NCT02088684 | Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer | COMPLETED | PHASE1 | 2014-05-19 | 2018-04-17 | 2018-04-17 |
| NCT02077933 | Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors | COMPLETED | PHASE1 | 2014-05-14 | 2019-04-12 | 2019-04-12 |
| NCT02058381 | A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer | COMPLETED | PHASE1 | 2014-05-06 | 2018-06-19 | 2018-06-19 |
| NCT02122952 | Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 | COMPLETED | PHASE1 | 2014-05-05 | 2017-12-15 | 2017-12-15 |
| NCT02140762 | Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents | COMPLETED | PHASE2 | 2014-05 | 2015-02 | 2014-11 |
| NCT02069093 | Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer | COMPLETED | PHASE2 | 2014-05 | 2016-03 | 2016-03 |
| NCT01982292 | Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure | COMPLETED | PHASE2 | 2014-05 | 2015-09 | 2015-09 |
| NCT02141516 | Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. | COMPLETED | PHASE3 | 2014-05 | 2015-03 | 2015-03 |
| NCT01992081 | Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD. | WITHDRAWN | PHASE4 | 2014-05 | 2015-06 | 2015-06 |
| NCT02081378 | A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL | COMPLETED | PHASE1 | 2014-04-24 | 2023-03-14 | 2021-06-03 |
| NCT02130024 | A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients | COMPLETED | PHASE4 | 2014-04-11 | 2017-11-15 | 2017-11-15 |
| NCT01989468 | 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis | COMPLETED | PHASE3 | 2014-04-10 | 2018-03-28 | 2015-05-27 |
| NCT02559622 | Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab | COMPLETED | PHASE3 | 2014-04 | 2016-04 | 2016-04 |
| NCT02125734 | Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients | COMPLETED | PHASE4 | 2014-04 | 2015-01 | 2015-01 |
| NCT01988662 | UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD) | COMPLETED | PHASE4 | 2014-04 | 2015-09 | 2015-09 |
| NCT01837927 | Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients. | WITHDRAWN | PHASE3 | 2014-04 | 2016-04 | 2016-04 |
| NCT02087059 | A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis | COMPLETED | PHASE3 | 2014-04 | 2015-04 | 2015-03 |
| NCT01996319 | Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD. | COMPLETED | PHASE3 | 2014-04 | 2015-02 | 2015-02 |
| NCT01868685 | Study of Muscle Effects of BYM338 in Mechanically Ventilated Patients | WITHDRAWN | PHASE2 | 2014-04 | 2015-01 | 2015-01 |
| NCT01865188 | Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension | WITHDRAWN | PHASE3 | 2014-04 | 2015-04 | 2015-04 |
| NCT02115113 | REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy | COMPLETED | PHASE3 | 2014-03-28 | 2016-09-30 | 2016-09-30 |
| NCT02075008 | Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201 | TERMINATED | PHASE2 | 2014-03-27 | 2016-03-22 | 2016-03-22 |
| NCT02038036 | Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy. | COMPLETED | PHASE3 | 2014-03-25 | 2020-04-07 | 2015-09-29 |
| NCT02078609 | A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) | COMPLETED | PHASE1 | 2014-03-20 | 2019-04-18 | 2019-04-18 |
| NCT02083354 | Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma | COMPLETED | PHASE2 | 2014-03-18 | 2021-04-19 | 2018-02-23 |
| NCT02034110 | Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers | COMPLETED | PHASE2 | 2014-03-12 | 2021-12-10 | 2021-12-10 |
| NCT02007720 | Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF | TERMINATED | PHASE3 | 2014-03-12 | 2017-06-16 | 2017-03-27 |
| NCT02250443 | Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis | COMPLETED | PHASE2, PHASE3 | 2014-03-11 | 2016-08-23 | 2016-08-23 |
| NCT01923168 | Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women | COMPLETED | PHASE2 | 2014-03-11 | 2017-07-08 | 2017-07-07 |
| NCT02040870 | LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib | COMPLETED | PHASE1, PHASE2 | 2014-03-07 | 2017-07-27 | 2017-07-27 |
| NCT01915303 | Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease | TERMINATED | PHASE2 | 2014-03-06 | 2019-09-04 | 2016-09-05 |
| NCT02051751 | A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer | COMPLETED | PHASE1 | 2014-03-05 | 2016-08-19 | 2016-08-19 |
| NCT01986907 | Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye | COMPLETED | PHASE4 | 2014-03-04 | 2016-06-15 | 2016-06-15 |
| NCT02048787 | Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment. | COMPLETED | PHASE1 | 2014-03 | 2015-03 | 2015-03 |
| NCT01934361 | Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme | COMPLETED | PHASE1 | 2014-02-28 | 2016-07-07 | 2016-07-07 |
| NCT02074982 | Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis | COMPLETED | PHASE3 | 2014-02-26 | 2016-06-29 | 2016-06-29 |
| NCT02039947 | Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain | COMPLETED | PHASE2 | 2014-02-21 | 2018-02-14 | 2017-05-12 |
| NCT01985334 | Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen | COMPLETED | PHASE4 | 2014-02-14 | 2016-04-29 | 2016-04-29 |
| NCT01883362 | Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML | COMPLETED | PHASE2 | 2014-02-06 | 2018-04-30 | 2018-04-30 |
| NCT02024932 | Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy | COMPLETED | PHASE2 | 2014-02-04 | 2016-04-13 | 2016-04-13 |
| NCT01979614 | Study of the Vascular Effects of Serelaxin | COMPLETED | PHASE2 | 2014-02-03 | 2016-08-17 | 2016-08-17 |
| NCT02062645 | Study of Efficacy and Safety of CVAA489 in Hypertensive Patients | COMPLETED | PHASE4 | 2014-02 | 2015-09 | 2015-09 |
| NCT02002689 | LDE225 for Patients With PTCH1 or SMO Mutated Tumors | TERMINATED | PHASE2 | 2014-02 | 2015-03 | 2015-03 |
| NCT02074995 | Study of Tolerability and Efficacy of BVS857 in Severe Burn Subjects | TERMINATED | PHASE2 | 2014-02 | 2015-01 | 2015-01 |
| NCT01959516 | Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD | COMPLETED | PHASE4 | 2014-02 | 2014-10 | 2014-10 |
| NCT02044848 | Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus | TERMINATED | PHASE2 | 2014-02 | 2014-09 | 2014-09 |
| NCT01605981 | Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase. | WITHDRAWN | PHASE4 | 2014-02 | 2017-01 | 2017-01 |
| NCT01948817 | Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses | WITHDRAWN | PHASE2 | 2014-02 | 2016-02 | 2016-02 |
| NCT02064868 | Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients | TERMINATED | PHASE3 | 2014-01-31 | 2017-04-25 | 2017-03-26 |
| NCT01868477 | Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome. | COMPLETED | PHASE2 | 2014-01-28 | 2017-04-05 | 2017-03-22 |
| NCT02042014 | Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan | COMPLETED | PHASE3 | 2014-01-22 | 2016-10-17 | 2016-10-17 |
| NCT02017860 | Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator. | COMPLETED | PHASE2 | 2014-01-16 | 2019-04-25 | 2019-04-25 |
| NCT02008916 | 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients | COMPLETED | PHASE3 | 2014-01-14 | 2017-12-11 | 2015-02-23 |
| NCT01870726 | Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma | TERMINATED | PHASE1, PHASE2 | 2014-01-09 | 2016-12-23 | 2016-12-23 |
| NCT02007278 | Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride | COMPLETED | PHASE4 | 2014-01-03 | 2016-02-22 | 2016-02-22 |
| NCT02015663 | Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles | TERMINATED | PHASE4 | 2014-01 | 2014-12 | 2014-12 |
| NCT01950481 | Effect of Hepatic Impairment on LDK378 Pharmacokinetics | COMPLETED | PHASE1 | 2014-01 | 2016-09 | 2016-09 |
| NCT01836458 | A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection | COMPLETED | PHASE2 | 2014-01 | 2015-03 | 2015-03 |
| NCT02002702 | Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients | COMPLETED | PHASE2 | 2014-01 | 2014-08 | 2014-08 |
| NCT02052687 | A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453 | COMPLETED | PHASE1 | 2014-01 | 2014-06 | 2014-06 |
| NCT02014636 | Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018) | COMPLETED | PHASE1 | 2013-12-27 | 2019-02-27 | 2019-02-27 |
| NCT02008890 | Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab | COMPLETED | PHASE3 | 2013-12-26 | 2017-05-31 | 2014-11-24 |
| NCT02038049 | A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis | TERMINATED | PHASE2 | 2013-12-20 | 2018-09-13 | 2015-05-05 |
| NCT02040584 | A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients. | COMPLETED | PHASE3 | 2013-12-20 | 2016-02-10 | 2016-02-10 |
| NCT01930175 | Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris | TERMINATED | PHASE2 | 2013-12-18 | 2019-09-25 | 2019-09-25 |
| NCT01958021 | Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer | COMPLETED | PHASE3 | 2013-12-17 | 2023-03-16 | 2016-01-29 |
| NCT01948830 | Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD | COMPLETED | PHASE3 | 2013-12-17 | 2015-11-19 | 2015-11-19 |
| NCT01975701 | A Phase 2 Study of BGJ398 in Patients With Recurrent GBM | COMPLETED | PHASE2 | 2013-12-09 | 2018-10-03 | 2018-10-03 |
| NCT01854606 | Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma | COMPLETED | PHASE1 | 2013-12-05 | 2016-06-01 | 2016-06-01 |
| NCT01950819 | Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) | COMPLETED | PHASE4 | 2013-12-03 | 2018-01-17 | 2017-02-01 |
| NCT02007252 | ACZ885 for the Treatment of Abdominal Aortic Aneurysm | TERMINATED | PHASE2 | 2013-12 | 2015-10 | 2015-10 |
| NCT01992536 | Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180) | COMPLETED | PHASE2 | 2013-12 | 2015-04 | 2014-05 |
| NCT02002221 | Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients | COMPLETED | PHASE4 | 2013-12 | 2015-02 | 2015-02 |
| NCT01860066 | A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD | WITHDRAWN | PHASE3 | 2013-12 | 2014-09 | 2014-09 |
| NCT01834885 | A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD | WITHDRAWN | PHASE3 | 2013-12 | 2014-09 | 2014-09 |
| NCT01976312 | Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO) | COMPLETED | PHASE3 | 2013-11-12 | 2016-03-14 | 2016-03-14 |
| NCT01976338 | Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) | COMPLETED | PHASE3 | 2013-11-12 | 2016-03-28 | 2016-03-28 |
| NCT01912872 | Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma | TERMINATED | PHASE4 | 2013-11-11 | 2016-01-08 | 2015-08-06 |
| NCT01863732 | Extension in AS: Sustainability of Benefits, Safety and Tolerability | COMPLETED | PHASE3 | 2013-11-06 | 2018-03-16 | 2018-03-16 |
| NCT01813019 | Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy | TERMINATED | PHASE2 | 2013-11 | 2014-11 | 2014-11 |
| NCT01972776 | A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076. | TERMINATED | PHASE2 | 2013-11 | 2015-05 | 2015-05 |
| NCT01968915 | Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2013-11 | 2015-06 | 2015-06 |
| NCT01992107 | Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old | COMPLETED | PHASE3 | 2013-11 | 2014-08 | 2014-08 |
| NCT01992094 | Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older | COMPLETED | PHASE3 | 2013-11 | 2014-07 | 2014-07 |
| NCT01973218 | Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years. | COMPLETED | PHASE3 | 2013-11 | 2014-04 | 2014-04 |
| NCT01994629 | Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers | COMPLETED | PHASE2 | 2013-11 | 2014-10 | 2014-04 |
| NCT01922089 | Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients | COMPLETED | PHASE2 | 2013-11 | 2014-08 | 2014-08 |
| NCT01959412 | Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma | COMPLETED | PHASE2 | 2013-11 | 2014-03 | 2014-03 |
| NCT01791192 | Study of FTY720 in Patients With Uveitis | WITHDRAWN | PHASE2 | 2013-11 | 2014-10 | 2014-10 |
| NCT01972789 | Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre) | COMPLETED | PHASE4 | 2013-10-31 | 2017-02-28 | 2017-02-28 |
| NCT01958918 | Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD | COMPLETED | PHASE4 | 2013-10-23 | 2017-05-29 | 2016-11-22 |
| NCT01872260 | Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2013-10-22 | 2025-12-31 | 2025-12-31 |
| NCT01957176 | A Rollover Study to Provide Continued Treatment With Eltrombopag | COMPLETED | PHASE4 | 2013-10-15 | 2022-02-23 | 2022-02-23 |
| NCT01961609 | Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants. | COMPLETED | PHASE3 | 2013-10-09 | 2016-07-12 | 2016-07-12 |
| NCT01870778 | Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF | COMPLETED | PHASE3 | 2013-10-02 | 2017-02-01 | 2017-01-23 |
| NCT01870739 | A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension | COMPLETED | PHASE2 | 2013-10 | 2015-06 | 2015-06 |
| NCT01911325 | Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients | TERMINATED | PHASE1 | 2013-10 | 2015-08 | 2015-08 |
| NCT01852292 | Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy | TERMINATED | PHASE2 | 2013-10-01 | 2017-03-30 | 2017-03-30 |
| NCT01928459 | Phase 1b Trial of BGJ398/BYL719 in Solid Tumors | COMPLETED | PHASE1 | 2013-10 | 2016-08 | 2016-08 |
| NCT01998477 | A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications | COMPLETED | PHASE3 | 2013-10 | 2014-07 | 2014-07 |
| NCT01846299 | To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema | COMPLETED | PHASE3 | 2013-10 | 2015-09 | 2015-09 |
| NCT01919229 | A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1) | TERMINATED | PHASE2 | 2013-10 | 2014-09 | 2014-09 |
| NCT01967550 | Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA) | COMPLETED | PHASE3 | 2013-10 | 2014-05 | 2014-05 |
| NCT01973205 | Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine | COMPLETED | PHASE3 | 2013-10 | 2014-07 | 2014-07 |
| NCT01900782 | Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo. | WITHDRAWN | PHASE3 | 2013-10 | 2015-06 | 2015-06 |
| NCT01892436 | Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis | COMPLETED | PHASE3 | 2013-09-30 | 2018-01-11 | 2018-01-11 |
| NCT01908816 | An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. | COMPLETED | PHASE3 | 2013-09-26 | 2016-01-08 | 2016-01-08 |
| NCT01925209 | Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients | COMPLETED | PHASE2, PHASE3 | 2013-09-26 | 2016-01-06 | 2016-01-06 |
| NCT01888432 | Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants | COMPLETED | PHASE3 | 2013-09-25 | 2018-04-21 | 2016-10-19 |
| NCT01922102 | Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia | COMPLETED | PHASE3 | 2013-09-11 | 2016-09-14 | 2016-09-14 |
| NCT01820325 | Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer | TERMINATED | PHASE1 | 2013-09-09 | 2014-06-18 | 2014-06-18 |
| NCT01857193 | Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer | COMPLETED | PHASE1 | 2013-09-06 | 2020-04-16 | 2018-03-14 |
| NCT01890746 | A Safety and Efficacy Study of Eltrombopag in Subjects With AML | COMPLETED | PHASE2 | 2013-09-05 | 2017-01-25 | 2015-03-13 |
| NCT01816594 | NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer | COMPLETED | PHASE2 | 2013-09-03 | 2015-02-18 | 2015-02-18 |
| NCT01610297 | Post Hematopoietic Stem Cell Transplantation | COMPLETED | PHASE4 | 2013-09 | 2015-10 | 2015-10 |
| NCT01840410 | Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. | COMPLETED | PHASE3 | 2013-09 | 2015-11 | 2015-11 |
| NCT01876368 | Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan | COMPLETED | PHASE3 | 2013-09 | 2014-08 | 2014-08 |
| NCT01911936 | A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2013-09 | 2015-03 | 2015-03 |
| NCT01742286 | Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) | COMPLETED | PHASE1 | 2013-08-28 | 2019-04-26 | 2019-04-26 |
| NCT02029274 | Safety and Efficacy of BAF312 in Dermatomyositis | TERMINATED | PHASE2 | 2013-08-25 | 2016-02-17 | 2016-02-17 |
| NCT01952015 | Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) | COMPLETED | PHASE3 | 2013-08-21 | 2016-03-15 | 2016-03-15 |
| NCT01844765 | Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. | COMPLETED | PHASE2 | 2013-08-20 | 2020-08-28 | 2016-06-01 |
| NCT01563354 | 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial | COMPLETED | PHASE2 | 2013-08-16 | 2020-02-10 | 2020-02-10 |
| NCT01920477 | Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris | TERMINATED | PHASE3 | 2013-08-13 | 2018-01-11 | 2016-04-13 |
| NCT01744665 | A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation | COMPLETED | PHASE2 | 2013-08-12 | 2018-09-29 | 2018-09-28 |
| NCT01846273 | Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT) | COMPLETED | PHASE4 | 2013-08-07 | 2017-03-02 | 2016-03-11 |
| NCT01928472 | Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years | COMPLETED | PHASE1 | 2013-08 | 2014-09 | 2014-09 |
| NCT01911221 | A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive. | COMPLETED | PHASE3 | 2013-08 | 2014-04 | 2014-04 |
| NCT01831726 | Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib | COMPLETED | PHASE2 | 2013-08 | 2015-12 | 2015-12 |
| NCT01844778 | Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI) | COMPLETED | PHASE4 | 2013-08 | 2015-10 | 2015-10 |
| NCT02047656 | To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension | TERMINATED | PHASE1 | 2013-08 | 2014-08 | 2014-08 |
| NCT01757691 | Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON) | TERMINATED | PHASE2 | 2013-08 | 2014-05 | 2014-05 |
| NCT01922271 | Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE4 | 2013-08 | 2014-01 | 2014-01 |
| NCT01875523 | PK of Serelaxin in Severe Renal Impairment and ESRD | COMPLETED | PHASE1 | 2013-08 | 2013-12 | 2013-12 |
| NCT01885117 | Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above | COMPLETED | PHASE3 | 2013-08 | 2013-09 | 2013-09 |
| NCT01880697 | Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above | COMPLETED | PHASE3 | 2013-08 | 2013-09 | 2013-09 |
| NCT01845623 | A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture | WITHDRAWN | PHASE2 | 2013-08 | 2013-12 | 2013-12 |
| NCT01892722 | Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis | ACTIVE_NOT_RECRUITING | PHASE3 | 2013-07-26 | 2030-02-18 | 2017-07-14 |
| NCT01822613 | Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC) | COMPLETED | PHASE1 | 2013-07-26 | 2016-06-03 | 2016-06-03 |
| NCT01828099 | LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer | COMPLETED | PHASE3 | 2013-07-09 | 2024-01-07 | 2016-06-24 |
| NCT01904214 | A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function | COMPLETED | PHASE1 | 2013-07 | 2014-11 | 2014-11 |
| NCT01448057 | Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu | COMPLETED | PHASE3 | 2013-07 | 2015-08 | 2015-08 |
| NCT01782326 | QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations) | COMPLETED | PHASE3 | 2013-07 | 2015-09 | 2015-09 |
| NCT01910441 | Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients | TERMINATED | PHASE4 | 2013-07 | 2014-09 | 2014-09 |
| NCT01860989 | A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection | COMPLETED | PHASE2 | 2013-07 | 2014-08 | 2014-08 |
| NCT01915849 | Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE1, PHASE2 | 2013-07 | 2014-01 | 2014-01 |
| NCT01709812 | Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMS | WITHDRAWN | PHASE4 | 2013-07 | 2013-07 | 2013-07 |
| NCT01879540 | Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age | COMPLETED | PHASE2 | 2013-07 | 2013-08 | 2013-08 |
| NCT01879553 | Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above | COMPLETED | PHASE2 | 2013-07 | 2013-08 | 2013-08 |
| NCT01828112 | LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib | COMPLETED | PHASE3 | 2013-06-28 | 2023-11-10 | 2016-01-26 |
| NCT01830010 | A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies | COMPLETED | PHASE1 | 2013-06-28 | 2018-08-21 | 2018-08-21 |
| NCT01863745 | Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment | COMPLETED | PHASE2 | 2013-06-25 | 2023-10-02 | 2023-10-02 |
| NCT01802879 | Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator | COMPLETED | PHASE2 | 2013-06-24 | 2018-11-19 | 2018-11-19 |
| NCT01807520 | Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis | COMPLETED | PHASE3 | 2013-06-20 | 2017-01-03 | 2017-01-03 |
| NCT01806597 | Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis | COMPLETED | PHASE3 | 2013-06-19 | 2016-11-02 | 2016-11-02 |
| NCT02201290 | A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | COMPLETED | PHASE3 | 2013-06-18 | 2017-07-04 | 2017-07-04 |
| NCT01780935 | Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration | COMPLETED | PHASE3 | 2013-06-03 | 2015-07-09 | 2015-07-09 |
| NCT01828086 | Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis | COMPLETED | PHASE1 | 2013-06 | 2015-10 | 2015-10 |
| NCT01894919 | Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28 | COMPLETED | PHASE3 | 2013-06 | 2015-11 | 2015-09 |
| NCT01772797 | Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer | COMPLETED | PHASE1 | 2013-06 | 2016-01 | 2016-01 |
| NCT01871558 | Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin | COMPLETED | PHASE3 | 2013-06 | 2015-02 | 2015-02 |
| NCT01811472 | Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients | COMPLETED | PHASE2 | 2013-06 | 2014-09 | 2014-09 |
| NCT01785602 | Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis. | COMPLETED | PHASE2 | 2013-06 | 2014-11 | 2014-11 |
| NCT01874340 | Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis | TERMINATED | PHASE2 | 2013-06 | 2014-04 | 2014-04 |
| NCT01621269 | ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon | WITHDRAWN | PHASE4 | 2013-06 | 2014-06 | 2014-06 |
| NCT01724138 | An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old | WITHDRAWN | PHASE4 | 2013-06 | 2014-10 | 2014-04 |
| NCT01747876 | Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma | TERMINATED | PHASE1 | 2013-05-28 | 2017-06-29 | 2017-06-29 |
| NCT01677741 | A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects | COMPLETED | PHASE1, PHASE2 | 2013-05-23 | 2020-12-04 | 2020-12-04 |
| NCT01789281 | Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. | COMPLETED | PHASE4 | 2013-05-14 | 2020-08-28 | 2020-08-28 |
| NCT01766778 | Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin | COMPLETED | PHASE4 | 2013-05-13 | 2015-10-22 | 2015-10-22 |
| NCT01787552 | A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF | COMPLETED | PHASE1, PHASE2 | 2013-05-08 | 2018-04-10 | 2018-04-10 |
| NCT01708174 | A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) | COMPLETED | PHASE2 | 2013-05-06 | 2016-10-05 | 2016-10-05 |
| NCT01862263 | Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes | TERMINATED | PHASE4 | 2013-05 | 2015-07 | 2015-07 |
| NCT01898845 | A Phase I Study of LEE011 in Asian Patients | COMPLETED | PHASE1 | 2013-05 | 2015-01 | 2015-01 |
| NCT01836471 | A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients | COMPLETED | PHASE2 | 2013-05 | 2016-02 | 2016-02 |
| NCT01845025 | Study of Safety of Foradil in Patients With Persistent Asthma | TERMINATED | PHASE4 | 2013-05 | 2016-05 | 2016-05 |
| NCT01826214 | Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia | COMPLETED | PHASE2 | 2013-05 | 2015-05 | 2015-05 |
| NCT01855945 | Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older. | COMPLETED | PHASE1 | 2013-05 | 2014-09 | 2014-09 |
| NCT01566630 | Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia | TERMINATED | PHASE2 | 2013-05 | 2014-08 | 2014-08 |
| NCT01478347 | A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults | COMPLETED | PHASE3 | 2013-05 | 2014-11 | 2014-03 |
| NCT01811485 | Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy | COMPLETED | PHASE3 | 2013-05 | 2014-02 | 2014-02 |
| NCT01857206 | Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age | COMPLETED | PHASE3 | 2013-05 | 2014-06 | 2014-06 |
| NCT01700270 | Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors. | COMPLETED | PHASE1 | 2013-05 | 2014-08 | 2014-08 |
| NCT01867021 | Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above | COMPLETED | PHASE4 | 2013-05 | 2013-12 | 2013-12 |
| NCT01823536 | Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose | COMPLETED | PHASE4 | 2013-05 | 2014-06 | 2013-10 |
| NCT01713946 | A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures | COMPLETED | PHASE3 | 2013-04-29 | 2017-10-25 | 2017-10-25 |
| NCT01801917 | Efficacy and Tolerability of BAF312 in Patients With Polymyositis | TERMINATED | PHASE2 | 2013-04-24 | 2016-08-05 | 2016-08-05 |
| NCT01743989 | A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML. | COMPLETED | PHASE3 | 2013-04-15 | 2020-07-08 | 2020-07-08 |
| NCT01752634 | Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis | COMPLETED | PHASE3 | 2013-04-14 | 2019-01-09 | 2014-05-12 |
| NCT01769768 | Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients | COMPLETED | PHASE1 | 2013-04 | 2016-08 | 2016-08 |
| NCT01727024 | Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients | COMPLETED | PHASE4 | 2013-04 | 2015-11 | 2015-11 |
| NCT01785472 | Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension | COMPLETED | PHASE3 | 2013-04 | 2014-08 | 2014-08 |
| NCT01582243 | Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients | COMPLETED | PHASE4 | 2013-04 | 2015-09 | 2015-09 |
| NCT01640964 | An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension | COMPLETED | PHASE2 | 2013-04 | 2014-12 | 2014-12 |
| NCT01757015 | Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS | WITHDRAWN | PHASE3 | 2013-04 | 2014-04 | 2014-04 |
| NCT01735955 | Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study | COMPLETED | PHASE4 | 2013-03-29 | 2023-07-07 | 2023-07-07 |
| NCT03176238 | Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer | COMPLETED | PHASE3 | 2013-03-29 | 2019-01-29 | 2019-01-29 |
| NCT01833169 | BKM120 for Patients With PI3K-activated Tumors | COMPLETED | PHASE2 | 2013-03-29 | 2016-09-26 | 2016-09-26 |
| NCT01742299 | Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator | ACTIVE_NOT_RECRUITING | PHASE4 | 2013-03-26 | 2033-04-21 | 2033-04-21 |
| NCT01737827 | Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma. | TERMINATED | PHASE2 | 2013-03-25 | 2023-05-24 | 2023-04-24 |
| NCT02566031 | A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients | COMPLETED | PHASE4 | 2013-03-23 | 2018-06-04 | 2018-06-04 |
| NCT01760525 | A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors | COMPLETED | PHASE1 | 2013-03-20 | 2020-07-24 | 2020-07-24 |
| NCT01784068 | Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients | COMPLETED | PHASE2 | 2013-03-19 | 2025-01-23 | 2016-05-31 |
| NCT01646684 | Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer | COMPLETED | PHASE1 | 2013-03-08 | 2018-11-13 | 2018-11-13 |
| NCT01698918 | Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer | COMPLETED | PHASE2 | 2013-03-07 | 2021-01-13 | 2015-12-17 |
| NCT01825980 | Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients | COMPLETED | PHASE1, PHASE2 | 2013-03 | 2014-12 | 2014-12 |
| NCT01753323 | Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection | COMPLETED | PHASE2 | 2013-03 | 2014-08 | 2014-08 |
| NCT01764776 | Effect of Hepatic Impairment on LDE225.. | COMPLETED | PHASE1 | 2013-03 | 2015-03 | 2015-03 |
| NCT01846468 | An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction | COMPLETED | PHASE1 | 2013-03-01 | 2014-06-28 | 2014-06-28 |
| NCT01693614 | Safety and Efficacy of BKM120 in Relapsed and Refractory NHL | COMPLETED | PHASE2 | 2013-02-28 | 2017-07-21 | 2017-07-21 |
| NCT01735968 | A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients | COMPLETED | PHASE1 | 2013-02-27 | 2018-10-19 | 2018-10-19 |
| NCT01783444 | A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. | COMPLETED | PHASE2 | 2013-02-26 | 2018-07-30 | 2018-07-02 |
| NCT01775124 | Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration) | COMPLETED | PHASE4 | 2013-02-22 | 2015-11-23 | 2015-11-23 |
| NCT01762761 | Eltrombopag Phase III Study In Chinese Chronic ITP Patients | COMPLETED | PHASE3 | 2013-02-18 | 2018-11-22 | 2014-06-05 |
| NCT01794780 | A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator | COMPLETED | PHASE4 | 2013-02-05 | 2015-05-25 | 2015-05-25 |
| NCT01736540 | An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study) | COMPLETED | PHASE4 | 2013-02 | 2015-05 | 2015-05 |
| NCT01589237 | Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. | TERMINATED | PHASE3 | 2013-02 | 2015-07 | 2015-07 |
| NCT01775137 | Ext. Long-term Safety Study in CF Patients: Single Arm TIP | COMPLETED | PHASE4 | 2013-02 | 2014-11 | 2014-11 |
| NCT01778062 | Indacaterol EfectIveness In COPD Patients With Tuberculosis History | COMPLETED | PHASE3 | 2013-02 | 2014-09 | 2014-09 |
| NCT01743560 | An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis | COMPLETED | PHASE4 | 2013-01-31 | 2016-08-15 | 2016-08-15 |
| NCT01723072 | Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy | COMPLETED | PHASE3 | 2013-01-23 | 2014-05-09 | 2014-05-09 |
| NCT01682083 | Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). | COMPLETED | PHASE3 | 2013-01-08 | 2023-07-31 | 2017-06-30 |
| NCT01637272 | Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome | COMPLETED | PHASE2 | 2013-01-08 | 2015-08-07 | 2015-08-07 |
| NCT02089087 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients | COMPLETED | PHASE1 | 2013-01-07 | 2017-02-03 | 2017-02-03 |
| NCT01766921 | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects | COMPLETED | PHASE2 | 2013-01 | 2014-07 | 2013-07 |
| NCT01776554 | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children | COMPLETED | PHASE2 | 2013-01 | 2014-06 | 2013-06 |
| NCT01691807 | Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma | COMPLETED | PHASE1 | 2013-01 | 2015-12 | 2015-12 |
| NCT01688882 | Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment | TERMINATED | PHASE2 | 2013-01 | 2015-03 | 2015-03 |
| NCT01676948 | An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) | WITHDRAWN | PHASE3 | 2013-01 | 2015-01 | 2015-01 |
| NCT01776541 | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults | COMPLETED | PHASE2 | 2013-01 | 2014-05 | 2013-06 |
| NCT01758380 | Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan | COMPLETED | PHASE4 | 2013-01 | 2013-09 | 2013-09 |
| NCT01843348 | 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients | COMPLETED | PHASE3 | 2012-12-27 | 2016-03-23 | 2016-03-23 |
| NCT01625182 | Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. | COMPLETED | PHASE3 | 2012-12-22 | 2016-09-03 | 2016-09-03 |
| NCT01698905 | Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop) | COMPLETED | PHASE2 | 2012-12-20 | 2025-01-29 | 2015-11-26 |
| NCT01665144 | Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) | COMPLETED | PHASE3 | 2012-12-20 | 2023-03-31 | 2016-04-29 |
| NCT01685138 | LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer | COMPLETED | PHASE2 | 2012-12-20 | 2018-01-22 | 2018-01-22 |
| NCT01526889 | Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis , | COMPLETED | PHASE2 | 2012-12-20 | 2017-08-24 | 2017-02-16 |
| NCT01750918 | BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) | COMPLETED | PHASE1, PHASE2 | 2012-12-19 | 2020-06-18 | 2020-06-18 |
| NCT01730248 | A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis | TERMINATED | PHASE1 | 2012-12-18 | 2017-09-28 | 2017-09-28 |
| NCT01594281 | Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) | COMPLETED | PHASE2 | 2012-12-11 | 2017-12-05 | 2016-11-30 |
| NCT01709838 | Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia | COMPLETED | PHASE4 | 2012-12-06 | 2019-01-17 | 2015-01-03 |
| NCT01647789 | A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer | TERMINATED | PHASE1 | 2012-12-04 | 2016-02-03 | 2016-02-03 |
| NCT01716754 | Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma | COMPLETED | PHASE2 | 2012-12 | 2016-01 | 2016-01 |
| NCT01613950 | PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer | COMPLETED | PHASE1 | 2012-12 | 2014-03 | 2014-03 |
| NCT01625377 | A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients | COMPLETED | PHASE3 | 2012-12 | 2015-03 | 2015-03 |
| NCT01624636 | Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD). | TERMINATED | PHASE2 | 2012-12 | 2013-05 | 2013-05 |
| NCT01692301 | Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension | COMPLETED | PHASE2 | 2012-12 | 2015-04 | 2015-04 |
| NCT01712516 | A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation | COMPLETED | PHASE3 | 2012-12 | 2014-02 | 2014-02 |
| NCT01708161 | A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors | TERMINATED | PHASE1, PHASE2 | 2012-11-27 | 2017-06-01 | 2014-12-26 |
| NCT01283542 | Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma. | COMPLETED | PHASE2 | 2012-11-26 | 2017-09-12 | 2017-09-12 |
| NCT01685060 | LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib | COMPLETED | PHASE2 | 2012-11-26 | 2016-03-29 | 2016-03-29 |
| NCT01646125 | An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations | TERMINATED | PHASE2 | 2012-11-23 | 2015-11-04 | 2015-11-04 |
| NCT01602315 | A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | TERMINATED | PHASE1, PHASE2 | 2012-11-12 | 2016-09-16 | 2016-09-16 |
| NCT01617681 | Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD | COMPLETED | PHASE3 | 2012-11-08 | 2017-01-24 | 2017-01-24 |
| NCT01725217 | Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia | COMPLETED | PHASE3 | 2012-11 | 2013-03 | 2013-03 |
| NCT01703312 | A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma | COMPLETED | PHASE1, PHASE2 | 2012-11 | 2013-10 | 2013-10 |
| NCT01658436 | BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. | COMPLETED | PHASE2 | 2012-11 | 2015-07 | 2015-07 |
| NCT01727141 | A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. | COMPLETED | PHASE3 | 2012-11 | 2014-02 | 2014-02 |
| NCT01652547 | A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma | COMPLETED | PHASE1 | 2012-11 | 2015-04 | 2015-04 |
| NCT01686932 | Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function | COMPLETED | PHASE4 | 2012-11 | 2014-09 | 2014-09 |
| NCT01699685 | Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide. | COMPLETED | PHASE3 | 2012-11 | 2014-06 | 2014-06 |
| NCT01709903 | A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149 | COMPLETED | PHASE3 | 2012-11 | 2014-02 | 2014-02 |
| NCT01715298 | NVA237 BID Versus Placebo Twelve-week Efficacy Study | COMPLETED | PHASE3 | 2012-11 | 2013-12 | 2013-12 |
| NCT01709864 | NVA237 Versus Placebo 12-week Efficacy Study | COMPLETED | PHASE3 | 2012-11 | 2013-10 | 2013-10 |
| NCT01717638 | Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1 | COMPLETED | PHASE3 | 2012-11 | 2013-10 | 2013-09 |
| NCT01636076 | Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2012-11 | 2013-09 | 2013-09 |
| NCT01715311 | Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control | WITHDRAWN | PHASE4 | 2012-11 | 2013-09 | 2013-09 |
| NCT01731990 | Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease | TERMINATED | PHASE2 | 2012-10-30 | 2016-08-04 | 2016-08-04 |
| NCT01697605 | A Phase I Study of Oral BGJ398 in Asian Patients | COMPLETED | PHASE1 | 2012-10-19 | 2019-02-07 | 2019-02-07 |
| NCT01649375 | 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis | COMPLETED | PHASE3 | 2012-10-18 | 2018-09-18 | 2014-08-04 |
| NCT01636687 | Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) | COMPLETED | PHASE3 | 2012-10-17 | 2016-10-27 | 2016-10-27 |
| NCT01649427 | Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients | COMPLETED | PHASE4 | 2012-10-17 | 2015-08-20 | 2015-08-20 |
| NCT01673646 | Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism | COMPLETED | PHASE2 | 2012-10-16 | 2017-04-10 | 2017-04-10 |
| NCT01633060 | A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi | TERMINATED | PHASE3 | 2012-10-03 | 2017-09-21 | 2016-05-23 |
| NCT01565902 | Pharmacokinetics of BAF312 in Patients With Hepatic Impairment | COMPLETED | PHASE1 | 2012-10 | 2014-03 | 2014-03 |
| NCT01598987 | Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. | COMPLETED | PHASE3 | 2012-10 | 2016-06 | 2016-06 |
| NCT01804400 | A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber | COMPLETED | PHASE2 | 2012-10 | 2013-10 | 2013-10 |
| NCT01770379 | Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents. | TERMINATED | PHASE3 | 2012-10 | 2015-05 | 2015-05 |
| NCT01610037 | Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation | COMPLETED | PHASE3 | 2012-10 | 2015-02 | 2015-02 |
| NCT01578330 | A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720 | COMPLETED | PHASE4 | 2012-10 | 2015-04 | 2015-04 |
| NCT01628913 | Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors | TERMINATED | PHASE2 | 2012-10 | 2014-09 | 2014-09 |
| NCT01682863 | A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation | COMPLETED | PHASE3 | 2012-10 | 2014-06 | 2014-06 |
| NCT01697696 | Long Term Safety Study of NVA237 vs QAB149 in COPD Patients | COMPLETED | PHASE3 | 2012-10 | 2014-11 | 2014-11 |
| NCT01619878 | Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg | COMPLETED | PHASE2, PHASE3 | 2012-10 | 2014-07 | 2014-07 |
| NCT01631864 | Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects | COMPLETED | PHASE2 | 2012-10 | 2013-07 | 2013-07 |
| NCT01602406 | Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer | COMPLETED | PHASE1 | 2012-09-21 | 2017-08-02 | 2017-08-02 |
| NCT01640951 | 4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis | COMPLETED | PHASE3 | 2012-09-16 | 2017-05-04 | 2017-05-04 |
| NCT02465203 | 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study | TERMINATED | PHASE3 | 2012-09-06 | 2014-01-23 | 2014-01-23 |
| NCT01730768 | A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients | COMPLETED | PHASE2 | 2012-09 | 2013-12 | 2013-12 |
| NCT01669174 | BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia | COMPLETED | PHASE2 | 2012-09 | 2014-12 | 2014-12 |
| NCT01601470 | Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension | COMPLETED | PHASE2 | 2012-09 | 2013-01 | 2013-01 |
| NCT01634061 | Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients | COMPLETED | PHASE1 | 2012-09 | 2015-07 | 2015-07 |
| NCT01621633 | A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers | COMPLETED | PHASE2 | 2012-09 | 2013-01 | 2013-01 |
| NCT01680016 | A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults | COMPLETED | PHASE3 | 2012-09 | 2013-01 | 2013-01 |
| NCT01593527 | Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease | WITHDRAWN | PHASE3 | 2012-09 | 2012-09 | 2012-09 |
| NCT01690871 | A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa | WITHDRAWN | PHASE2 | 2012-09 | 2015-01 | 2015-01 |
| NCT01705236 | A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® | COMPLETED | PHASE4 | 2012-08-20 | 2019-02-18 | 2019-02-18 |
| NCT01544491 | Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients | COMPLETED | PHASE3 | 2012-08-17 | 2018-09-24 | 2016-10-03 |
| NCT01633112 | MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone | TERMINATED | PHASE3 | 2012-08-09 | 2018-04-30 | 2018-04-30 |
| NCT01610284 | Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor | COMPLETED | PHASE3 | 2012-08-07 | 2019-04-19 | 2015-04-29 |
| NCT01613976 | A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients | COMPLETED | PHASE1 | 2012-08 | 2014-05 | 2014-05 |
| NCT01585272 | Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia | COMPLETED | PHASE4 | 2012-08 | 2015-06 | 2015-06 |
| NCT01572727 | A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation | COMPLETED | PHASE2, PHASE3 | 2012-08 | 2015-06 | 2015-06 |
| NCT01649466 | Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients. | COMPLETED | PHASE4 | 2012-08 | 2013-10 | 2013-10 |
| NCT01617668 | A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer | COMPLETED | PHASE2 | 2012-08 | 2014-09 | 2014-09 |
| NCT01615198 | Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension | COMPLETED | PHASE3 | 2012-08 | 2013-07 | 2013-07 |
| NCT01663233 | Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine | COMPLETED | PHASE3 | 2012-08 | 2013-05 | 2013-05 |
| NCT01681576 | Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension | COMPLETED | PHASE2 | 2012-08 | 2013-10 | 2013-10 |
| NCT01609478 | Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma | COMPLETED | PHASE2 | 2012-08 | 2013-07 | 2013-07 |
| NCT01662440 | Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects | COMPLETED | PHASE3 | 2012-08 | 2013-10 | 2012-12 |
| NCT01666197 | Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain | COMPLETED | PHASE4 | 2012-08 | 2013-01 | 2013-01 |
| NCT02190604 | Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients | TERMINATED | PHASE1, PHASE2 | 2012-07-31 | 2015-11-30 | 2015-11-30 |
| NCT02137889 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients | TERMINATED | PHASE1 | 2012-07 | 2012-11 | 2012-11 |
| NCT01576666 | Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2012-07 | 2015-04 | 2015-04 |
| NCT01640314 | Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above | COMPLETED | PHASE3 | 2012-07 | 2012-08 | 2012-08 |
| NCT01636102 | Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above | COMPLETED | PHASE2 | 2012-07 | 2012-07 | 2012-07 |
| NCT01640327 | Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above | COMPLETED | PHASE3 | 2012-07 | 2012-08 | 2012-08 |
| NCT01646671 | Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients | COMPLETED | PHASE3 | 2012-07 | 2013-02 | 2013-02 |
| NCT01614886 | Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20) | COMPLETED | PHASE3 | 2012-07 | 2014-05 | 2014-05 |
| NCT01514461 | A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome | COMPLETED | PHASE3 | 2012-07 | 2014-05 | 2014-05 |
| NCT01555151 | Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma | COMPLETED | PHASE2 | 2012-07 | 2013-07 | 2013-07 |
| NCT01626209 | A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2012-07 | 2014-04 | 2014-04 |
| NCT01651104 | Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects | COMPLETED | PHASE2 | 2012-07 | 2012-08 | 2012-08 |
| NCT01598077 | A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer | COMPLETED | PHASE1 | 2012-07 | 2014-03 | 2014-03 |
| NCT01544595 | Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab | COMPLETED | PHASE3 | 2012-06-19 | 2017-06-26 | 2017-06-26 |
| NCT01623596 | Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. | COMPLETED | PHASE4 | 2012-06-08 | 2015-07-13 | 2015-07-13 |
| NCT01597908 | Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma | COMPLETED | PHASE3 | 2012-06-04 | 2019-04-25 | 2014-04-17 |
| NCT01576380 | A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients | COMPLETED | PHASE2 | 2012-06 | 2013-09 | 2013-09 |
| NCT01626222 | 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer | COMPLETED | PHASE3 | 2012-06 | 2013-11 | 2013-11 |
| NCT01634763 | Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) | COMPLETED | PHASE1 | 2012-06 | 2016-01 | 2016-01 |
| NCT01594983 | A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia | COMPLETED | PHASE2 | 2012-06 | 2013-07 | 2013-07 |
| NCT01599104 | Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension | COMPLETED | PHASE3 | 2012-06 | 2013-04 | 2013-04 |
| NCT01610050 | A Phase I Study of LFA102 in Japanese Patients | COMPLETED | PHASE1 | 2012-06 | 2014-02 | 2014-02 |
| NCT01613326 | Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2012-06 | 2013-01 | 2013-01 |
| NCT01744028 | Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool. | COMPLETED | PHASE1 | 2012-06 | 2014-01 | 2014-01 |
| NCT01632358 | Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients | COMPLETED | PHASE1 | 2012-06 | 2012-12 | 2012-12 |
| NCT01529307 | First in Human Trial of TAS266 in Patients With Advanced Solid Tumors | TERMINATED | PHASE1 | 2012-06 | 2012-09 | 2012-09 |
| NCT01551212 | Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients | COMPLETED | PHASE4 | 2012-05-24 | 2017-08-08 | 2017-08-08 |
| NCT01514448 | Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib | COMPLETED | PHASE4 | 2012-05-21 | 2016-04-01 | 2016-04-01 |
| NCT01590199 | Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs | COMPLETED | PHASE1 | 2012-05-18 | 2018-09-11 | 2018-09-11 |
| NCT01555125 | First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks | COMPLETED | PHASE3 | 2012-05-08 | 2016-10-24 | 2016-10-24 |
| NCT01584648 | A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma | COMPLETED | PHASE3 | 2012-05-04 | 2019-02-28 | 2013-08-26 |
| NCT01578928 | A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers | COMPLETED | PHASE1 | 2012-05 | 2014-05 | 2014-05 |
| NCT01599650 | Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion | COMPLETED | PHASE3 | 2012-05 | 2015-05 | 2015-05 |
| NCT01580020 | Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO | COMPLETED | PHASE4 | 2012-05 | 2014-10 | 2014-10 |
| NCT01593787 | Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction | COMPLETED | PHASE3 | 2012-05 | 2013-03 | 2013-03 |
| NCT01596647 | Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2012-05 | 2014-07 | 2014-07 |
| NCT01558739 | Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF) | COMPLETED | PHASE4 | 2012-05 | 2014-01 | 2014-01 |
| NCT01604278 | Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2012-05 | 2013-01 | 2013-01 |
| NCT01574651 | The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2012-05 | 2013-04 | 2013-04 |
| NCT01529632 | Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2012-05 | 2012-12 | 2012-12 |
| NCT01558323 | Pharmacokinetics of LCQ908 in Patients With Renal Impairment | COMPLETED | PHASE1 | 2012-05 | 2013-03 | 2013-03 |
| NCT01586962 | Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI | COMPLETED | PHASE3 | 2012-05 | 2012-05 | 2012-05 |
| NCT01585298 | STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) | COMPLETED | PHASE4 | 2012-04-29 | 2016-12-12 | 2016-12-12 |
| NCT01456689 | A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma | COMPLETED | PHASE1 | 2012-04-25 | 2019-06-05 | 2019-06-05 |
| NCT01643850 | MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) | COMPLETED | PHASE2 | 2012-04-23 | 2018-12-21 | 2017-12-07 |
| NCT01468688 | A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients | COMPLETED | PHASE1 | 2012-04-20 | 2016-07-29 | 2016-07-29 |
| NCT01545817 | Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma | TERMINATED | PHASE2 | 2012-04-19 | 2016-11-18 | 2016-11-18 |
| NCT01610336 | A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment | COMPLETED | PHASE2 | 2012-04-05 | 2020-05-27 | 2016-06-10 |
| NCT01528345 | Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer | TERMINATED | PHASE2 | 2012-04 | 2015-04 | 2015-04 |
| NCT01365468 | Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1) | TERMINATED | PHASE2 | 2012-04 | 2015-04 | 2015-04 |
| NCT01491529 | Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias | COMPLETED | PHASE2 | 2012-04 | 2013-04 | 2013-04 |
| NCT01220648 | Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) | COMPLETED | PHASE1 | 2012-04 | 2014-01 | 2014-01 |
| NCT01513460 | Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2012-04 | 2013-12 | 2013-12 |
| NCT01599637 | Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment | COMPLETED | PHASE2 | 2012-04 | 2013-09 | 2013-09 |
| NCT01570686 | 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension | COMPLETED | PHASE4 | 2012-04 | 2012-11 | 2012-11 |
| NCT01582230 | Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | 2012-04 | 2013-05 | 2013-05 |
| NCT01594957 | Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment | COMPLETED | PHASE1 | 2012-04 | 2013-04 | 2013-04 |
| NCT01524783 | Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) | COMPLETED | PHASE3 | 2012-03-30 | 2020-08-07 | 2014-11-28 |
| NCT01528254 | VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2012-03-30 | 2019-04-04 | 2019-04-04 |
| NCT01562041 | Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease | TERMINATED | PHASE2 | 2012-03-09 | 2014-01-02 | 2014-01-02 |
| NCT01547715 | Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India | COMPLETED | PHASE3 | 2012-03 | 2014-04 | 2014-04 |
| NCT01594268 | A Prospective, Open Label Study of CERtican in KIdney Transplantation | COMPLETED | PHASE4 | 2012-03 | 2013-10 | 2013-10 |
| NCT01491932 | Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias | COMPLETED | PHASE2 | 2012-03 | 2013-10 | 2013-10 |
| NCT01902992 | Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch | COMPLETED | PHASE3 | 2012-03 | 2012-07 | 2012-07 |
| NCT01520922 | Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) | COMPLETED | PHASE2 | 2012-03 | 2015-11 | 2013-02 |
| NCT01529619 | Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors | COMPLETED | PHASE4 | 2012-03 | 2013-12 | 2013-12 |
| NCT01619332 | Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 | COMPLETED | PHASE1, PHASE2 | 2012-03 | 2013-09 | 2013-09 |
| NCT01529645 | Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years | COMPLETED | PHASE1 | 2012-03 | 2013-07 | 2012-07 |
| NCT01487785 | Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients | COMPLETED | PHASE1 | 2012-03 | 2014-07 | 2014-07 |
| NCT01478360 | Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma | TERMINATED | PHASE2 | 2012-03 | 2014-11 | 2014-11 |
| NCT01482143 | Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS) | COMPLETED | PHASE1 | 2012-03 | 2013-10 | 2013-10 |
| NCT01543854 | Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure | COMPLETED | PHASE2 | 2012-03 | 2013-01 | 2013-01 |
| NCT01566604 | Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2012-03 | 2013-06 | 2013-06 |
| NCT01596062 | Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) | COMPLETED | PHASE2 | 2012-03 | 2013-03 | 2013-03 |
| NCT01576809 | Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI) | COMPLETED | PHASE3 | 2012-03 | 2012-05 | 2012-05 |
| NCT01288092 | BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer | WITHDRAWN | PHASE2 | 2012-03 | | 2015-09 |
| NCT01290406 | BEZ235 Trial in Patients With Advanced Endometrial Carcinoma | WITHDRAWN | PHASE2 | 2012-03 | 2017-12 | 2014-09 |
| NCT01324479 | Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors | COMPLETED | PHASE1 | 2012-02-29 | 2017-07-04 | 2017-07-04 |
| NCT01531894 | Continuation Study of the Oral AKT Inhibitor GSK2110183 | COMPLETED | PHASE2 | 2012-02-08 | 2018-06-20 | 2018-06-20 |
| NCT01404325 | Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients | COMPLETED | PHASE3 | 2012-02-01 | 2017-01-05 | 2017-01-05 |
| NCT01471847 | A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab | COMPLETED | PHASE1 | 2012-02 | 2012-06 | 2012-06 |
| NCT01541189 | Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients. | COMPLETED | PHASE4 | 2012-02 | 2013-01 | 2013-01 |
| NCT01541956 | Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION) | COMPLETED | PHASE4 | 2012-02 | 2013-12 | 2013-12 |
| NCT01535261 | Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion | COMPLETED | PHASE3 | 2012-02 | 2015-03 | 2015-03 |
| NCT01479595 | A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma | COMPLETED | PHASE2 | 2012-02 | 2015-02 | 2015-02 |
| NCT01546428 | A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2012-02 | 2016-01 | 2016-01 |
| NCT01535950 | Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD) | COMPLETED | PHASE2 | 2012-02 | 2013-07 | 2013-07 |
| NCT01433250 | A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE2 | 2012-02 | 2014-06 | 2014-06 |
| NCT01555138 | Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) | COMPLETED | PHASE4 | 2012-02 | 2014-02 | 2014-02 |
| NCT01497262 | Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE3 | 2012-02 | 2014-04 | 2014-04 |
| NCT01539213 | Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg | COMPLETED | PHASE1 | 2012-02 | 2013-01 | 2013-01 |
| NCT01545726 | Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma | COMPLETED | PHASE2 | 2012-02 | 2013-06 | 2013-06 |
| NCT01546532 | Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF) | COMPLETED | PHASE2 | 2012-02 | 2012-12 | 2012-12 |
| NCT01495247 | Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer | TERMINATED | PHASE1, PHASE2 | 2012-01-30 | 2014-05-19 | 2014-05-19 |
| NCT01527500 | Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD) | COMPLETED | PHASE2 | 2012-01-25 | 2015-06-24 | 2015-06-24 |
| NCT01576367 | Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease | COMPLETED | PHASE3 | 2012-01-16 | 2015-10-13 | 2015-10-13 |
| NCT01474681 | Safety and Tolerability of HSC835 in Patients With Hematological Malignancies | COMPLETED | PHASE1, PHASE2 | 2012-01-09 | 2016-10-03 | 2016-10-03 |
| NCT01552629 | A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients | COMPLETED | PHASE2 | 2012-01-05 | 2013-08-28 | 2013-08-28 |
| NCT01337752 | Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency | COMPLETED | PHASE2 | 2012-01 | 2013-05 | 2013-05 |
| NCT01518101 | Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications | COMPLETED | PHASE4 | 2012-01 | 2012-10 | 2012-10 |
| NCT01601600 | A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults | COMPLETED | PHASE2 | 2012-01 | 2013-12 | 2013-12 |
| NCT01456676 | Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy | COMPLETED | PHASE1 | 2012-01 | 2014-02 | 2014-02 |
| NCT01598103 | Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions | TERMINATED | PHASE2 | 2012-01 | 2012-09 | 2012-09 |
| NCT01478373 | Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib | COMPLETED | PHASE2 | 2012-01 | 2014-07 | 2014-07 |
| NCT01482156 | Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2012-01 | 2015-02 | 2015-02 |
| NCT01537432 | Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients | COMPLETED | PHASE2 | 2012-01 | 2014-12 | 2014-12 |
| NCT01551173 | Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia | COMPLETED | PHASE4 | 2012-01 | 2013-05 | 2013-05 |
| NCT01519661 | Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis | COMPLETED | PHASE4 | 2012-01 | 2014-01 | 2014-01 |
| NCT01534182 | Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC) | COMPLETED | PHASE4 | 2012-01 | 2013-06 | 2013-06 |
| NCT01543828 | Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 | 2012-01 | 2012-03 | 2012-03 |
| NCT01524341 | Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection | COMPLETED | PHASE2 | 2012-01 | 2012-06 | 2012-06 |
| NCT01473901 | A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma | COMPLETED | PHASE1 | 2011-12-30 | 2017-05-17 | 2017-05-17 |
| NCT01498887 | Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy | COMPLETED | PHASE4 | 2011-12-24 | 2015-12-26 | 2015-12-26 |
| NCT01430416 | Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients | COMPLETED | PHASE1 | 2011-12-20 | 2019-05-22 | 2019-05-22 |
| NCT01351103 | A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands | COMPLETED | PHASE1 | 2011-12-01 | 2024-06-17 | 2021-06-01 |
| NCT01428492 | Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma | COMPLETED | PHASE1 | 2011-12 | 2015-10 | 2015-10 |
| NCT01470287 | Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age | COMPLETED | PHASE3 | 2011-12 | 2012-04 | 2012-04 |
| NCT01326845 | Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study | TERMINATED | PHASE4 | 2011-12 | 2012-09 | 2012-09 |
| NCT01497522 | Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2011-12 | 2013-02 | 2013-02 |
| NCT01474434 | Efficacy of LCQ908 on Cardiovascular Risk | TERMINATED | PHASE2 | 2011-12 | 2014-06 | 2014-06 |
| NCT01217177 | A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer | COMPLETED | PHASE1 | 2011-12 | 2014-04 | 2014-04 |
| NCT01412944 | Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis | COMPLETED | PHASE3 | 2011-12 | 2013-04 | 2013-04 |
| NCT01421004 | Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2011-12 | 2014-07 | 2014-07 |
| NCT01660295 | Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects | COMPLETED | PHASE1, PHASE2 | 2011-12 | | 2012-06 |
| NCT01374906 | Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease | COMPLETED | PHASE3 | 2011-11-04 | 2016-12-21 | 2016-12-21 |
| NCT01433445 | Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis | COMPLETED | PHASE1 | 2011-11-01 | 2020-06-22 | 2020-06-22 |
| NCT01470989 | β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3) | COMPLETED | PHASE3 | 2011-11 | 2013-05 | 2013-05 |
| NCT01402401 | Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients | TERMINATED | PHASE2 | 2011-11 | 2013-06 | 2013-06 |
| NCT01443481 | Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function | COMPLETED | PHASE1 | 2011-11 | 2014-10 | 2014-10 |
| NCT01410448 | Everolimus in de Novo Kidney Transplant Recipients | COMPLETED | PHASE3 | 2011-11 | 2015-12 | 2015-12 |
| NCT01491672 | Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma | COMPLETED | PHASE2 | 2011-11 | 2015-05 | 2015-05 |
| NCT01487460 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients | COMPLETED | PHASE1 | 2011-11 | 2012-06 | 2012-06 |
| NCT01490840 | Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis | TERMINATED | PHASE4 | 2011-11 | 2014-07 | 2014-07 |
| NCT01385592 | Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias | COMPLETED | PHASE2 | 2011-11 | 2012-09 | 2012-09 |
| NCT01433354 | Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label) | TERMINATED | PHASE2, PHASE3 | 2011-11 | 2014-09 | 2014-09 |
| NCT01379534 | A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer | COMPLETED | PHASE2 | 2011-11 | 2014-03 | 2014-03 |
| NCT01484197 | A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device | COMPLETED | PHASE2 | 2011-11 | 2012-05 | 2012-05 |
| NCT01402440 | Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma | TERMINATED | PHASE1 | 2011-11 | 2014-04 | 2014-04 |
| NCT01436643 | Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression | TERMINATED | PHASE4 | 2011-11 | 2013-09 | 2013-09 |
| NCT01466387 | A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults | COMPLETED | PHASE3 | 2011-11 | 2012-04 | 2012-04 |
| NCT01453348 | Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine | COMPLETED | PHASE3 | 2011-10 | 2012-01 | 2012-01 |
| NCT01358175 | 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis | COMPLETED | PHASE3 | 2011-10 | 2014-12 | 2014-12 |
| NCT01359943 | Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate | COMPLETED | PHASE2 | 2011-10 | 2013-12 | 2013-12 |
| NCT01546415 | Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia | COMPLETED | PHASE4 | 2011-10 | 2013-11 | 2013-11 |
| NCT01727128 | Pharmacokinetic Study of BKM120 in Subjects With Hepatic Impairment | COMPLETED | PHASE1 | 2011-10 | 2013-08 | 2013-08 |
| NCT01437267 | Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants | COMPLETED | PHASE2 | 2011-10 | 2012-08 | 2012-08 |
| NCT01438996 | Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults | COMPLETED | PHASE2 | 2011-10 | 2011-12 | 2011-12 |
| NCT01490125 | The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2011-10 | 2012-08 | 2012-08 |
| NCT01387321 | A Study of BYL719 in Adult Patients With Advanced Solid Malignancies | COMPLETED | PHASE1 | 2011-09-22 | 2015-11-25 | 2015-11-25 |
| NCT01474421 | Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease | COMPLETED | PHASE2 | 2011-09-15 | 2013-02-21 | 2013-02-21 |
| NCT01449591 | Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients | COMPLETED | PHASE2 | 2011-09 | 2012-02 | 2012-02 |
| NCT01440374 | A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia | COMPLETED | PHASE2 | 2011-09 | 2015-12 | 2015-03 |
| NCT01434680 | Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers | COMPLETED | PHASE2 | 2011-09 | 2012-11 | 2012-11 |
| NCT01338831 | Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer | COMPLETED | PHASE1 | 2011-09 | 2014-03 | 2014-03 |
| NCT01350804 | Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) | COMPLETED | PHASE3 | 2011-09 | 2015-02 | 2015-02 |
| NCT01392326 | Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) | COMPLETED | PHASE3 | 2011-09 | 2014-10 | 2014-10 |
| NCT01412801 | Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings | COMPLETED | PHASE2 | 2011-09 | 2012-12 | 2012-10 |
| NCT01446289 | Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings | COMPLETED | PHASE2 | 2011-09 | 2013-10 | 2013-04 |
| NCT01499667 | Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod | TERMINATED | PHASE3 | 2011-09 | 2012-11 | 2012-11 |
| NCT01424644 | A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents | COMPLETED | PHASE4 | 2011-09 | 2012-12 | 2012-12 |
| NCT01377428 | Efficacy of Indacaterol 150 µg Versus Formoterol | WITHDRAWN | PHASE4 | 2011-09 | 2012-02 | 2012-02 |
| NCT01422512 | Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects | COMPLETED | PHASE3 | 2011-09 | 2011-10 | 2011-10 |
| NCT01377012 | Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents | COMPLETED | PHASE3 | 2011-08-30 | 2015-09-09 | 2015-09-09 |
| NCT01431638 | Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients | COMPLETED | PHASE3 | 2011-08-25 | 2013-05-09 | 2013-05-09 |
| NCT01493414 | INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis. | COMPLETED | PHASE3 | 2011-08-16 | 2017-01-26 | 2017-01-26 |
| NCT01582061 | An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. | COMPLETED | PHASE3 | 2011-08-16 | 2017-01-26 | 2017-01-26 |
| NCT01231659 | Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | COMPLETED | PHASE2 | 2011-08-09 | 2017-04-30 | 2012-11-20 |
| NCT01336634 | Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer. | COMPLETED | PHASE2 | 2011-08-05 | 2021-01-07 | 2015-10-01 |
| NCT01437735 | Dose Finding Study for QAW039 in Asthma | COMPLETED | PHASE2 | 2011-08 | 2013-11 | 2013-11 |
| NCT01272180 | Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults | COMPLETED | PHASE2 | 2011-08 | 2012-09 | 2011-10 |
| NCT01423110 | Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis | COMPLETED | PHASE2 | 2011-08 | 2012-05 | 2012-05 |
| NCT01420055 | Fingolimod -Response According to Coping - Evaluation | COMPLETED | PHASE4 | 2011-08 | 2013-06 | 2013-06 |
| NCT01396083 | Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) | COMPLETED | PHASE3 | 2011-08 | 2014-01 | 2014-01 |
| NCT01365481 | Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age | COMPLETED | PHASE3 | 2011-08 | 2015-09 | 2015-09 |
| NCT01364415 | Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs) | COMPLETED | PHASE1 | 2011-08 | 2016-04 | 2016-04 |
| NCT01348087 | Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome | TERMINATED | PHASE2 | 2011-08 | 2014-09 | 2014-09 |
| NCT01433263 | Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas | COMPLETED | PHASE2 | 2011-08 | 2014-04 | 2014-04 |
| NCT01426789 | A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients | COMPLETED | PHASE2 | 2011-08 | 2014-02 | 2014-02 |
| NCT01406938 | Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens | COMPLETED | PHASE3 | 2011-08 | 2013-05 | 2013-05 |
| NCT01423084 | Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years | COMPLETED | PHASE3 | 2011-08 | 2011-12 | 2011-12 |
| NCT01410474 | Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan | COMPLETED | PHASE3 | 2011-08 | 2012-01 | 2012-01 |
| NCT01433107 | Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis | COMPLETED | PHASE3 | 2011-08 | 2012-02 | 2012-02 |
| NCT01404962 | Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children | COMPLETED | PHASE4 | 2011-08 | 2012-07 | 2012-07 |
| NCT01447485 | Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients | COMPLETED | PHASE1 | 2011-08 | 2011-10 | 2011-10 |
| NCT01859455 | Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins | COMPLETED | PHASE1 | 2011-07 | 2012-07 | 2012-07 |
| NCT01232296 | A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment | COMPLETED | PHASE2 | 2011-07 | 2014-04 | 2014-04 |
| NCT01367158 | Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines | COMPLETED | PHASE2 | 2011-07 | 2012-07 | 2012-01 |
| NCT01396057 | Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) | COMPLETED | PHASE3 | 2011-07 | 2013-06 | 2013-06 |
| NCT01399125 | A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease | COMPLETED | PHASE3 | 2011-07 | 2013-05 | 2013-05 |
| NCT01365494 | Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules | COMPLETED | PHASE4 | 2011-07 | 2011-11 | 2011-11 |
| NCT01433458 | Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Subjects | COMPLETED | PHASE1 | 2011-07 | 2011-12 | 2011-12 |
| NCT01387958 | A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients | TERMINATED | PHASE2 | 2011-07 | 2012-02 | 2012-02 |
| NCT01327053 | A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | COMPLETED | PHASE2 | 2011-06-29 | 2018-06-29 | 2013-06-28 |
| NCT01362608 | Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective | TERMINATED | PHASE3 | 2011-06-20 | 2015-05-19 | 2015-05-19 |
| NCT01365455 | Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year | COMPLETED | PHASE3 | 2011-06 | 2013-04 | 2013-04 |
| NCT01358578 | Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis | COMPLETED | PHASE3 | 2011-06 | 2013-07 | 2013-07 |
| NCT01379521 | Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC | TERMINATED | PHASE2 | 2011-06 | 2015-06 | 2015-06 |
| NCT01355614 | A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients | COMPLETED | PHASE2 | 2011-06 | 2013-03 | 2013-03 |
| NCT01377597 | Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion | COMPLETED | PHASE3 | 2011-06 | 2012-04 | 2012-04 |
| NCT01374451 | Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET | TERMINATED | PHASE2 | 2011-06 | 2015-02 | 2015-02 |
| NCT01338805 | Phase II BGG492 Capsule Extension for Partial Epilepsy | COMPLETED | PHASE2 | 2011-06 | 2012-07 | 2012-07 |
| NCT01392495 | Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) | TERMINATED | PHASE3 | 2011-06 | 2014-03 | 2014-03 |
| NCT01407003 | Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM) | COMPLETED | PHASE1, PHASE2 | 2011-06 | 2013-02 | 2013-02 |
| NCT01398592 | Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy | COMPLETED | PHASE4 | 2011-06 | 2012-06 | 2012-06 |
| NCT01294579 | Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) | COMPLETED | PHASE2 | 2011-05-17 | 2016-12-20 | 2016-12-20 |
| NCT01320358 | Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients | COMPLETED | PHASE2 | 2011-05-10 | 2011-11-18 | 2011-11-18 |
| NCT01160211 | A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer | COMPLETED | PHASE3 | 2011-05-05 | 2022-06-06 | 2016-03-11 |
| NCT01344057 | Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012 | COMPLETED | PHASE2 | 2011-05 | 2011-06 | 2011-06 |
| NCT01342796 | Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects | COMPLETED | PHASE2 | 2011-05 | 2012-02 | 2012-02 |
| NCT01345721 | Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine | COMPLETED | PHASE3 | 2011-05 | 2011-09 | 2011-09 |
| NCT01302886 | Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma | COMPLETED | PHASE2 | 2011-05 | 2013-11 | 2013-11 |
| NCT01333501 | Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms | COMPLETED | PHASE4 | 2011-05 | 2015-09 | 2015-09 |
| NCT01297491 | Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer | COMPLETED | PHASE2 | 2011-05 | 2014-10 | 2014-10 |
| NCT01317004 | Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change | COMPLETED | PHASE4 | 2011-05 | 2014-06 | 2014-06 |
| NCT01357239 | Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome | COMPLETED | PHASE2 | 2011-05 | 2014-01 | 2014-01 |
| NCT01428297 | A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome | COMPLETED | PHASE1 | 2011-05 | 2014-02 | 2014-02 |
| NCT01356602 | Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients | COMPLETED | PHASE3 | 2011-05 | 2012-09 | 2012-09 |
| NCT01368536 | Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes | TERMINATED | PHASE4 | 2011-05 | 2012-02 | 2012-02 |
| NCT01456663 | A Study to Evaluate the Pharmacokinetics of AFQ056 in Subjects With Hepatic Impairment Compared to Healthy Subjects | COMPLETED | PHASE1 | 2011-05 | 2012-07 | 2012-07 |
| NCT01373086 | LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension | TERMINATED | PHASE2 | 2011-05 | 2011-10 | 2011-10 |
| NCT01357265 | Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects | COMPLETED | PHASE2 | 2011-05 | 2011-06 | 2011-05 |
| NCT01595009 | An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1) | COMPLETED | PHASE4 | 2011-04-27 | 2016-08-09 | 2016-08-09 |
| NCT01392469 | Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants | COMPLETED | PHASE3 | 2011-04-20 | 2012-10-25 | 2012-10-25 |
| NCT01077544 | A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) | COMPLETED | PHASE1 | 2011-04-14 | 2015-07-01 | 2015-07-01 |
| NCT01313689 | Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia | COMPLETED | PHASE3 | 2011-04-14 | 2017-04-24 | 2014-03-18 |
| NCT01327846 | Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) | COMPLETED | PHASE3 | 2011-04-11 | 2019-04-14 | 2017-03-28 |
| NCT01240655 | A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2011-04 | 2015-01 | 2015-01 |
| NCT01275196 | Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients | COMPLETED | PHASE3 | 2011-04 | 2014-10 | 2014-10 |
| NCT01339923 | A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years | COMPLETED | PHASE3 | 2011-04 | 2014-12 | 2014-01 |
| NCT01254188 | Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients | COMPLETED | PHASE3 | 2011-04 | 2014-11 | 2014-11 |
| NCT01317615 | RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation | COMPLETED | PHASE4 | 2011-04 | 2015-03 | 2015-03 |
| NCT01350115 | Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | COMPLETED | PHASE2 | 2011-04 | 2012-10 | 2012-10 |
| NCT01346592 | Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age | COMPLETED | PHASE3 | 2011-04 | 2012-07 | 2012-07 |
| NCT01338818 | Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder | COMPLETED | PHASE3 | 2011-04 | 2013-02 | 2013-02 |
| NCT01357252 | Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes | COMPLETED | PHASE3 | 2011-04 | 2013-01 | 2013-01 |
| NCT01348100 | Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients | COMPLETED | PHASE1, PHASE2 | 2011-04 | 2012-07 | 2012-07 |
| NCT01356381 | Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes | COMPLETED | PHASE4 | 2011-04 | 2013-08 | 2013-08 |
| NCT01335724 | Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain | COMPLETED | PHASE4 | 2011-04 | 2011-07 | 2011-07 |
| NCT01257126 | Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection | WITHDRAWN | PHASE4 | 2011-04 | | 2011-12 |
| NCT01331239 | Safety and Efficacy of LCI699 in Cushing's Disease Patients | COMPLETED | PHASE2 | 2011-03-23 | 2019-10-22 | 2019-10-22 |
| NCT01379508 | Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept | COMPLETED | PHASE4 | 2011-03-21 | 2015-12-10 | 2015-12-10 |
| NCT01429337 | PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function | COMPLETED | PHASE1 | 2011-03-07 | 2020-05-09 | 2020-04-13 |
| NCT01328886 | Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children | COMPLETED | PHASE3 | 2011-03 | 2013-12 | 2013-12 |
| NCT01223027 | Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma | COMPLETED | PHASE3 | 2011-03 | 2014-06 | 2014-06 |
| NCT01353508 | Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers | COMPLETED | PHASE2 | 2011-03 | 2012-08 | 2012-08 |
| NCT01303380 | Canakinumab in Patients With Active Hyper-IgD Syndrome | COMPLETED | PHASE2 | 2011-03 | 2014-07 | 2014-07 |
| NCT01435330 | Safety and Tolerability of BVS857 in Subjects With Insulin Resistance | COMPLETED | PHASE1 | 2011-03 | 2012-03 | 2012-03 |
| NCT01229176 | Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants | COMPLETED | PHASE2 | 2011-03 | 2012-06 | 2012-06 |
| NCT01327664 | Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis | WITHDRAWN | PHASE3 | 2011-03 | | 2014-05 |
| NCT01232894 | 12-week Open-label Evaluation of Efficacy and Safety of Indacaterol | COMPLETED | PHASE3 | 2011-03 | 2012-05 | 2012-05 |
| NCT01315249 | QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2011-03 | 2012-03 | 2012-03 |
| NCT01596712 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects | COMPLETED | PHASE1 | 2011-03 | 2012-08 | 2012-08 |
| NCT01322321 | ACZ885 in Type 1 Diabetes Mellitus | WITHDRAWN | PHASE2 | 2011-03 | | 2011-06 |
| NCT01459250 | Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects | COMPLETED | PHASE1 | 2011-03 | | 2011-08 |
| NCT01364389 | A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica | TERMINATED | PHASE2 | 2011-02-14 | 2013-01-29 | 2013-01-29 |
| NCT01531309 | Pharmacokinetics of AGO178 in Participants With Liver Impairment | COMPLETED | PHASE1 | 2011-02-08 | 2011-09-02 | 2011-09-02 |
| NCT01289041 | BKM120 as Second-line Therapy for Advanced Endometrial Cancer | COMPLETED | PHASE2 | 2011-02 | 2014-03 | 2014-03 |
| NCT01294774 | Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus | COMPLETED | PHASE2 | 2011-02 | 2012-10 | 2012-10 |
| NCT01315275 | A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema | COMPLETED | PHASE4 | 2011-02 | 2012-08 | 2012-08 |
| NCT01309698 | Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes | COMPLETED | PHASE4 | 2011-02 | | 2011-04 |
| NCT01310166 | Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE4 | 2011-02 | 2012-07 | 2012-07 |
| NCT01125800 | A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB | COMPLETED | PHASE1, PHASE2 | 2011-02 | 2014-10 | 2014-10 |
| NCT01294787 | Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2011-02 | 2011-11 | 2011-11 |
| NCT01275209 | Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma | COMPLETED | PHASE1 | 2011-02 | 2012-05 | 2012-05 |
| NCT01274351 | Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) | COMPLETED | PHASE2 | 2011-01-25 | 2019-08-01 | 2019-08-01 |
| NCT01283516 | A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase | COMPLETED | PHASE1 | 2011-01-24 | 2016-05-03 | 2016-05-03 |
| NCT01542866 | A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD) | COMPLETED | NA | 2011-01-11 | 2011-11-30 | 2011-11-30 |
| NCT01254227 | Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload | COMPLETED | PHASE2 | 2011-01 | 2013-11 | 2013-11 |
| NCT01459718 | Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload | TERMINATED | PHASE2 | 2011-01 | 2014-06 | 2014-06 |
| NCT01302873 | Study of BGG492 in Patients With Chronic Subjective Tinnitus | COMPLETED | PHASE2 | 2011-01 | 2012-01 | 2012-01 |
| NCT01442259 | An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects | COMPLETED | PHASE1 | 2011-01 | 2011-08 | 2011-08 |
| NCT01297569 | Ranibizumab "Treat and Extend" in Diabetic Macular Edma | COMPLETED | PHASE4 | 2011-01 | 2012-11 | 2012-11 |
| NCT01237873 | Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension | COMPLETED | PHASE3 | 2011-01 | 2012-02 | 2012-02 |
| NCT01285466 | A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab | COMPLETED | PHASE1 | 2011-01 | 2014-10 | 2014-10 |
| NCT01281306 | An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension | COMPLETED | PHASE2 | 2011-01 | 2011-12 | 2011-12 |
| NCT01257815 | Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment | COMPLETED | PHASE4 | 2011-01 | 2013-04 | 2013-04 |
| NCT01259297 | A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People | TERMINATED | PHASE3 | 2011-01 | 2012-11 | 2012-11 |
| NCT01285492 | Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2011-01 | 2012-09 | 2012-09 |
| NCT01272934 | Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain | COMPLETED | PHASE3 | 2011-01 | 2011-08 | 2011-08 |
| NCT01302899 | To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy | TERMINATED | PHASE2 | 2011-01 | 2011-12 | 2011-12 |
| NCT01272947 | Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries | COMPLETED | PHASE3 | 2011-01 | 2011-07 | 2011-07 |
| NCT01237236 | A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. | COMPLETED | PHASE1 | 2010-12-21 | 2017-03-09 | 2017-03-09 |
| NCT02675803 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients | COMPLETED | PHASE1 | 2010-12-20 | 2018-01-22 | 2018-01-22 |
| NCT01103024 | Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis | WITHDRAWN | PHASE3 | 2010-12 | 2011-02 | 2011-02 |
| NCT01148797 | Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF) | COMPLETED | PHASE2 | 2010-12 | | 2012-02 |
| NCT01375179 | Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients | TERMINATED | PHASE2 | 2010-12 | 2012-05 | 2012-05 |
| NCT01266135 | Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF) | TERMINATED | PHASE2 | 2010-12 | 2013-04 | 2013-04 |
| NCT01324492 | Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor | COMPLETED | PHASE1 | 2010-12 | 2014-06 | 2014-06 |
| NCT01979601 | Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia | COMPLETED | PHASE1 | 2010-12 | 2011-11 | 2011-11 |
| NCT01265446 | Efficacy and Safety of a Sore Throat Lozenge Containing Lidocaine and Cetylpyridinium Chloride in Patients With Sore Throat Due to a Common Cold. | COMPLETED | PHASE3 | 2010-12 | 2011-04 | 2011-04 |
| NCT01257451 | Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients | COMPLETED | PHASE3 | 2010-12 | 2012-03 | 2012-03 |
| NCT01274897 | A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea | COMPLETED | PHASE3 | 2010-12 | 2011-03 | 2011-03 |
| NCT01210885 | Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents | COMPLETED | PHASE2 | 2010-12 | 2011-07 | 2011-07 |
| NCT01235962 | A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) | COMPLETED | PHASE3 | 2010-11-30 | 2019-04-15 | 2015-10-15 |
| NCT01231594 | A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors | COMPLETED | PHASE1 | 2010-11-05 | 2018-04-09 | 2018-04-09 |
| NCT01376310 | GSK1120212 Rollover Study | TERMINATED | PHASE2 | 2010-11-02 | 2018-01-18 | 2018-01-18 |
| NCT01302860 | Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease | COMPLETED | PHASE3 | 2010-11 | 2014-11 | 2014-11 |
| NCT01262586 | Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device. | COMPLETED | PHASE3 | 2010-11 | 2011-03 | 2011-03 |
| NCT01263353 | Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs | COMPLETED | PHASE1 | 2010-11 | 2014-03 | 2014-03 |
| NCT01253629 | Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome | COMPLETED | PHASE2 | 2010-11 | 2013-08 | 2013-08 |
| NCT01227577 | CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib | COMPLETED | PHASE4 | 2010-11 | 2014-11 | 2014-11 |
| NCT01256411 | A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension | COMPLETED | PHASE2 | 2010-11 | 2012-04 | 2012-04 |
| NCT01259492 | Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD) | COMPLETED | PHASE3 | 2010-11 | 2012-08 | 2012-08 |
| NCT01256658 | A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®) | COMPLETED | PHASE4 | 2010-11 | 2012-07 | 2012-07 |
| NCT01253603 | Efficacy, Safety, and Pharmacokinetics of QAW039 | COMPLETED | PHASE2 | 2010-11 | 2011-09 | 2011-09 |
| NCT01250171 | The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients | COMPLETED | PHASE2 | 2010-11 | 2011-09 | 2011-09 |
| NCT01255423 | Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain | COMPLETED | PHASE3 | 2010-11 | 2011-06 | 2011-06 |
| NCT01179620 | Certoparin in Renal Patients Undergoing Hemodialysis | COMPLETED | PHASE3 | 2010-11 | 2011-03 | 2011-03 |
| NCT01248468 | Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine | COMPLETED | PHASE4 | 2010-11 | 2011-03 | 2011-03 |
| NCT01255462 | Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration | COMPLETED | PHASE1 | 2010-11 | 2011-09 | 2011-09 |
| NCT01197300 | 1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids | COMPLETED | PHASE3 | 2010-10-25 | 2019-02-27 | 2019-02-27 |
| NCT01131325 | Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations | TERMINATED | PHASE4 | 2010-10-21 | 2011-05-12 | 2011-05-12 |
| NCT01392443 | Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF | COMPLETED | PHASE2 | 2010-10-14 | 2017-10-31 | 2017-10-31 |
| NCT01200589 | Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy | TERMINATED | PHASE3 | 2010-10-11 | 2016-12-19 | 2016-12-19 |
| NCT01219699 | A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene | COMPLETED | PHASE1 | 2010-10-05 | 2020-04-16 | 2015-02-05 |
| NCT01222403 | A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older | COMPLETED | PHASE4 | 2010-10 | 2014-10 | 2014-10 |
| NCT01214837 | Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life | COMPLETED | PHASE3 | 2010-10 | 2012-05 | 2012-04 |
| NCT01173731 | Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias | COMPLETED | PHASE2 | 2010-10 | 2013-10 | 2013-10 |
| NCT01426802 | Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin | COMPLETED | PHASE4 | 2010-10 | 2011-04 | 2011-04 |
| NCT01238978 | Phase 4 Study in the Elderly Patients With T2DM | COMPLETED | PHASE4 | 2010-10 | 2011-12 | 2011-12 |
| NCT01233622 | Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride | COMPLETED | PHASE3 | 2010-10 | 2011-11 | 2011-11 |
| NCT01208831 | An East Asian Study of LDE225 | COMPLETED | PHASE1 | 2010-10 | 2013-10 | 2013-10 |
| NCT01195376 | A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2010-10 | 2013-07 | 2013-07 |
| NCT01124864 | A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. | COMPLETED | PHASE2 | 2010-10 | 2014-08 | 2014-08 |
| NCT01106508 | A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2010-10 | 2015-06 | 2015-06 |
| NCT01242813 | Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS). | COMPLETED | PHASE2 | 2010-10 | 2014-06 | 2014-06 |
| NCT01242774 | Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) | COMPLETED | PHASE1 | 2010-10 | 2014-05 | 2014-05 |
| NCT01232595 | Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections | COMPLETED | PHASE2 | 2010-10 | 2013-07 | 2013-07 |
| NCT01193920 | Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age | COMPLETED | PHASE1, PHASE2 | 2010-10 | 2012-12 | 2011-12 |
| NCT01217944 | Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia | COMPLETED | PHASE3 | 2010-10 | 2012-08 | 2012-08 |
| NCT01193907 | Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old) | COMPLETED | PHASE2 | 2010-10 | 2010-11 | 2010-11 |
| NCT01166178 | Zoledronic Acid in MS-patients With Osteoporosis | TERMINATED | PHASE3 | 2010-10 | 2012-06 | 2012-06 |
| NCT01237223 | Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension | COMPLETED | PHASE3 | 2010-10 | 2011-05 | 2011-05 |
| NCT01256294 | Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients | COMPLETED | PHASE4 | 2010-10 | 2011-05 | 2011-05 |
| NCT01066468 | Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders. | TERMINATED | PHASE1 | 2010-10 | | 2011-05 |
| NCT01568762 | To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma | COMPLETED | PHASE1 | 2010-10 | | 2011-07 |
| NCT01226953 | Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants | COMPLETED | PHASE3 | 2010-10 | 2011-03 | 2010-12 |
| NCT01201356 | Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis | COMPLETED | PHASE3 | 2010-09-13 | 2018-10-19 | 2018-10-19 |
| NCT01224366 | Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 | 2010-09 | 2011-10 | 2011-10 |
| NCT01271920 | Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab | COMPLETED | PHASE1, PHASE2 | 2010-09 | 2013-10 | 2013-10 |
| NCT01214850 | Novartis Vaccine and Diagnostics Carriage Trial | COMPLETED | PHASE3 | 2010-09 | 2012-01 | 2012-01 |
| NCT01026961 | Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers | WITHDRAWN | PHASE1, PHASE2 | 2010-09 | | 2010-11 |
| NCT01202903 | Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy | COMPLETED | PHASE3 | 2010-09 | 2013-10 | 2013-10 |
| NCT01171976 | Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus | COMPLETED | PHASE3 | 2010-09 | 2013-04 | 2013-04 |
| NCT01209780 | Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age | COMPLETED | PHASE3 | 2010-09 | 2011-09 | 2011-03 |
| NCT01202188 | A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2010-09 | 2012-03 | 2012-02 |
| NCT01210898 | Immunogenicity and Safety of V70P5 Revaccination Subjects | COMPLETED | PHASE3 | 2010-09 | 2011-12 | 2011-01 |
| NCT01224717 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women | COMPLETED | PHASE1 | 2010-09 | | 2011-04 |
| NCT01185821 | Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE2 | 2010-08-30 | 2016-10-10 | 2016-10-10 |
| NCT01077518 | Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy | TERMINATED | PHASE3 | 2010-08-26 | 2018-12-26 | 2018-01-03 |
| NCT01114529 | Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients | COMPLETED | PHASE3 | 2010-08-09 | 2014-10-30 | 2014-10-30 |
| NCT01216085 | An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints | COMPLETED | PHASE2 | 2010-08 | 2011-07 | 2011-07 |
| NCT01148524 | Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10 | COMPLETED | PHASE2, PHASE3 | 2010-08 | 2012-01 | 2012-01 |
| NCT01105507 | The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada | COMPLETED | PHASE3 | 2010-08 | 2012-05-12 | 2012-05-12 |
| NCT01193101 | Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension | COMPLETED | PHASE2 | 2010-08 | 2011-04 | 2011-04 |
| NCT01151410 | An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age | COMPLETED | PHASE3 | 2010-08 | 2015-08 | 2015-08 |
| NCT01090310 | Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis | TERMINATED | PHASE3 | 2010-08 | 2011-07 | 2011-07 |
| NCT01169701 | 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients | COMPLETED | PHASE4 | 2010-08 | 2014-03 | 2014-03 |
| NCT01162122 | Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects | COMPLETED | PHASE3 | 2010-08 | 2011-11 | 2011-08 |
| NCT01216072 | A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis | COMPLETED | PHASE4 | 2010-08 | 2012-08 | 2012-08 |
| NCT01529294 | Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers | COMPLETED | PHASE1 | 2010-08 | 2012-07 | 2012-07 |
| NCT01207414 | Switching to Iloperidone From Other Antipsychotics in Schizophrenia | COMPLETED | PHASE4 | 2010-08 | 2012-01 | 2012-01 |
| NCT01199861 | Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS) | COMPLETED | PHASE3 | 2010-08 | 2011-05 | 2011-05 |
| NCT01167335 | Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures | WITHDRAWN | PHASE2 | 2010-08 | | 2010-11 |
| NCT01137682 | Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly | COMPLETED | PHASE3 | 2010-07-19 | 2017-02-28 | 2013-01-22 |
| NCT01148017 | Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine | COMPLETED | PHASE3 | 2010-07 | 2013-04 | 2013-04 |
| NCT01155713 | Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2010-07 | 2013-11 | 2013-11 |
| NCT01135914 | Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) | COMPLETED | PHASE3 | 2010-07 | 2013-03 | 2013-03 |
| NCT01179737 | Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) | TERMINATED | PHASE2 | 2010-07 | 2013-01 | 2013-01 |
| NCT01161264 | Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects | COMPLETED | PHASE3 | 2010-07 | 2010-07 | 2010-07 |
| NCT01148810 | Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis | TERMINATED | PHASE2 | 2010-06-15 | 2012-06-13 | 2012-06-13 |
| NCT01169844 | Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis | COMPLETED | PHASE2 | 2010-06 | 2012-11 | 2012-11 |
| NCT01083602 | Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma | COMPLETED | PHASE2 | 2010-06 | 2014-02 | 2014-02 |
| NCT01155700 | Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years) | COMPLETED | PHASE3 | 2010-06 | 2012-02 | 2012-02 |
| NCT01034163 | A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) | COMPLETED | PHASE3 | 2010-06 | 2012-05 | 2012-05 |
| NCT01223898 | To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib | COMPLETED | PHASE1 | 2010-06 | 2013-12 | 2013-12 |
| NCT00997477 | Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics | WITHDRAWN | PHASE4 | 2010-06 | | 2010-07 |
| NCT01152814 | Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011 | COMPLETED | PHASE2 | 2010-06 | 2010-07 | 2010-06 |
| NCT01028222 | A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation | COMPLETED | PHASE2 | 2010-06 | 2014-12 | 2014-12 |
| NCT01150357 | Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age | COMPLETED | PHASE3 | 2010-06 | 2014-08 | 2014-08 |
| NCT01139021 | One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of Age | COMPLETED | PHASE3 | 2010-06 | 2011-09 | 2010-11 |
| NCT01176032 | ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling | COMPLETED | PHASE4 | 2010-06 | 2013-04 | 2013-04 |
| NCT01129336 | Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients | COMPLETED | PHASE4 | 2010-06 | 2012-08 | 2012-08 |
| NCT01147003 | Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures | COMPLETED | PHASE2 | 2010-06 | 2011-09 | 2011-09 |
| NCT01156415 | Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) | TERMINATED | PHASE3 | 2010-06 | 2011-10 | 2011-10 |
| NCT01131585 | Safety and Efficacy of Ranibizumab in Diabetic Macular Edema | TERMINATED | PHASE3 | 2010-06 | 2011-07 | 2011-07 |
| NCT01613690 | Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment | COMPLETED | PHASE1 | 2010-06 | 2010-11 | 2010-11 |
| NCT01193296 | Glycemic Holter Study (Continuous Glucose Monitoring) - | COMPLETED | PHASE4 | 2010-06 | 2011-06 | 2011-06 |
| NCT01159249 | Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2010-06 | 2012-01 | 2012-01 |
| NCT01154127 | Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2010-06 | 2011-02 | 2011-02 |
| NCT01568775 | Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects | COMPLETED | PHASE1 | 2010-06 | 2010-09 | 2010-09 |
| NCT01151059 | Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly Subjects | COMPLETED | PHASE2 | 2010-06 | 2010-07 | 2010-06 |
| NCT01147081 | Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2010/2011 | COMPLETED | PHASE3 | 2010-06 | 2010-07 | 2010-07 |
| NCT01147822 | Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma | COMPLETED | PHASE2 | 2010-05-19 | 2021-09-03 | 2012-05-21 |
| NCT01064310 | Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer | COMPLETED | PHASE3 | 2010-05-17 | 2015-11-23 | 2011-10-19 |
| NCT01132612 | AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis | COMPLETED | PHASE2 | 2010-05-11 | 2016-10-18 | 2016-10-18 |
| NCT01039376 | Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy | TERMINATED | PHASE3 | 2010-05-06 | 2018-06-26 | 2017-02-20 |
| NCT01058434 | Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation | COMPLETED | PHASE2 | 2010-05 | 2013-02 | 2013-02 |
| NCT01150123 | Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women | COMPLETED | PHASE1 | 2010-05 | 2012-10 | 2011-11 |
| NCT01130064 | Efficacy of QAX576 in Asthma | COMPLETED | PHASE2 | 2010-05 | 2012-04 | 2012-04 |
| NCT01127750 | Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients | COMPLETED | PHASE3 | 2010-05 | 2011-10 | 2011-10 |
| NCT01061177 | Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase | COMPLETED | PHASE4 | 2010-05 | 2014-07 | 2014-07 |
| NCT01132664 | Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer | TERMINATED | PHASE1, PHASE2 | 2010-05 | 2014-08 | 2014-08 |
| NCT01056822 | Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study. | COMPLETED | PHASE4 | 2010-05 | 2013-04 | 2013-04 |
| NCT01152801 | Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer | COMPLETED | PHASE1 | 2010-05 | 2013-12 | 2013-12 |
| NCT01123941 | Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old) | COMPLETED | PHASE1 | 2010-05 | 2010-11 | 2010-06 |
| NCT01113047 | Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine | COMPLETED | PHASE3 | 2010-05 | | 2010-10 |
| NCT01163227 | Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia | COMPLETED | PHASE2 | 2010-05 | 2011-09 | 2011-09 |
| NCT01110889 | Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder | COMPLETED | PHASE3 | 2010-05 | | 2011-07 |
| NCT01146522 | Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia | COMPLETED | PHASE1, PHASE2 | 2010-05 | 2011-10 | 2011-10 |
| NCT01119937 | Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients | COMPLETED | PHASE3 | 2010-05 | | 2011-11 |
| NCT01110902 | Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) | COMPLETED | PHASE3 | 2010-05 | 2011-06 | 2011-06 |
| NCT01125514 | A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure | COMPLETED | PHASE2 | 2010-05 | 2011-08 | 2011-08 |
| NCT01167153 | Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients | COMPLETED | PHASE4 | 2010-05 | 2011-04 | 2011-04 |
| NCT01109940 | Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis | COMPLETED | PHASE2 | 2010-04 | 2012-12 | 2012-12 |
| NCT01084330 | Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer | COMPLETED | PHASE2 | 2010-04 | 2012-05 | 2012-05 |
| NCT00572585 | Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE2 | 2010-04 | 2012-04 | 2012-04 |
| NCT01128335 | Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients | COMPLETED | PHASE2 | 2010-04 | 2012-07 | 2012-07 |
| NCT01272362 | To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol | COMPLETED | PHASE4 | 2010-04 | 2012-05 | 2012-05 |
| NCT01035229 | Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. | COMPLETED | PHASE3 | 2010-04 | 2013-10 | 2013-10 |
| NCT01155453 | A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients | COMPLETED | PHASE1 | 2010-04 | 2014-11 | 2014-11 |
| NCT01082367 | Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years | COMPLETED | PHASE3 | 2010-04 | 2015-06 | 2015-06 |
| NCT01095250 | Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis | TERMINATED | PHASE3 | 2010-04 | 2010-10 | 2010-10 |
| NCT01117987 | Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) | TERMINATED | PHASE3 | 2010-04 | 2014-04 | 2014-04 |
| NCT01119950 | Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2010-04 | 2010-12 | 2010-12 |
| NCT01120691 | Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations | COMPLETED | PHASE3 | 2010-04 | 2012-07 | 2012-07 |
| NCT01120717 | A Study to Assess the Long-term Safety of QVA149 | COMPLETED | PHASE3 | 2010-04 | 2011-12 | 2011-12 |
| NCT01160822 | To Determine the Safety, Tolerability, Pharmacokinetics and Effect on Pain of a Single Intra-articular Administration of Canakinumab in Patients With Osteoarthritis in the Knee | COMPLETED | PHASE2 | 2010-04 | 2011-07 | 2011-07 |
| NCT01047579 | A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease | COMPLETED | PHASE4 | 2010-04 | 2012-01 | 2012-01 |
| NCT01088880 | Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever | COMPLETED | PHASE2 | 2010-04 | 2011-08 | 2011-08 |
| NCT01044316 | Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China | COMPLETED | PHASE3 | 2010-04 | 2010-12 | 2010-07 |
| NCT01150097 | Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients | COMPLETED | PHASE3 | 2010-03-31 | 2013-05-03 | 2013-05-03 |
| NCT01072175 | Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212 | COMPLETED | PHASE2 | 2010-03-26 | 2018-02-27 | 2012-05-31 |
| NCT00940602 | Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study | COMPLETED | PHASE2 | 2010-03-22 | 2018-02-27 | 2018-02-27 |
| NCT01103050 | A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine | COMPLETED | PHASE2 | 2010-03-22 | 2010-07-28 | 2010-07-28 |
| NCT01097096 | Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients | COMPLETED | PHASE2 | 2010-03 | 2012-12 | 2012-12 |
| NCT00790426 | Phase II Study of TKI258 in Advanced Urothelial Carcinoma | COMPLETED | PHASE2 | 2010-03 | 2012-04 | 2012-04 |
| NCT00997399 | Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function | COMPLETED | PHASE1 | 2010-03 | 2014-06 | 2014-06 |
| NCT01196546 | Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM) | COMPLETED | PHASE4 | 2010-03 | 2011-10 | 2011-10 |
| NCT01007968 | Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function | COMPLETED | PHASE1 | 2010-03 | 2012-11 | 2012-11 |
| NCT01093846 | 38 Week Extension Study to CAIN457C2303 | TERMINATED | PHASE3 | 2010-03 | 2011-01 | 2011-01 |
| NCT01071252 | A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis | COMPLETED | PHASE2 | 2010-03 | 2011-02 | 2011-02 |
| NCT01080131 | Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. | COMPLETED | PHASE3 | 2010-03 | 2011-10 | 2010-11 |
| NCT01092065 | Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia | COMPLETED | PHASE2 | 2010-03 | 2011-07 | 2011-07 |
| NCT01278758 | A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function | TERMINATED | PHASE1 | 2010-03 | | 2010-11 |
| NCT01019980 | Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections | TERMINATED | PHASE4 | 2010-03 | | 2010-03 |
| NCT01184872 | Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections | COMPLETED | PHASE3 | 2010-03 | 2011-03 | 2011-03 |
| NCT01103037 | Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma | TERMINATED | PHASE2 | 2010-03 | 2010-09 | 2010-09 |
| NCT01069367 | Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects | COMPLETED | PHASE4 | 2010-03 | 2010-04 | 2010-04 |
| NCT01089127 | Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2010-03 | 2010-07 | 2010-07 |
| NCT01156844 | Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol | COMPLETED | PHASE2 | 2010-03 | | 2010-07 |
| NCT01069705 | Second Open Label Extension to Bridging Study CTBM100C2303 | COMPLETED | PHASE3 | 2010-02-12 | 2012-03-19 | 2012-03-19 |
| NCT01056731 | A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients. | COMPLETED | PHASE4 | 2010-02 | 2011-10 | 2011-10 |
| NCT01032915 | Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis | TERMINATED | PHASE3 | 2010-02 | 2011-06 | 2011-06 |
| NCT01026974 | Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine | COMPLETED | PHASE2 | 2010-02 | 2012-05 | 2010-09 |
| NCT01030055 | Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2010-02 | 2012-06 | 2012-06 |
| NCT01148511 | Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD) | COMPLETED | PHASE4 | 2010-02 | 2012-04 | 2012-04 |
| NCT01064089 | Dose Escalation of HSP990 in Japan/Korea | TERMINATED | PHASE1 | 2010-02 | 2012-01 | 2012-01 |
| NCT01080768 | Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension | TERMINATED | PHASE2 | 2010-02 | 2010-11 | 2010-11 |
| NCT01290380 | A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies | TERMINATED | PHASE1 | 2010-02 | | 2010-11 |
| NCT01068860 | To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies | COMPLETED | PHASE2 | 2010-02 | 2010-08 | 2010-08 |
| NCT01069692 | Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients | COMPLETED | PHASE3 | 2010-02 | | 2010-10 |
| NCT01079130 | Efficacy and Safety of Different Doses of Indacaterol | COMPLETED | PHASE3 | 2010-02 | | 2010-07 |
| NCT00968968 | Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone | TERMINATED | PHASE3 | 2010-01-20 | 2018-03-30 | 2014-02-21 |
| NCT01059318 | A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis | COMPLETED | PHASE2 | 2010-01 | 2012-06 | 2012-06 |
| NCT01027351 | Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine | COMPLETED | PHASE2 | 2010-01 | 2012-05 | 2010-09 |
| NCT01052935 | A Study to Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine | COMPLETED | PHASE1 | 2010-01 | 2010-10 | 2010-01 |
| NCT01070030 | Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension | COMPLETED | PHASE4 | 2010-01 | 2010-10 | 2010-10 |
| NCT01037348 | Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen | COMPLETED | PHASE2 | 2010-01 | 2012-05 | 2012-05 |
| NCT01025817 | Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients | COMPLETED | PHASE3 | 2010-01 | 2013-03 | 2013-03 |
| NCT01018732 | A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY | COMPLETED | PHASE2 | 2010-01 | 2010-07 | 2010-07 |
| NCT01240642 | An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404 | TERMINATED | PHASE1 | 2010-01 | | 2010-12 |
| NCT01278849 | An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function | TERMINATED | PHASE1 | 2010-01 | | 2010-11 |
| NCT01068613 | Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients | COMPLETED | PHASE2 | 2010-01 | 2010-08 | 2010-08 |
| NCT01123954 | Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese Volunteers | COMPLETED | PHASE2 | 2010-01 | 2010-04 | 2010-03 |
| NCT01053767 | A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine | COMPLETED | PHASE1 | 2010-01 | 2010-12 | 2010-08 |
| NCT01072448 | 12-week Efficacy of Indacaterol | COMPLETED | PHASE3 | 2010-01 | 2010-07 | 2010-07 |
| NCT01068600 | Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks | COMPLETED | PHASE3 | 2010-01 | | 2010-06 |
| NCT01023308 | Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma | COMPLETED | PHASE3 | 2009-12-21 | 2015-07-30 | 2015-07-30 |
| NCT01004224 | A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies | COMPLETED | PHASE1 | 2009-12-11 | 2018-10-08 | 2018-10-08 |
| NCT00946647 | A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML). | COMPLETED | PHASE1, PHASE2 | 2009-12-02 | 2019-04-29 | 2019-04-29 |
| NCT00980018 | An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment | COMPLETED | PHASE4 | 2009-12 | 2012-12 | 2012-12 |
| NCT01064791 | Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients | COMPLETED | PHASE2 | 2009-12 | 2012-08 | 2012-08 |
| NCT01035255 | This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure | TERMINATED | PHASE3 | 2009-12 | 2014-05 | 2014-05 |
| NCT01022996 | Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. | COMPLETED | PHASE2 | 2009-12 | 2014-11 | 2014-11 |
| NCT01043874 | Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response | COMPLETED | PHASE4 | 2009-12 | 2014-01 | 2013-12 |
| NCT01033019 | To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC) | TERMINATED | PHASE2 | 2009-12 | 2011-02 | 2011-02 |
| NCT00995930 | Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients | COMPLETED | PHASE2 | 2009-12 | 2014-02 | 2014-02 |
| NCT01051817 | POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler | COMPLETED | PHASE2 | 2009-12 | 2012-04 | 2012-04 |
| NCT00965094 | Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients | COMPLETED | PHASE4 | 2009-12 | 2013-06 | 2013-06 |
| NCT01023685 | To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients | COMPLETED | PHASE2 | 2009-12 | 2012-02 | 2012-02 |
| NCT01029652 | Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study | COMPLETED | PHASE3 | 2009-12 | 2010-10 | 2010-10 |
| NCT01030952 | Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion | COMPLETED | PHASE4 | 2009-12 | 2011-02 | 2011-02 |
| NCT01250951 | This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload. | COMPLETED | PHASE4 | 2009-12 | 2011-09 | 2011-07 |
| NCT01037452 | Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn | COMPLETED | PHASE2 | 2009-12 | | 2010-01 |
| NCT01089855 | Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain | COMPLETED | PHASE4 | 2009-12 | | 2010-07 |
| NCT01013740 | Lapatinib in Combination With Vinorelbine | COMPLETED | PHASE2 | 2009-11-25 | 2016-03-01 | 2012-08-21 |
| NCT01206764 | A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. | COMPLETED | PHASE4 | 2009-11-11 | 2017-07-01 | 2017-06-06 |
| NCT01022970 | Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis | COMPLETED | PHASE2 | 2009-11 | | 2012-02 |
| NCT01034657 | LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS) | TERMINATED | PHASE2 | 2009-11 | 2012-08 | 2012-08 |
| NCT00909961 | A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years | COMPLETED | PHASE3 | 2009-11 | 2011-12-16 | 2011-12 |
| NCT01033097 | Safety and Efficacy of DNK333 in Atopic Dermatitis Patients | COMPLETED | PHASE2 | 2009-11 | 2011-07 | 2011-07 |
| NCT01018693 | A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance | COMPLETED | PHASE2 | 2009-11 | 2011-10 | 2011-10 |
| NCT00968591 | Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency | COMPLETED | PHASE1 | 2009-11 | | 2010-11 |
| NCT01012765 | Effect of Indacaterol on Inspiratory Capacity (IC) | COMPLETED | PHASE3 | 2009-11 | | 2011-01 |
| NCT00887588 | LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction | COMPLETED | PHASE2 | 2009-11 | 2011-12 | 2011-12 |
| NCT01266148 | SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance | COMPLETED | PHASE4 | 2009-11 | 2012-12 | 2012-12 |
| NCT00901186 | Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema | COMPLETED | PHASE2 | 2009-11 | 2012-08 | 2012-08 |
| NCT01000311 | A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months | COMPLETED | PHASE3 | 2009-11 | 2011-11 | 2011-11 |
| NCT01042392 | Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients | COMPLETED | PHASE4 | 2009-11 | 2011-01 | 2011-01 |
| NCT01019473 | Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea | TERMINATED | PHASE2 | 2009-11 | | 2011-08 |
| NCT01009281 | An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease | TERMINATED | PHASE2 | 2009-10-30 | 2010-08-19 | 2010-08-19 |
| NCT00991146 | Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase | COMPLETED | PHASE3 | 2009-10 | 2012-02 | 2012-02 |
| NCT00996307 | Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months | COMPLETED | PHASE2, PHASE3 | 2009-10 | 2010-12 | 2009-12 |
| NCT01007942 | Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer | COMPLETED | PHASE3 | 2009-10 | 2015-06 | 2015-06 |
| NCT00903175 | Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma | COMPLETED | PHASE2 | 2009-10 | 2015-05 | 2015-05 |
| NCT01283503 | A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2009-10 | 2011-10 | 2011-10 |
| NCT00999908 | Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity | COMPLETED | PHASE3 | 2009-10 | 2010-03 | 2010-03 |
| NCT00995709 | Phase III Study in Refractory Behcet's Disease | COMPLETED | PHASE3 | 2009-10 | 2010-07 | 2010-07 |
| NCT01000207 | Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects | COMPLETED | PHASE2, PHASE3 | 2009-10 | 2009-12 | 2009-12 |
| NCT01005901 | A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo | COMPLETED | PHASE3 | 2009-10 | 2010-12 | 2010-12 |
| NCT01012739 | Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices | COMPLETED | PHASE2 | 2009-10 | 2010-03 | 2010-03 |
| NCT00876395 | Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer | COMPLETED | PHASE3 | 2009-09-10 | 2017-10-23 | 2014-05-30 |
| NCT00986882 | To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients | COMPLETED | PHASE2 | 2009-09 | 2011-03 | 2011-03 |
| NCT00891046 | An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. | COMPLETED | PHASE3 | 2009-09 | 2014-12 | 2014-12 |
| NCT00986414 | Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease | COMPLETED | PHASE2 | 2009-09 | | 2010-12 |
| NCT00983060 | Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients | COMPLETED | PHASE2 | 2009-09 | | 2011-04 |
| NCT00958841 | Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin | TERMINATED | PHASE2 | 2009-09 | 2015-06 | 2015-06 |
| NCT00972816 | Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years) | COMPLETED | PHASE2, PHASE3 | 2009-09 | 2010-10 | 2009-11 |
| NCT00866281 | A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia | TERMINATED | PHASE1, PHASE2 | 2009-09 | 2014-09 | 2014-09 |
| NCT00973349 | Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults | COMPLETED | PHASE2, PHASE3 | 2009-09 | 2010-12 | 2009-11 |
| NCT00914771 | Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects | COMPLETED | PHASE2 | 2009-09 | 2009-12 | 2009-12 |
| NCT00938860 | Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C | COMPLETED | PHASE4 | 2009-09 | 2013-05 | 2013-05 |
| NCT01017029 | Everolimus in de Novo Heart Transplant Recipients | COMPLETED | PHASE4 | 2009-09 | 2013-12 | 2013-12 |
| NCT00975715 | Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures | COMPLETED | PHASE2, PHASE3 | 2009-09 | 2012-10 | 2012-10 |
| NCT01079143 | Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients | COMPLETED | PHASE3 | 2009-09 | 2012-06 | 2012-06 |
| NCT00902174 | Imatinib (QTI571) in Pulmonary Arterial Hypertension | COMPLETED | PHASE3 | 2009-09 | 2011-05 | 2011-05 |
| NCT01055483 | A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia | COMPLETED | PHASE1 | 2009-09 | 2012-02 | 2012-02 |
| NCT00996138 | Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects | COMPLETED | PHASE2, PHASE3 | 2009-09 | 2009-11 | 2009-11 |
| NCT00989989 | Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema | COMPLETED | PHASE3 | 2009-09 | 2011-08 | 2011-08 |
| NCT01007149 | Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma | COMPLETED | PHASE3 | 2009-09 | 2011-02 | 2011-02 |
| NCT01025544 | Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China | COMPLETED | PHASE3 | 2009-09 | 2010-04 | 2009-12 |
| NCT00956410 | To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients | COMPLETED | PHASE2 | 2009-09 | 2011-06 | 2011-06 |
| NCT00971542 | Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age | COMPLETED | PHASE3 | 2009-09 | 2011-07 | 2010-02 |
| NCT01001572 | Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension | COMPLETED | PHASE3 | 2009-09 | 2010-05 | 2010-05 |
| NCT00987870 | Safety and Efficacy of BFH772 in Psoriasis Patients | COMPLETED | PHASE1, PHASE2 | 2009-09 | | 2010-02 |
| NCT00931762 | A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis | TERMINATED | PHASE2 | 2009-08-31 | 2011-08-29 | 2011-08-29 |
| NCT00982930 | Open Label Extension to Bridging Study CTBM100C2303 | COMPLETED | PHASE3 | 2009-08-12 | 2011-10-06 | 2011-10 |
| NCT00909324 | Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery | COMPLETED | PHASE4 | 2009-08-01 | 2010-01-01 | 2010-01-01 |
| NCT00880269 | Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML) | COMPLETED | PHASE2 | 2009-08 | 2012-02 | 2012-02 |
| NCT00970177 | Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age | COMPLETED | PHASE3 | 2009-08 | 2011-03 | 2009-10 |
| NCT00789828 | Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) | COMPLETED | PHASE3 | 2009-08 | 2014-10 | 2011-03 |
| NCT00973700 | Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years) | COMPLETED | PHASE3 | 2009-08 | 2010-10 | 2009-10 |
| NCT00992212 | Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10 | COMPLETED | PHASE2 | 2009-08 | 2009-11 | 2009-10 |
| NCT01125527 | Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children | COMPLETED | PHASE3 | 2009-08 | 2010-04 | 2009-10 |
| NCT00971100 | Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age | COMPLETED | PHASE3 | 2009-08 | 2011-08 | 2010-03 |
| NCT00971906 | Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age | COMPLETED | PHASE3 | 2009-08 | 2011-04 | 2009-10 |
| NCT01299415 | Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor | TERMINATED | PHASE1 | 2009-08 | | 2010-09 |
| NCT00790036 | Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy | COMPLETED | PHASE3 | 2009-07-24 | 2016-06-15 | 2016-06-15 |
| NCT00867113 | Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) | COMPLETED | PHASE2 | 2009-07-22 | 2016-12-20 | 2016-12-20 |
| NCT00958971 | Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer | COMPLETED | PHASE2 | 2009-07 | 2011-03 | 2011-03 |
| NCT00934544 | Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial | COMPLETED | PHASE3 | 2009-07-01 | 2015-03-04 | 2015-03-04 |
| NCT00944034 | Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12 | COMPLETED | PHASE2, PHASE3 | 2009-07 | 2012-01 | 2011-08 |
| NCT00886769 | Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) | TERMINATED | PHASE3 | 2009-07 | 2011-01 | 2010-12 |
| NCT00939588 | Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients | COMPLETED | PHASE2 | 2009-07 | | 2009-12 |
| NCT00688753 | RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe | COMPLETED | PHASE2 | 2009-07 | 2014-10 | 2014-10 |
| NCT00928512 | Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) | COMPLETED | PHASE2 | 2009-07 | 2011-03 | 2011-03 |
| NCT00961896 | A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients | COMPLETED | PHASE2 | 2009-07 | | 2010-08 |
| NCT00879333 | Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC) | COMPLETED | PHASE3 | 2009-07 | 2014-01 | 2014-01 |
| NCT00941031 | AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis | COMPLETED | PHASE2 | 2009-07 | 2010-12 | 2010-12 |
| NCT00937521 | Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants | COMPLETED | PHASE2 | 2009-07 | 2012-02 | 2010-11 |
| NCT00956293 | Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program | TERMINATED | PHASE4 | 2009-07 | 2013-03 | 2013-03 |
| NCT00948766 | Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 | COMPLETED | PHASE4 | 2009-07 | 2012-06 | 2012-01 |
| NCT00902304 | Valsartan Intensified Primary Care Reduction of Blood Pressure Study | COMPLETED | PHASE4 | 2009-07 | 2011-07 | 2011-07 |
| NCT00889863 | Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) | COMPLETED | PHASE3 | 2009-07 | 2011-09 | 2011-09 |
| NCT00941798 | Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma | COMPLETED | PHASE2 | 2009-07 | 2011-05 | 2011-05 |
| NCT01594255 | CAEB071 Thorough QTc Study in Healthy Volunteers | COMPLETED | PHASE1 | 2009-07 | | 2009-09 |
| NCT00928889 | Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors | COMPLETED | PHASE4 | 2009-07 | 2010-06 | 2010-06 |
| NCT00931710 | Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension | COMPLETED | PHASE4 | 2009-07 | 2010-01 | 2010-01 |
| NCT00955513 | Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain | COMPLETED | PHASE3 | 2009-07 | 2009-12 | 2009-12 |
| NCT00964665 | Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects | TERMINATED | PHASE1, PHASE2 | 2009-07 | | 2010-11 |
| NCT00940160 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients | COMPLETED | PHASE1, PHASE2 | 2009-07 | | 2010-01 |
| NCT00688623 | RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe | COMPLETED | PHASE2 | 2009-06-24 | 2016-11-07 | 2016-11-07 |
| NCT00927810 | Long Term Study of Canakinumab (ACZ885) in Patients With Gout | COMPLETED | PHASE2 | 2009-06-05 | 2010-08-04 | 2010-08-04 |
| NCT00863655 | Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole | COMPLETED | PHASE3 | 2009-06-03 | 2014-12-04 | 2014-12-04 |
| NCT00945841 | Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010 | COMPLETED | PHASE3 | 2009-06 | 2009-06 | 2009-06 |
| NCT00956449 | Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects | COMPLETED | PHASE2 | 2009-06 | 2009-07 | 2009-07 |
| NCT00760877 | Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR) | COMPLETED | PHASE3 | 2009-06 | 2015-07 | 2015-07 |
| NCT00956761 | Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010 | COMPLETED | PHASE2 | 2009-06 | 2009-06 | 2009-06 |
| NCT00751036 | Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg | TERMINATED | PHASE3 | 2009-06 | 2012-08 | 2012-08 |
| NCT00927901 | Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma | COMPLETED | PHASE2 | 2009-06 | 2009-11 | 2009-11 |
| NCT00918957 | A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo | COMPLETED | PHASE3 | 2009-06 | 2011-05 | 2011-05 |
| NCT00929110 | 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2009-06 | 2011-04 | 2011-04 |
| NCT00929968 | Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis | COMPLETED | PHASE2 | 2009-06 | | 2011-02 |
| NCT00987545 | Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence | TERMINATED | PHASE2 | 2009-06 | 2010-11 | 2010-11 |
| NCT00918268 | Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects | COMPLETED | PHASE2 | 2009-06 | 2009-07 | 2009-07 |
| NCT01070043 | To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone | COMPLETED | PHASE4 | 2009-06 | 2010-09 | 2010-09 |
| NCT00900731 | A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2009-06 | 2010-03 | 2010-03 |
| NCT00942994 | Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension | COMPLETED | PHASE4 | 2009-06 | | 2010-03 |
| NCT00933920 | Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate Hypertension | COMPLETED | PHASE1 | 2009-06 | | 2009-12 |
| NCT00907998 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180 | COMPLETED | PHASE1 | 2009-06 | | 2009-10 |
| NCT00866697 | Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | COMPLETED | PHASE3 | 2009-05-26 | 2017-08-24 | 2012-07-08 |
| NCT00845871 | Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food | COMPLETED | PHASE4 | 2009-05 | 2010-08 | 2010-08 |
| NCT00913653 | Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure | COMPLETED | PHASE2 | 2009-05 | | 2009-07 |
| NCT00802841 | Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib | COMPLETED | PHASE3 | 2009-05 | 2014-07 | 2014-07 |
| NCT00894868 | Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure | COMPLETED | PHASE4 | 2009-05 | 2012-08 | 2012-08 |
| NCT00894387 | Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure | COMPLETED | PHASE3 | 2009-05 | 2012-08 | 2012-08 |
| NCT00927394 | Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus | COMPLETED | PHASE4 | 2009-05 | 2011-10 | 2011-10 |
| NCT00879905 | A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2009-05 | 2012-07 | 2012-07 |
| NCT00923156 | Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure | COMPLETED | PHASE2 | 2009-05 | 2011-02 | 2011-02 |
| NCT01106482 | An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE | COMPLETED | PHASE4 | 2009-05 | 2011-05 | 2011-05 |
| NCT00820222 | Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer | COMPLETED | PHASE3 | 2009-04-14 | 2018-03-22 | 2012-06-11 |
| NCT00790400 | Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) | COMPLETED | PHASE3 | 2009-04 | 2015-11 | 2011-06 |
| NCT00862706 | Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks | WITHDRAWN | PHASE4 | 2009-04 | 2011-04 | 2011-04 |
| NCT01023815 | Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids. | COMPLETED | PHASE3 | 2009-04 | 2012-07 | 2012-07 |
| NCT00885196 | A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis | COMPLETED | PHASE2 | 2009-04 | | 2011-08 |
| NCT00892203 | Efficacy and Safety of BGG492 in the Treatment of Migraine | COMPLETED | PHASE2 | 2009-04 | 2010-08 | 2010-08 |
| NCT00901979 | A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) | COMPLETED | PHASE2 | 2009-04 | 2010-06 | 2010-06 |
| NCT00881205 | Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment | TERMINATED | PHASE4 | 2009-04 | 2011-01 | 2011-01 |
| NCT00900146 | Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients | TERMINATED | PHASE2, PHASE3 | 2009-04 | 2010-11 | 2010-11 |
| NCT00877383 | Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2009-04 | 2010-02 | 2010-02 |
| NCT00834041 | A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age | COMPLETED | PHASE1, PHASE2 | 2009-04 | 2010-01 | 2010-01 |
| NCT00879658 | Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE2 | 2009-03-30 | 2011-05-04 | 2011-05-04 |
| NCT00878072 | Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis | COMPLETED | PHASE2, PHASE3 | 2009-03-25 | 2010-06-02 | 2010-06-02 |
| NCT00824265 | Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia | COMPLETED | PHASE3 | 2009-03-12 | 2017-10-25 | 2014-12-17 |
| NCT00887861 | Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery | COMPLETED | PHASE2 | 2009-03 | 2010-08 | 2010-08 |
| NCT00853658 | Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure | COMPLETED | PHASE3 | 2009-03 | 2015-10 | 2015-10 |
| NCT00785785 | A Study of Nilotinib Versus Imatinib in GIST Patients | COMPLETED | PHASE3 | 2009-03 | 2014-10 | 2014-10 |
| NCT00888004 | Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients | COMPLETED | PHASE2 | 2009-03 | | 2009-08 |
| NCT00809614 | Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis | COMPLETED | PHASE2 | 2009-03 | 2010-12 | 2010-12 |
| NCT01569828 | Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function | COMPLETED | PHASE2 | 2009-03 | 2009-09 | 2009-09 |
| NCT00809159 | Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis | COMPLETED | PHASE2 | 2009-03 | 2011-05 | 2011-05 |
| NCT00880308 | Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2009-03 | 2013-07 | 2013-07 |
| NCT00853827 | Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients | COMPLETED | PHASE3 | 2009-03 | 2013-01 | 2013-01 |
| NCT00845728 | Exacerbation Study | COMPLETED | PHASE3 | 2009-03 | 2012-07 | 2012-07 |
| NCT01285453 | Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors | COMPLETED | PHASE1 | 2009-03 | | 2009-12 |
| NCT00877149 | Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B | COMPLETED | PHASE4 | 2009-03 | | 2011-04 |
| NCT00876694 | Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2009-03 | 2010-10 | 2010-10 |
| NCT00870584 | Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma | COMPLETED | PHASE4 | 2009-03 | 2010-03 | 2010-03 |
| NCT00846586 | Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2009-03 | 2010-03 | 2010-03 |
| NCT00865020 | Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal | COMPLETED | PHASE4 | 2009-03 | 2010-06 | 2010-06 |
| NCT00867490 | Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension | COMPLETED | PHASE3 | 2009-03 | 2009-08 | 2009-08 |
| NCT00862979 | A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients | COMPLETED | PHASE4 | 2009-02-24 | 2017-03-06 | 2017-03-06 |
| NCT00856297 | Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine | COMPLETED | PHASE3 | 2009-02 | 2012-11 | 2012-11 |
| NCT01206088 | Tasigna in Glivec-resistant or Intolerant Patients in CML | COMPLETED | PHASE4 | 2009-02 | 2012-09 | 2012-09 |
| NCT01241487 | A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy | COMPLETED | PHASE4 | 2009-02 | 2011-01 | 2011-01 |
| NCT01569815 | Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function | COMPLETED | PHASE1 | 2009-02 | 2014-08 | 2014-08 |
| NCT00847145 | Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers | COMPLETED | PHASE3 | 2009-02 | 2010-08 | 2010-08 |
| NCT00860288 | Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE2, PHASE3 | 2009-02 | 2011-03 | 2011-03 |
| NCT00907894 | Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B | COMPLETED | PHASE1 | 2009-02 | | 2012-03 |
| NCT00853957 | Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension | COMPLETED | PHASE4 | 2009-02 | 2009-08 | 2009-08 |
| NCT00879242 | Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec | COMPLETED | PHASE2 | 2009-02 | | 2011-05 |
| NCT00857259 | The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration | TERMINATED | PHASE2 | 2009-02 | | 2010-07 |
| NCT00819767 | Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise | COMPLETED | PHASE2 | 2009-02 | 2009-10 | 2009-10 |
| NCT00856193 | A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2009-02 | 2009-05 | 2009-05 |
| NCT00770601 | Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease | TERMINATED | PHASE3 | 2009-01-26 | 2011-02-17 | 2011-02-17 |
| NCT00817414 | A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension | COMPLETED | PHASE2 | 2009-01-14 | 2009-08-12 | 2009-08-12 |
| NCT01126892 | A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase | COMPLETED | PHASE3 | 2009-01 | 2011-04 | 2011-04 |
| NCT00826371 | Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients | COMPLETED | PHASE3 | 2009-01 | | 2010-07 |
| NCT00741377 | A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients | COMPLETED | PHASE1 | 2009-01 | 2011-12 | 2011-12 |
| NCT00825539 | Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia | COMPLETED | PHASE1, PHASE2 | 2009-01 | 2011-11 | 2011-11 |
| NCT00846989 | Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension | COMPLETED | PHASE1, PHASE2 | 2009-01 | 2009-04 | 2009-04 |
| NCT00821093 | Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2009-01 | 2009-10 | 2009-10 |
| NCT00841672 | Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension | COMPLETED | PHASE3 | 2009-01 | 2009-09 | 2009-09 |
| NCT00809926 | 8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension | COMPLETED | PHASE4 | 2009-01 | 2009-07 | 2009-07 |
| NCT00920933 | Effect of AIN457 on Ozone-induced Airway Neutrophilia Compared to Placebo and Corticosteroid in Healthy Subjects | COMPLETED | PHASE1, PHASE2 | 2009-01 | | 2009-11 |
| NCT00817635 | A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension | COMPLETED | PHASE2 | 2008-12-22 | 2009-10-13 | 2009-10-13 |
| NCT00748189 | Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia | TERMINATED | PHASE3 | 2008-12-22 | 2018-05-17 | 2013-03-20 |
| NCT00799266 | An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids | COMPLETED | PHASE3 | 2008-12-04 | 2018-03-05 | 2018-03-05 |
| NCT00819585 | A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study) | COMPLETED | PHASE2 | 2008-12 | 2010-08 | 2010-08 |
| NCT00814216 | Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients | COMPLETED | PHASE2 | 2008-12 | | 2009-10 |
| NCT01299701 | A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors | TERMINATED | PHASE1 | 2008-12 | 2009-07 | 2009-07 |
| NCT00822211 | Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy | COMPLETED | PHASE3 | 2008-12 | 2009-12 | 2009-12 |
| NCT01368523 | Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial | COMPLETED | PHASE4 | 2008-12 | | 2010-01 |
| NCT00942864 | Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) | COMPLETED | PHASE3 | 2008-12 | 2009-12 | 2009-12 |
| NCT00818571 | Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients | COMPLETED | PHASE1, PHASE2 | 2008-12 | | 2009-05 |
| NCT00805480 | Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis | COMPLETED | PHASE2 | 2008-12 | 2010-09 | 2010-09 |
| NCT00806195 | Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants | COMPLETED | PHASE3 | 2008-12 | 2011-11 | 2011-03 |
| NCT00828594 | Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma | TERMINATED | PHASE1 | 2008-12 | 2011-06 | 2011-06 |
| NCT00788931 | A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer | COMPLETED | PHASE1 | 2008-12 | | 2010-08 |
| NCT00738387 | A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer | TERMINATED | PHASE3 | 2008-12 | | 2010-12 |
| NCT01335035 | Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload | COMPLETED | PHASE4 | 2008-12 | | 2011-05 |
| NCT00841646 | Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects | COMPLETED | PHASE2 | 2008-12 | 2009-11 | 2009-07 |
| NCT00820534 | A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers | COMPLETED | PHASE4 | 2008-12 | 2009-11 | 2009-11 |
| NCT00742105 | Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan | TERMINATED | PHASE1 | 2008-11-17 | 2009-12-22 | 2009-12-22 |
| NCT00719264 | Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer | COMPLETED | PHASE2 | 2008-11-12 | 2013-04-15 | 2011-12-31 |
| NCT01289028 | Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. | COMPLETED | PHASE3 | 2008-11 | 2014-07 | 2014-07 |
| NCT00873041 | Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study | COMPLETED | PHASE2 | 2008-11 | 2012-06 | 2011-06 |
| NCT01068483 | Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients | COMPLETED | PHASE1 | 2008-11 | 2012-08 | 2011-09 |
| NCT01132625 | Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan | COMPLETED | PHASE1 | 2008-11 | 2012-05 | 2012-05 |
| NCT01098838 | Safety and Efficacy of LCL161 in Patients With Solid Tumors | COMPLETED | PHASE1 | 2008-11 | 2011-01 | 2011-01 |
| NCT00821977 | Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes | COMPLETED | PHASE2, PHASE3 | 2008-11 | 2010-10 | 2010-10 |
| NCT00798369 | Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients | COMPLETED | PHASE2 | 2008-11 | 2009-08 | 2009-08 |
| NCT00805675 | Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB | COMPLETED | PHASE3 | 2008-11 | | 2010-12 |
| NCT00848029 | Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules | COMPLETED | PHASE3 | 2008-11 | 2009-06 | 2009-06 |
| NCT00808392 | Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b | COMPLETED | PHASE3 | 2008-11 | 2009-02 | 2009-02 |
| NCT00825305 | Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule) | COMPLETED | PHASE3 | 2008-11 | 2009-01 | 2008-12 |
| NCT00787917 | An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) | TERMINATED | PHASE4 | 2008-11 | 2010-07 | 2010-07 |
| NCT00792805 | Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2008-11 | 2010-02 | 2010-02 |
| NCT00794157 | Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2008-11 | 2009-10 | 2009-10 |
| NCT00797862 | Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension | COMPLETED | PHASE3 | 2008-11 | 2010-11 | 2010-11 |
| NCT00787605 | Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus | COMPLETED | PHASE4 | 2008-11 | 2010-01 | 2010-01 |
| NCT00797316 | Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension | COMPLETED | PHASE4 | 2008-11 | 2009-12 | 2009-12 |
| NCT00774020 | Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB) | COMPLETED | PHASE4 | 2008-10-30 | 2011-01-14 | 2011-01-14 |
| NCT00740129 | Re-treatment of Participants With Paget's Disease Using Zoledronic Acid | COMPLETED | PHASE4 | 2008-10-21 | 2011-03-14 | 2011-03-14 |
| NCT00782067 | Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia | COMPLETED | PHASE2 | 2008-10-13 | 2017-08-24 | 2014-12-01 |
| NCT00667251 | Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer | COMPLETED | PHASE3 | 2008-10-07 | 2022-07-27 | 2012-08-01 |
| NCT00644878 | Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib | TERMINATED | PHASE2 | 2008-10 | 2012-03 | 2012-03 |
| NCT00841763 | Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects | COMPLETED | PHASE3 | 2008-10 | 2009-11 | 2009-04 |
| NCT00790816 | Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents | COMPLETED | PHASE1 | 2008-10 | 2016-08-19 | 2016-08-19 |
| NCT00736476 | Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults | COMPLETED | PHASE1 | 2008-10 | 2010-04 | 2010-03 |
| NCT00784212 | Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy | COMPLETED | PHASE2 | 2008-10 | 2010-09 | 2010-09 |
| NCT00848887 | A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age | COMPLETED | PHASE1 | 2008-10 | 2009-05 | 2009-05 |
| NCT00795418 | Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients | COMPLETED | PHASE2 | 2008-10 | | 2010-11 |
| NCT00777946 | Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone | COMPLETED | PHASE3 | 2008-10 | 2009-05 | 2009-05 |
| NCT00776009 | Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. | COMPLETED | PHASE4 | 2008-10 | 2008-12 | 2008-12 |
| NCT00759200 | Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients | COMPLETED | PHASE2 | 2008-10 | 2010-12 | 2010-12 |
| NCT00778921 | Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone | COMPLETED | PHASE3 | 2008-10 | 2009-06 | 2009-06 |
| NCT00742027 | Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma | COMPLETED | PHASE2 | 2008-09-16 | 2013-08-12 | 2013-08-12 |
| NCT00758524 | A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension | COMPLETED | PHASE2 | 2008-09-11 | 2009-07-02 | 2009-07-02 |
| NCT00770965 | Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis | COMPLETED | PHASE2 | 2008-09-10 | 2009-09-17 | 2009-09-17 |
| NCT00414765 | Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma | COMPLETED | PHASE4 | 2008-09-03 | 2010-03-28 | 2010-03-28 |
| NCT00757757 | A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases | TERMINATED | PHASE1, PHASE2 | 2008-09 | 2009-08 | 2009-08 |
| NCT00765947 | Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension | COMPLETED | PHASE4 | 2008-09 | 2009-08 | 2009-08 |
| NCT00670553 | A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer | COMPLETED | PHASE1 | 2008-09 | 2010-01 | 2010-01 |
| NCT01110668 | Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | COMPLETED | PHASE2 | 2008-09 | 2011-09 | 2011-09 |
| NCT00820911 | Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients | COMPLETED | PHASE2 | 2008-09 | 2012-07 | 2012-07 |
| NCT00718562 | Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib | COMPLETED | PHASE2 | 2008-09 | 2013-07 | 2013-07 |
| NCT00785083 | A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma | COMPLETED | PHASE2 | 2008-09 | | 2009-02 |
| NCT00784732 | A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber | COMPLETED | PHASE2 | 2008-09 | 2008-12 | 2008-12 |
| NCT01471548 | Phase I Dose Escalating Study of TKI258 | COMPLETED | PHASE1 | 2008-09 | 2012-05 | 2012-05 |
| NCT00765830 | Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension) | COMPLETED | PHASE3 | 2008-09 | 2011-04 | 2011-04 |
| NCT00770081 | Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) | COMPLETED | PHASE3 | 2008-09 | 2011-04 | 2011-04 |
| NCT00768040 | Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema | TERMINATED | PHASE2 | 2008-09 | 2011-02 | 2011-02 |
| NCT00739973 | Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension | COMPLETED | PHASE3 | 2008-09 | 2009-05 | 2009-05 |
| NCT00765674 | Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension | COMPLETED | PHASE3 | 2008-09 | 2009-08 | 2009-08 |
| NCT00760266 | Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population | COMPLETED | PHASE4 | 2008-09 | 2009-04 | 2009-04 |
| NCT00756509 | Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib | COMPLETED | PHASE4 | 2008-08-29 | 2024-12-18 | 2024-12-18 |
| NCT00702052 | Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy | COMPLETED | PHASE2 | 2008-08-22 | 2012-04-20 | 2012-04-20 |
| NCT00720941 | Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma | COMPLETED | PHASE3 | 2008-08-14 | 2021-03-24 | 2012-05-21 |
| NCT01172548 | Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) | COMPLETED | PHASE2 | 2008-08 | 2014-03 | 2014-03 |
| NCT00736047 | Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking. | COMPLETED | PHASE2 | 2008-08 | 2009-10 | 2009-10 |
| NCT00781105 | Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B | COMPLETED | PHASE4 | 2008-08-01 | 2010-09-16 | 2010-09-16 |
| NCT00786812 | Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase | COMPLETED | PHASE4 | 2008-08 | 2012-01 | 2012-01 |
| NCT01269684 | Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients | WITHDRAWN | PHASE4 | 2008-08 | 2008-08 | 2008-08 |
| NCT00745485 | Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid | COMPLETED | PHASE4 | 2008-08 | | 2010-07 |
| NCT00704678 | Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis | COMPLETED | PHASE2 | 2008-08 | | 2010-06 |
| NCT00584740 | Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease | TERMINATED | PHASE2 | 2008-08 | 2010-08 | 2010-08 |
| NCT00721396 | Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules | COMPLETED | PHASE2 | 2008-08 | 2010-07 | 2010-07 |
| NCT00601978 | Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off | WITHDRAWN | PHASE4 | 2008-08 | 2009-11 | 2009-11 |
| NCT01528241 | Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET) | COMPLETED | PHASE1 | 2008-08 | 2010-05 | 2010-05 |
| NCT00746330 | Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma | COMPLETED | PHASE2 | 2008-08 | 2009-04 | 2009-04 |
| NCT00772577 | Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension | COMPLETED | PHASE4 | 2008-08 | 2009-03 | 2009-03 |
| NCT00731692 | This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. | TERMINATED | PHASE3 | 2008-07-28 | 2015-06-22 | 2015-06-22 |
| NCT00709761 | Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC | COMPLETED | PHASE2 | 2008-07-02 | 2018-01-03 | 2011-01-05 |
| NCT00731224 | Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. | COMPLETED | PHASE4 | 2008-07 | 2011-10 | 2011-10 |
| NCT00615693 | Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis | COMPLETED | PHASE2 | 2008-07 | | 2009-10 |
| NCT00698464 | Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function | COMPLETED | PHASE1 | 2008-07 | | 2009-04 |
| NCT00704483 | Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis | COMPLETED | PHASE2 | 2008-07 | | 2010-08 |
| NCT00708292 | A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma. | COMPLETED | PHASE1, PHASE2 | 2008-07 | 2011-01 | 2011-01 |
| NCT00715182 | A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer | COMPLETED | PHASE1 | 2008-07 | 2012-07 | 2012-07 |
| NCT00734565 | Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b | COMPLETED | PHASE1 | 2008-07 | 2008-10 | 2008-10 |
| NCT00748150 | Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects | COMPLETED | PHASE2 | 2008-07 | 2008-08 | 2008-08 |
| NCT00731523 | Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects. | COMPLETED | PHASE1 | 2008-07 | | 2008-08 |
| NCT00739596 | Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans | COMPLETED | PHASE4 | 2008-07 | 2009-03 | 2009-03 |
| NCT00724776 | Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients | COMPLETED | PHASE1 | 2008-07 | | 2009-07 |
| NCT00733863 | Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients. | COMPLETED | PHASE2 | 2008-07 | | 2010-02 |
| NCT00739414 | Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2008-07 | | 2009-11 |
| NCT00667719 | A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension | COMPLETED | PHASE3 | 2008-06-05 | 2009-10-05 | 2009-10-05 |
| NCT00680901 | LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib | COMPLETED | PHASE3 | 2008-06-04 | 2024-10-03 | 2012-09-24 |
| NCT00661713 | Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules | COMPLETED | PHASE2, PHASE3 | 2008-06 | 2010-12 | 2010-04 |
| NCT00633295 | Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor | COMPLETED | PHASE2 | 2008-06 | 2010-05 | 2010-05 |
| NCT00685399 | Safety and Efficacy of AIN457 in Noninfectious Uveitis | COMPLETED | PHASE2 | 2008-06 | 2013-09 | 2013-09 |
| NCT01483014 | Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) | COMPLETED | PHASE2 | 2008-06 | 2012-01 | 2012-01 |
| NCT00734734 | Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009 | COMPLETED | PHASE2 | 2008-06 | 2008-07 | 2008-07 |
| NCT00735020 | Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines | COMPLETED | PHASE1 | 2008-06 | 2008-08 | 2008-08 |
| NCT00728351 | Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%) | COMPLETED | PHASE3 | 2008-06 | | 2010-02 |
| NCT00748813 | Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009 | COMPLETED | PHASE2 | 2008-06 | 2008-07 | 2008-07 |
| NCT00735410 | Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009 | COMPLETED | PHASE3 | 2008-06 | 2008-07 | 2008-07 |
| NCT00705575 | Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension | COMPLETED | PHASE3 | 2008-06 | 2009-04 | 2009-04 |
| NCT00718341 | Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients | COMPLETED | PHASE2 | 2008-06 | | 2009-02 |
| NCT00732771 | Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism | COMPLETED | PHASE2 | 2008-06 | | 2009-05 |
| NCT00646737 | Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant | COMPLETED | PHASE4 | 2008-05 | 2008-12 | 2008-12 |
| NCT00685373 | Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease | COMPLETED | PHASE3 | 2008-05 | 2010-04 | 2010-04 |
| NCT00668200 | Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast® | COMPLETED | PHASE4 | 2008-05 | 2012-11 | 2012-11 |
| NCT00718861 | 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs | COMPLETED | PHASE3 | 2008-05 | 2013-04 | 2013-04 |
| NCT00687804 | A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study | COMPLETED | PHASE3 | 2008-05 | 2012-01 | 2010-01 |
| NCT00699296 | Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma | TERMINATED | PHASE2 | 2008-05 | | 2008-12 |
| NCT00703703 | Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects | COMPLETED | PHASE1 | 2008-05 | 2008-10 | 2008-10 |
| NCT00677807 | Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2008-05 | 2009-03 | 2009-03 |
| NCT00706134 | Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study | COMPLETED | PHASE3 | 2008-05 | 2009-04 | 2009-04 |
| NCT00699192 | Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension | COMPLETED | PHASE3 | 2008-05 | 2009-05 | 2009-05 |
| NCT00676312 | Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects | COMPLETED | PHASE1 | 2008-05 | | 2008-08 |
| NCT00532675 | Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma. | COMPLETED | PHASE1 | 2008-04-22 | 2017-11-08 | 2017-11-08 |
| NCT00674102 | An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC) | COMPLETED | PHASE1 | 2008-04 | | 2009-03 |
| NCT00567879 | A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab | TERMINATED | PHASE1, PHASE2 | 2008-04 | 2011-05 | 2011-05 |
| NCT00582426 | Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea | COMPLETED | PHASE3 | 2008-04 | 2010-09 | 2010-09 |
| NCT00690430 | Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease | COMPLETED | PHASE3 | 2008-04 | 2012-04 | 2012-04 |
| NCT00670449 | An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis | COMPLETED | PHASE2 | 2008-04 | 2012-04 | 2012-04 |
| NCT00663169 | Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout | COMPLETED | PHASE2 | 2008-04 | 2009-10 | 2009-10 |
| NCT00670930 | Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists | COMPLETED | PHASE4 | 2008-04 | 2011-11 | 2011-11 |
| NCT00660309 | A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2008-04 | 2009-12 | 2009-12 |
| NCT00662597 | ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer | TERMINATED | PHASE3 | 2008-04 | 2010-05 | 2010-05 |
| NCT00669617 | Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2008-04 | 2008-08 | 2008-08 |
| NCT00669097 | Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies | COMPLETED | PHASE1 | 2008-04 | | 2010-01 |
| NCT00620022 | The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 | 2008-04 | 2009-01 | 2009-01 |
| NCT00674323 | Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy | COMPLETED | PHASE4 | 2008-04 | | 2009-05 |
| NCT00698646 | Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. | COMPLETED | PHASE4 | 2008-04 | 2009-06 | 2009-06 |
| NCT01263808 | Cardiac Safety of Indacaterol | COMPLETED | PHASE1 | 2008-04 | | 2008-08 |
| NCT00767819 | Treatment of Patients With RAD001 With Progressive Sarcoma | COMPLETED | PHASE2 | 2008-03-31 | 2017-05-17 | 2017-05-17 |
| NCT00667862 | Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer | COMPLETED | PHASE2 | 2008-03-18 | 2010-11-05 | 2010-11-05 |
| NCT00688909 | Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer | COMPLETED | PHASE4 | 2008-03 | 2009-06 | 2009-06 |
| NCT00657709 | Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants | COMPLETED | PHASE3 | 2008-03 | 2010-01 | 2010-01 |
| NCT00646503 | Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B | COMPLETED | PHASE4 | 2008-03 | 2009-09 | 2009-09 |
| NCT00640588 | Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine | COMPLETED | PHASE3 | 2008-03 | 2009-12 | 2009-12 |
| NCT00616421 | Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children | COMPLETED | PHASE3 | 2008-03 | 2009-10 | 2009-04 |
| NCT00622258 | A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | COMPLETED | PHASE1 | 2008-03 | 2014-01 | 2014-01 |
| NCT00634920 | Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients | COMPLETED | PHASE4 | 2008-03 | 2013-05 | 2013-05 |
| NCT00670592 | Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies | COMPLETED | PHASE1, PHASE2 | 2008-03 | 2013-02 | 2013-02 |
| NCT00667602 | Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers | COMPLETED | PHASE3 | 2008-03 | 2010-10 | 2009-07 |
| NCT00658333 | A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms | TERMINATED | PHASE4 | 2008-03 | 2009-03 | 2009-03 |
| NCT00654875 | Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension. | COMPLETED | PHASE4 | 2008-03 | 2008-11 | 2008-11 |
| NCT00542269 | Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome | TERMINATED | PHASE4 | 2008-03 | 2009-07 | 2009-07 |
| NCT00666536 | The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy | COMPLETED | PHASE4 | 2008-03 | | 2009-01 |
| NCT00642356 | Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off | TERMINATED | PHASE4 | 2008-03 | 2009-05 | 2009-05 |
| NCT00600886 | Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly | COMPLETED | PHASE3 | 2008-02-11 | 2016-03-11 | 2016-03-11 |
| NCT00634192 | Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin | COMPLETED | PHASE3 | 2008-02 | 2009-08 | 2009-02 |
| NCT00651105 | Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects | COMPLETED | PHASE3 | 2008-02 | | 2009-05 |
| NCT00654589 | Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload | COMPLETED | PHASE4 | 2008-02 | 2012-01 | 2012-01 |
| NCT00633997 | Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes | TERMINATED | PHASE1, PHASE2 | 2008-02 | | 2008-12 |
| NCT00601731 | Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months | COMPLETED | PHASE2 | 2008-02 | 2010-09 | 2010-07 |
| NCT00651209 | A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) | COMPLETED | PHASE4 | 2008-02 | | 2011-12 |
| NCT00658320 | Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids | COMPLETED | PHASE3 | 2008-02 | 2012-05 | 2010-08 |
| NCT00626327 | Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers | COMPLETED | PHASE3 | 2008-02 | 2010-10 | 2010-07 |
| NCT00662649 | Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE3 | 2008-02 | 2011-06 | 2011-06 |
| NCT00663832 | A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer | COMPLETED | PHASE1 | 2008-02 | | 2011-12 |
| NCT00645346 | A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age | COMPLETED | PHASE1 | 2008-02 | 2009-07 | 2009-05 |
| NCT00624286 | Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2008-02 | 2008-07 | 2008-07 |
| NCT00615459 | A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control | COMPLETED | PHASE3 | 2008-02 | 2008-12 | 2008-12 |
| NCT00636961 | An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD) | COMPLETED | PHASE2 | 2008-02 | 2008-08 | 2008-08 |
| NCT00631917 | A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension | COMPLETED | PHASE4 | 2008-02 | 2009-09 | 2009-09 |
| NCT00624832 | A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels | COMPLETED | PHASE4 | 2008-02 | 2009-01 | 2009-01 |
| NCT00624702 | Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma | COMPLETED | PHASE1 | 2008-02 | 2008-09 | 2008-09 |
| NCT00553358 | Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study | COMPLETED | PHASE3 | 2008-01-05 | 2019-12-23 | 2010-05-27 |
| NCT00613171 | Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis | COMPLETED | PHASE2 | 2008-01-02 | 2010-01-13 | 2010-01-13 |
| NCT00649883 | Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months | COMPLETED | PHASE2 | 2008-01 | 2008-10 | 2008-04 |
| NCT00477217 | Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee | WITHDRAWN | PHASE2 | 2008-01 | 2009-05 | 2009-05 |
| NCT00598104 | Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma | WITHDRAWN | PHASE1, PHASE2 | 2008-01 | | 2008-12 |
| NCT00622869 | Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients | COMPLETED | PHASE3 | 2008-01 | 2012-04 | 2012-04 |
| NCT00605306 | Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma | COMPLETED | PHASE2 | 2008-01 | 2008-04 | 2008-04 |
| NCT00616811 | Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency | COMPLETED | PHASE3 | 2008-01 | 2010-10 | 2010-10 |
| NCT00623103 | Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) | COMPLETED | PHASE3 | 2008-01 | | 2010-11 |
| NCT00622635 | A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2008-01 | 2008-07 | 2008-07 |
| NCT00615030 | Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2008-01 | 2008-08 | 2008-07 |
| NCT00622713 | A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) | COMPLETED | PHASE4 | 2008-01 | 2009-01 | 2009-01 |
| NCT00687973 | Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg | COMPLETED | PHASE4 | 2008-01 | 2009-01 | 2009-01 |
| NCT00584298 | Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide | COMPLETED | PHASE1 | 2008-01 | | 2009-04 |
| NCT00570778 | Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2007-12 | 2008-09 | 2008-09 |
| NCT00584584 | An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever | COMPLETED | PHASE2 | 2007-12 | | 2008-08 |
| NCT00564941 | Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload | COMPLETED | PHASE4 | 2007-12 | 2011-07 | 2011-07 |
| NCT00582855 | Effect of AQW051 in Patients With Memory Impairment | TERMINATED | PHASE2 | 2007-12 | | 2009-02 |
| NCT00600275 | A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer | COMPLETED | PHASE1, PHASE2 | 2007-12 | | 2010-03 |
| NCT00582738 | Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection | TERMINATED | PHASE2 | 2007-12 | 2010-01 | 2010-01 |
| NCT00581997 | QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis | TERMINATED | PHASE2 | 2007-12 | | 2009-04 |
| NCT00605475 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes | COMPLETED | PHASE2 | 2007-12 | 2010-09 | 2010-09 |
| NCT00657683 | A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age | COMPLETED | PHASE1 | 2007-12 | 2009-05 | 2009-04 |
| NCT00622505 | Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants | COMPLETED | PHASE4 | 2007-11-07 | 2012-04-03 | 2012-04-03 |
| NCT00673608 | Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload | COMPLETED | PHASE4 | 2007-11 | 2011-09 | 2011-09 |
| NCT00570284 | A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2007-11 | 2011-02 | 2011-02 |
| NCT00620815 | Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above | COMPLETED | PHASE2 | 2007-11 | 2008-12 | 2008-01 |
| NCT00560066 | Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions | COMPLETED | PHASE4 | 2007-11 | 2008-07 | 2008-07 |
| NCT00644059 | Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines | COMPLETED | PHASE3 | 2007-11 | 2010-08 | 2010-04 |
| NCT00600938 | Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload | COMPLETED | PHASE2 | 2007-11 | 2013-03 | 2013-03 |
| NCT00644540 | Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study | COMPLETED | PHASE2 | 2007-11 | 2008-06 | 2008-01 |
| NCT00558285 | Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2007-11 | 2008-07 | 2008-07 |
| NCT00535951 | Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma | COMPLETED | PHASE1 | 2007-11 | | 2009-01 |
| NCT00568594 | Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD) | COMPLETED | PHASE1, PHASE2 | 2007-11 | | 2009-09 |
| NCT00606099 | Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B | WITHDRAWN | PHASE4 | 2007-11 | | 2009-11 |
| NCT00617851 | Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old | COMPLETED | PHASE3 | 2007-11 | 2008-06 | 2007-12 |
| NCT00561392 | Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease | COMPLETED | PHASE4 | 2007-11 | 2008-11 | 2008-11 |
| NCT00567996 | Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control | COMPLETED | PHASE3 | 2007-11 | | 2009-01 |
| NCT00567476 | Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma | COMPLETED | PHASE4 | 2007-11 | 2010-04 | 2010-04 |
| NCT00573768 | Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain | COMPLETED | PHASE2 | 2007-11 | 2008-07 | 2007-12 |
| NCT00557440 | Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma | COMPLETED | PHASE2 | 2007-11 | 2008-04 | 2008-04 |
| NCT00554606 | Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis | COMPLETED | PHASE2 | 2007-10-11 | 2009-08-13 | 2009-08-13 |
| NCT00630331 | Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects | COMPLETED | PHASE3 | 2007-10 | 2008-07 | 2008-07 |
| NCT00631163 | Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis | COMPLETED | PHASE2 | 2007-10 | 2012-02 | 2011-01 |
| NCT00645411 | Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents | COMPLETED | PHASE2, PHASE3 | 2007-10 | 2008-07 | 2008-02 |
| NCT00532389 | Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma | COMPLETED | PHASE1 | 2007-10 | 2013-10 | 2013-10 |
| NCT00549757 | Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) | TERMINATED | PHASE3 | 2007-10 | 2013-02 | 2013-02 |
| NCT00556673 | Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma | COMPLETED | PHASE2 | 2007-10 | 2008-04 | 2008-04 |
| NCT00557466 | A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2007-10 | 2008-05 | 2008-05 |
| NCT00545272 | A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma | COMPLETED | PHASE2 | 2007-10 | 2008-04 | 2008-04 |
| NCT00560963 | Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine | COMPLETED | PHASE1, PHASE2 | 2007-10 | 2011-01 | 2011-01 |
| NCT00579345 | Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup | COMPLETED | PHASE3 | 2007-10 | 2008-06 | 2008-06 |
| NCT00555789 | 24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients | TERMINATED | PHASE2 | 2007-10 | 2008-03 | 2008-03 |
| NCT00520806 | Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure | COMPLETED | PHASE2, PHASE3 | 2007-10 | 2012-09 | 2012-09 |
| NCT00564954 | A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) | COMPLETED | PHASE4 | 2007-10 | 2007-11 | 2007-11 |
| NCT00572650 | Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients | COMPLETED | PHASE1 | 2007-10 | 2007-11 | 2007-11 |
| NCT00561184 | Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine | COMPLETED | PHASE2 | 2007-10 | 2008-06 | 2007-12 |
| NCT00519090 | Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) | TERMINATED | PHASE3 | 2007-10 | 2008-10 | 2008-10 |
| NCT00417170 | Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome | COMPLETED | PHASE2 | 2007-10 | 2010-07 | 2010-07 |
| NCT00700271 | Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day | COMPLETED | PHASE4 | 2007-10 | 2008-08 | 2008-08 |
| NCT00568503 | Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients. | COMPLETED | PHASE1 | 2007-10 | 2008-02 | 2008-02 |
| NCT00448227 | Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection | COMPLETED | PHASE2 | 2007-10 | | 2008-11 |
| NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | TERMINATED | PHASE1 | 2007-10 | | 2009-08 |
| NCT00620230 | Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects | COMPLETED | PHASE1 | 2007-10 | 2008-04 | 2008-04 |
| NCT00582673 | Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa | COMPLETED | PHASE2 | 2007-10 | | 2008-05 |
| NCT00559975 | Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine | COMPLETED | PHASE1 | 2007-10 | 2008-05 | |
| NCT00545259 | Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation | COMPLETED | PHASE1 | 2007-10 | | 2009-02 |
| NCT00532233 | SD, IL-13 Production Rate in IPF | COMPLETED | PHASE2 | 2007-09 | 2009-06 | 2009-06 |
| NCT00560820 | Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload | COMPLETED | PHASE1 | 2007-09 | 2012-04 | 2012-04 |
| NCT00549770 | Efficacy and Safety of LCZ696A in Patients With Essential Hypertension | COMPLETED | PHASE2 | 2007-09 | 2008-07 | 2008-07 |
| NCT00503451 | A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2007-09 | | 2010-04 |
| NCT00537524 | Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years | COMPLETED | PHASE2 | 2007-09 | 2008-05 | 2007-10 |
| NCT00529529 | Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma | COMPLETED | PHASE3 | 2007-09 | 2008-08 | 2008-08 |
| NCT00537082 | Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS) | COMPLETED | PHASE2 | 2007-09 | | 2010-02 |
| NCT00549601 | Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease | COMPLETED | PHASE4 | 2007-09 | 2009-04 | 2009-04 |
| NCT00529451 | Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg | COMPLETED | PHASE3 | 2007-09 | 2008-07 | 2008-07 |
| NCT00548067 | Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension | COMPLETED | PHASE3 | 2007-09 | 2008-03 | |
| NCT00552214 | Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens | COMPLETED | NA | 2007-08-08 | 2008-07-01 | 2008-07-01 |
| NCT00519324 | Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer | COMPLETED | PHASE2 | 2007-08 | | 2009-01 |
| NCT00537537 | To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB) | COMPLETED | PHASE4 | 2007-08 | | 2011-06 |
| NCT00510510 | Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 | 2007-08 | 2008-01 | 2008-01 |
| NCT00531050 | Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol | COMPLETED | PHASE2 | 2007-08 | 2008-06 | 2008-06 |
| NCT00515086 | Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM) | TERMINATED | PHASE2 | 2007-08 | 2009-08 | 2009-08 |
| NCT00505089 | Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis | TERMINATED | PHASE1, PHASE2 | 2007-08 | | 2009-05 |
| NCT00471497 | A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) | COMPLETED | PHASE3 | 2007-07-31 | 2019-08-21 | 2009-09-02 |
| NCT00508274 | Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China | TERMINATED | PHASE3 | 2007-07-18 | 2020-07-01 | 2015-12-02 |
| NCT00490776 | Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL) | TERMINATED | PHASE2 | 2007-07-05 | 2009-09-22 | 2009-09 |
| NCT00523744 | Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension | COMPLETED | PHASE3 | 2007-07 | 2007-12 | 2007-12 |
| NCT00514514 | Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen | COMPLETED | PHASE3 | 2007-07 | 2015-06 | 2015-06 |
| NCT00504543 | Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients | COMPLETED | PHASE2 | 2007-07 | 2011-04 | 2011-04 |
| NCT00518180 | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents | COMPLETED | PHASE3 | 2007-07 | 2008-10 | 2008-04 |
| NCT00504959 | Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration | COMPLETED | PHASE4 | 2007-07 | 2010-01 | 2010-01 |
| NCT00560313 | Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults | COMPLETED | PHASE2 | 2007-07 | 2009-11 | 2009-11 |
| NCT00426556 | Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer | COMPLETED | PHASE1 | 2007-07 | 2014-03 | 2014-03 |
| NCT00510068 | Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors | COMPLETED | PHASE3 | 2007-07 | 2014-03 | 2010-02 |
| NCT00488683 | B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants | COMPLETED | PHASE2 | 2007-07 | 2009-06 | 2009-05 |
| NCT00526045 | Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients | COMPLETED | PHASE1, PHASE2 | 2007-07 | 2012-04 | 2012-04 |
| NCT00511914 | Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008 | COMPLETED | PHASE3 | 2007-07 | 2007-08 | 2007-08 |
| NCT00506792 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis | COMPLETED | PHASE2 | 2007-07 | 2009-11 | 2008-12 |
| NCT00442741 | Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) | WITHDRAWN | PHASE1 | 2007-07 | | 2007-07 |
| NCT00518453 | Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008 | COMPLETED | PHASE2 | 2007-07 | 2007-08 | 2007-08 |
| NCT00500539 | Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation. | COMPLETED | PHASE3 | 2007-07 | 2008-09 | 2008-09 |
| NCT00501852 | Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator Tiotropium | COMPLETED | PHASE2 | 2007-07 | | 2007-12 |
| NCT00546143 | Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma | COMPLETED | PHASE4 | 2007-07 | | 2008-08 |
| NCT00532350 | Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE1 | 2007-07 | 2008-01 | |
| NCT00567047 | Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment | COMPLETED | PHASE1 | 2007-07 | | 2009-01 |
| NCT00513487 | Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity | COMPLETED | NA | 2007-07 | 2007-11 | |
| NCT00515424 | Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension | COMPLETED | PHASE1 | 2007-07 | | |
| NCT00545311 | Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients | COMPLETED | PHASE1 | 2007-07 | 2007-10 | |
| NCT00550095 | To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2007-06 | 2009-11 | 2009-11 |
| NCT00494884 | Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin | COMPLETED | PHASE3 | 2007-06 | 2008-07 | 2008-07 |
| NCT00470678 | EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) | COMPLETED | PHASE3 | 2007-06 | 2008-11 | 2008-11 |
| NCT00498433 | Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension | TERMINATED | PHASE2 | 2007-06 | 2012-03 | 2012-03 |
| NCT00506415 | Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline | COMPLETED | PHASE3 | 2007-06 | 2011-05 | 2011-05 |
| NCT00522067 | Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases. | COMPLETED | PHASE2 | 2007-06 | 2007-07 | 2007-07 |
| NCT00522236 | Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects | COMPLETED | PHASE2 | 2007-06 | 2007-07 | 2007-07 |
| NCT00518726 | Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects | COMPLETED | PHASE2 | 2007-06 | 2007-07 | 2007-07 |
| NCT00446511 | Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension | COMPLETED | PHASE3 | 2007-06 | 2009-06 | 2009-06 |
| NCT00477334 | Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients | COMPLETED | PHASE4 | 2007-06 | 2009-03 | 2009-03 |
| NCT00489424 | Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass | COMPLETED | PHASE4 | 2007-06 | 2007-12 | 2007-12 |
| NCT00498303 | Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008 | COMPLETED | PHASE3 | 2007-06 | | |
| NCT00490139 | ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D | COMPLETED | PHASE3 | 2007-05-16 | 2021-07-01 | 2013-12-06 |
| NCT00481143 | Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload | COMPLETED | PHASE4 | 2007-05 | | 2010-11 |
| NCT00474487 | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults | COMPLETED | PHASE3 | 2007-05 | 2008-02 | 2007-08 |
| NCT00478634 | A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE1 | 2007-05 | 2009-09 | 2009-09 |
| NCT00504595 | Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis | COMPLETED | PHASE2 | 2007-05 | 2008-09 | 2008-09 |
| NCT00472368 | A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589 | COMPLETED | PHASE1 | 2007-05 | | 2008-06 |
| NCT00478816 | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines | COMPLETED | PHASE2 | 2007-05 | 2009-02 | 2009-02 |
| NCT00481676 | Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria | COMPLETED | PHASE2 | 2007-05 | 2009-04 | 2009-04 |
| NCT00433017 | Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) | TERMINATED | PHASE2, PHASE3 | 2007-05 | 2009-07 | 2009-07 |
| NCT00444106 | Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function | COMPLETED | PHASE4 | 2007-05 | 2008-11 | 2008-11 |
| NCT00468260 | The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies | TERMINATED | PHASE1 | 2007-05 | | |
| NCT00487058 | A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2007-05 | | 2008-06 |
| NCT00445068 | Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma | TERMINATED | PHASE2 | 2007-04-16 | 2009-12-25 | 2008-05-19 |
| NCT00457626 | A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension | COMPLETED | PHASE3 | 2007-04-09 | 2009-05-25 | 2009-05-25 |
| NCT00465985 | Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome | COMPLETED | PHASE3 | 2007-04 | | 2008-10 |
| NCT00464672 | Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old | COMPLETED | PHASE3 | 2007-04 | 2007-12 | 2007-07 |
| NCT00481065 | Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects | COMPLETED | PHASE2 | 2007-04 | 2008-12 | 2008-12 |
| NCT00467545 | An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B | COMPLETED | PHASE4 | 2007-04 | 2009-09 | 2009-09 |
| NCT00467402 | Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder | COMPLETED | PHASE3 | 2007-04 | | 2009-09 |
| NCT01539915 | Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients | COMPLETED | PHASE1 | 2007-04 | | 2007-11 |
| NCT00466466 | Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients | COMPLETED | PHASE1 | 2007-04 | | 2010-11 |
| NCT00463567 | 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2, PHASE3 | 2007-04 | 2008-08 | 2008-08 |
| NCT00428792 | Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD) | COMPLETED | PHASE3 | 2007-04 | 2007-12 | 2007-12 |
| NCT00413920 | Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients | COMPLETED | PHASE3 | 2007-04 | | 2009-03 |
| NCT00503360 | Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension | COMPLETED | PHASE1 | 2007-04 | | |
| NCT00468039 | A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin | COMPLETED | PHASE3 | 2007-03-06 | 2008-06-06 | 2008-06-06 |
| NCT00450437 | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults | COMPLETED | PHASE3 | 2007-03 | 2008-01 | 2007-08 |
| NCT00474526 | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants | COMPLETED | PHASE3 | 2007-03 | 2009-11 | 2008-09 |
| NCT00487825 | Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis | COMPLETED | PHASE2 | 2007-03 | 2008-12 | 2008-12 |
| NCT00471328 | Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib | COMPLETED | PHASE3 | 2007-03 | 2011-06 | 2008-08 |
| NCT00463242 | A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD) | COMPLETED | PHASE3 | 2007-03 | | 2008-06 |
| NCT00459537 | Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis | COMPLETED | PHASE3 | 2007-03 | 2009-01 | 2009-01 |
| NCT00446563 | Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy | COMPLETED | PHASE3 | 2007-03 | 2010-03 | 2010-03 |
| NCT00435162 | Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure | COMPLETED | PHASE3 | 2007-03 | 2009-01 | 2009-01 |
| NCT00460577 | Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction | COMPLETED | PHASE4 | 2007-03 | 2008-09 | 2008-09 |
| NCT00434590 | Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients | TERMINATED | PHASE4 | 2007-03 | 2008-05 | 2008-05 |
| NCT00448396 | Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies | COMPLETED | PHASE1 | 2007-03 | | 2008-02 |
| NCT00324025 | Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS | TERMINATED | PHASE2 | 2007-03 | 2007-09 | 2007-09 |
| NCT00452270 | Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold | COMPLETED | PHASE3 | 2007-03 | 2007-04 | |
| NCT00444535 | Lapatinib and Bevacizumab for Metastatic Breast Cancer | COMPLETED | PHASE2 | 2007-02-27 | 2020-06-19 | 2008-07-22 |
| NCT00449761 | Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase | TERMINATED | PHASE2 | 2007-02-23 | 2008-08-26 | 2008-01-29 |
| NCT00451035 | Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase | TERMINATED | PHASE2 | 2007-02-19 | 2008-09-30 | 2008-04-13 |
| NCT00446524 | Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301) | COMPLETED | PHASE3 | 2007-02 | 2008-10 | 2008-10 |
| NCT00443482 | Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer) | COMPLETED | PHASE2 | 2007-02 | 2007-05 | 2007-05 |
| NCT00427999 | Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer | COMPLETED | PHASE2 | 2007-02 | 2015-08 | 2015-06 |
| NCT00426530 | Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer | COMPLETED | PHASE1 | 2007-02 | 2010-06 | 2010-06 |
| NCT00669916 | A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis | COMPLETED | PHASE1, PHASE2 | 2007-02 | 2007-11 | 2007-11 |
| NCT00433914 | Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants | COMPLETED | PHASE2 | 2007-02 | 2008-07 | 2007-12 |
| NCT00457119 | Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients | COMPLETED | PHASE1 | 2007-02 | 2009-11 | 2009-11 |
| NCT00414024 | Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. | TERMINATED | PHASE3 | 2007-02 | 2007-05 | 2007-05 |
| NCT00750295 | A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis | COMPLETED | PHASE1, PHASE2 | 2007-02 | 2008-01 | 2008-01 |
| NCT00423098 | Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare | COMPLETED | PHASE2 | 2007-02 | 2009-11 | 2009-11 |
| NCT00409578 | Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome | COMPLETED | PHASE2 | 2007-02 | 2009-04 | 2009-04 |
| NCT00436553 | Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization | COMPLETED | PHASE3 | 2007-02 | 2009-10 | 2009-10 |
| NCT00452621 | Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years | COMPLETED | PHASE4 | 2007-02 | | |
| NCT00425555 | Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma | COMPLETED | PHASE2 | 2007-01 | 2013-06 | 2013-06 |
| NCT00492869 | Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation | COMPLETED | PHASE1, PHASE2 | 2007-01 | | 2008-05 |
| NCT00432068 | Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers | COMPLETED | PHASE1 | 2007-01 | 2010-06 | 2010-06 |
| NCT00437645 | Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension | COMPLETED | PHASE3 | 2007-01 | 2007-11 | 2007-11 |
| NCT00428389 | Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease | COMPLETED | PHASE3 | 2007-01 | 2008-02 | 2008-02 |
| NCT00423085 | Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease | COMPLETED | PHASE3 | 2007-01 | 2010-04 | 2009-03 |
| NCT00451412 | A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients | COMPLETED | PHASE3 | 2007-01 | 2009-06 | 2009-06 |
| NCT00390975 | Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis | TERMINATED | PHASE4 | 2007-01 | 2007-03 | 2007-03 |
| NCT00441610 | An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor | COMPLETED | PHASE1 | 2007-01 | | 2009-09 |
| NCT00376259 | Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone | TERMINATED | PHASE3 | 2007-01 | | 2008-08 |
| NCT00581945 | Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients | COMPLETED | PHASE1, PHASE2 | 2007-01 | 2010-05 | 2010-05 |
| NCT00413049 | Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension | COMPLETED | PHASE3 | 2007-01 | 2007-11 | 2007-11 |
| NCT00413413 | Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension | COMPLETED | PHASE3 | 2007-01 | 2007-11 | 2007-11 |
| NCT00433836 | Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure | COMPLETED | PHASE3 | 2007-01 | 2009-02 | 2009-02 |
| NCT00431444 | Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density | COMPLETED | PHASE4 | 2007-01 | 2008-07 | 2008-07 |
| NCT00463801 | Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections | TERMINATED | PHASE4 | 2007-01 | | 2007-11 |
| NCT00405652 | Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients | COMPLETED | PHASE3 | 2007-01 | 2008-09 | 2008-09 |
| NCT00441064 | Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren | COMPLETED | PHASE4 | 2007-01 | 2007-11 | 2007-11 |
| NCT00701259 | Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn | COMPLETED | PHASE3 | 2007-01 | 2007-08 | |
| NCT00419172 | Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers | COMPLETED | PHASE1 | 2007-01 | | |
| NCT00434733 | Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects | COMPLETED | PHASE3 | 2007-01 | | |
| NCT00424541 | Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension | COMPLETED | PHASE1 | 2007-01 | 2007-08 | |
| NCT00620594 | A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer | COMPLETED | PHASE1 | 2006-12-21 | 2013-01-08 | 2013-01-08 |
| NCT00367471 | Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer. | COMPLETED | PHASE1 | 2006-12-07 | 2019-09-12 | 2010-12-22 |
| NCT00419159 | Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy | COMPLETED | PHASE2 | 2006-12 | 2009-03 | 2009-03 |
| NCT00529269 | Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms | COMPLETED | PHASE4 | 2006-12 | | 2007-06 |
| NCT00439738 | Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults | COMPLETED | PHASE4 | 2006-12 | | 2007-11 |
| NCT00432627 | Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox. | COMPLETED | PHASE1 | 2006-12 | 2010-08 | 2010-08 |
| NCT00434148 | Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease | COMPLETED | PHASE3 | 2006-12 | 2014-05 | 2010-03 |
| NCT00412529 | Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B | COMPLETED | PHASE3 | 2006-12 | | 2008-02 |
| NCT00414440 | Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease | COMPLETED | PHASE4 | 2006-12 | 2013-10 | 2013-10 |
| NCT00412061 | Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor | COMPLETED | PHASE3 | 2006-12 | 2013-06 | 2010-04 |
| NCT00434174 | Safety of Everolimus and Pemetrexed in Lung Cancer Patients | COMPLETED | PHASE1 | 2006-12 | 2010-12 | 2010-12 |
| NCT00414609 | Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE) | COMPLETED | PHASE3 | 2006-12 | 2011-07 | 2009-09 |
| NCT00411099 | Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder | COMPLETED | PHASE3 | 2006-12 | | 2008-01 |
| NCT00443898 | Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail | COMPLETED | PHASE3 | 2006-12 | | 2008-06 |
| NCT00411242 | Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder | COMPLETED | PHASE3 | 2006-12 | | 2008-01 |
| NCT00420615 | Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies | COMPLETED | PHASE1 | 2006-12 | | 2008-08 |
| NCT00421226 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers | COMPLETED | PHASE1 | 2006-12 | 2007-12 | 2007-10 |
| NCT00439647 | Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis | COMPLETED | PHASE3 | 2006-12 | 2010-10 | 2010-10 |
| NCT00454051 | Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma | COMPLETED | PHASE4 | 2006-12 | 2008-03 | 2008-03 |
| NCT00426218 | Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) | COMPLETED | PHASE1, PHASE2 | 2006-12 | | 2010-03 |
| NCT00403845 | Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2006-12 | 2007-10 | 2007-10 |
| NCT00425997 | Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension | COMPLETED | PHASE4 | 2006-12 | 2007-10 | 2007-10 |
| NCT00412750 | Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) | TERMINATED | PHASE3 | 2006-12 | 2009-02 | 2009-02 |
| NCT00443820 | Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail | COMPLETED | PHASE3 | 2006-12 | 2008-06 | 2008-06 |
| NCT00439244 | Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis | COMPLETED | PHASE3 | 2006-12 | 2009-02 | 2009-02 |
| NCT00419926 | Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients | COMPLETED | PHASE4 | 2006-12 | 2009-06 | 2009-06 |
| NCT00434447 | Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases | COMPLETED | PHASE4 | 2006-12 | | 2009-09 |
| NCT00417196 | Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers. | COMPLETED | PHASE1 | 2006-12 | 2007-08 | |
| NCT00426179 | Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen | COMPLETED | PHASE1, PHASE2 | 2006-12 | 2007-08 | |
| NCT00410501 | Evaluation of Pharmacokinetic Interaction of Indacaterol With Ketoconazole in Healthy Adult Subjects | COMPLETED | PHASE1 | 2006-12 | | |
| NCT00414947 | Bioequivalence of Vildagliptin Tablet Manufactured in China Compared to Imported Vildagliptin Tablet in Chinese Healthy Volunteers | COMPLETED | PHASE1 | 2006-12 | | |
| NCT00402909 | Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone | COMPLETED | PHASE4 | 2006-11 | 2007-08 | 2007-08 |
| NCT00403637 | Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma | COMPLETED | PHASE2, PHASE3 | 2006-11 | 2007-02 | 2007-02 |
| NCT00428909 | Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP) | COMPLETED | PHASE1 | 2006-11 | 2008-08 | 2008-08 |
| NCT00424983 | Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year | COMPLETED | PHASE1 | 2006-11 | 2009-11 | 2009-11 |
| NCT00406575 | Recombinant Human Relaxin for the Treatment of Decompensated CHF | TERMINATED | PHASE2 | 2006-11 | 2007-01 | 2007-01 |
| NCT00424346 | Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE2 | 2006-11 | 2009-10 | 2008-09 |
| NCT00441155 | Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib | COMPLETED | PHASE1 | 2006-11 | 2011-01 | 2011-01 |
| NCT00410124 | RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib | COMPLETED | PHASE3 | 2006-11 | 2011-10 | 2008-02 |
| NCT00412997 | LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma | COMPLETED | PHASE1 | 2006-11 | | 2008-05 |
| NCT00399659 | Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. | TERMINATED | PHASE3 | 2006-11 | 2007-04 | 2007-04 |
| NCT00523549 | The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction | COMPLETED | PHASE4 | 2006-11 | 2008-01 | 2008-01 |
| NCT00418626 | Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function | COMPLETED | PHASE1 | 2006-11 | | 2007-09 |
| NCT00382187 | Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults | COMPLETED | PHASE2 | 2006-11 | 2008-01 | 2008-01 |
| NCT00519064 | Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases | COMPLETED | PHASE3 | 2006-11 | 2007-05 | 2006-12 |
| NCT00408395 | Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children | COMPLETED | PHASE2 | 2006-11 | 2007-08 | 2007-08 |
| NCT00403754 | Dose Ranging Study for Indacaterol in Japanese Asthma Patients | COMPLETED | PHASE2 | 2006-11 | 2007-11 | 2007-11 |
| NCT00425373 | Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension | COMPLETED | PHASE2, PHASE3 | 2006-11 | 2008-03 | 2008-03 |
| NCT00409708 | Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD) | COMPLETED | PHASE2 | 2006-11 | | 2008-03 |
| NCT00402103 | An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure | COMPLETED | PHASE3 | 2006-11 | 2008-04 | 2008-04 |
| NCT00426478 | Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients | COMPLETED | PHASE4 | 2006-11 | 2007-09 | |
| NCT00416702 | Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function | COMPLETED | PHASE1 | 2006-11 | 2008-03 | |
| NCT00417261 | Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects. | COMPLETED | PHASE1 | 2006-11 | 2008-04 | |
| NCT00413790 | Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects | COMPLETED | PHASE4 | 2006-11 | 2007-09 | |
| NCT00426621 | Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis | COMPLETED | PHASE3 | 2006-11 | 2007-06 | |
| NCT00417820 | Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis. | COMPLETED | PHASE1 | 2006-11 | 2007-11 | |
| NCT00419796 | Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension | COMPLETED | PHASE4 | 2006-11 | 2007-09 | |
| NCT00418509 | Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers | COMPLETED | PHASE1 | 2006-11 | | |
| NCT00424671 | Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Metabolism of a Single Dose of Licarbazepine | COMPLETED | PHASE1 | 2006-11 | | |
| NCT00416728 | Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects. | COMPLETED | PHASE1 | 2006-11 | | |
| NCT00416468 | Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects. | COMPLETED | PHASE1 | 2006-11 | | |
| NCT00441051 | Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn | COMPLETED | PHASE3 | 2006-11 | 2006-12 | |
| NCT00403416 | Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients | COMPLETED | PHASE1, PHASE2 | 2006-10 | 2008-05 | 2008-05 |
| NCT00342940 | Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older | WITHDRAWN | PHASE2 | 2006-10 | | |
| NCT00387517 | Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension | COMPLETED | PHASE3 | 2006-10 | 2007-08 | 2007-08 |
| NCT00425308 | Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance. | COMPLETED | PHASE3 | 2006-10 | | 2009-05 |
| NCT00510354 | Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate | COMPLETED | PHASE4 | 2006-10 | 2012-11 | 2012-11 |
| NCT00396071 | Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin | COMPLETED | PHASE3 | 2006-10 | | 2007-11 |
| NCT00396227 | Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone | COMPLETED | PHASE3 | 2006-10 | | 2007-10 |
| NCT00386607 | A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide. | COMPLETED | PHASE3 | 2006-10 | 2008-07 | 2008-07 |
| NCT00396357 | Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone | COMPLETED | PHASE3 | 2006-10 | | 2008-06 |
| NCT00416442 | Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects. | COMPLETED | PHASE1 | 2006-10 | | 2006-11 |
| NCT00396604 | Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2, PHASE3 | 2006-10 | 2007-01 | 2007-01 |
| NCT00400400 | Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance | COMPLETED | PHASE4 | 2006-10 | | 2008-06 |
| NCT00393458 | Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control | COMPLETED | PHASE3 | 2006-10 | 2008-07 | 2008-07 |
| NCT00404820 | Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE3 | 2006-10 | 2008-12 | 2008-12 |
| NCT00391898 | Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off | COMPLETED | PHASE4 | 2006-10 | 2008-06 | 2008-06 |
| NCT00414778 | Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects | COMPLETED | PHASE1 | 2006-10 | | 2006-10 |
| NCT00416845 | Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers | COMPLETED | PHASE1 | 2006-10 | | 2007-03 |
| NCT00333307 | Evaluation of the Safety of Relaxin in Preeclampsia | SUSPENDED | PHASE1 | 2006-10 | | |
| NCT00418756 | Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects | COMPLETED | PHASE1 | 2006-10 | | 2006-11 |
| NCT00391950 | Maintaining Bone Strength in Men With Prostate Cancer | TERMINATED | PHASE3 | 2006-10 | | 2007-05 |
| NCT00389415 | Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-10 | | |
| NCT00416546 | Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects | COMPLETED | PHASE1 | 2006-10 | 2007-10 | |
| NCT00422175 | Single Dose Study to Assess the Safety, Tolerability, Concentration in Body and Effect of BAF312 | COMPLETED | PHASE1 | 2006-10 | 2007-11 | |
| NCT00421590 | Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide). | COMPLETED | PHASE2 | 2006-10 | | |
| NCT00409500 | Effect of Food on the Pharmacokinetics of AQW051 in Japanese Healthy Male Subjects | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00395395 | Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women | COMPLETED | PHASE1 | 2006-10 | | |
| NCT00275912 | Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures | COMPLETED | PHASE4 | 2006-09-11 | 2007-09-28 | 2007-09-28 |
| NCT00411528 | Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer | COMPLETED | PHASE2 | 2006-09 | 2012-09 | 2012-09 |
| NCT00382096 | Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-09 | 2008-06-03 | 2008-06-03 |
| NCT00386139 | A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients | COMPLETED | PHASE3 | 2006-09 | 2007-07 | 2007-07 |
| NCT01278342 | Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients | COMPLETED | PHASE4 | 2006-09 | 2009-11 | 2009-11 |
| NCT00394173 | Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) | COMPLETED | PHASE2 | 2006-09 | 2007-10 | 2007-10 |
| NCT00464399 | Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients | COMPLETED | PHASE3 | 2006-09 | | 2012-12 |
| NCT00751608 | Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients | WITHDRAWN | PHASE2 | 2006-09 | 2009-02 | 2009-02 |
| NCT00420043 | Effect of Food on Bioavailability of Modified Release Formulations of Imatinib | COMPLETED | PHASE1 | 2006-09 | 2006-11 | 2006-11 |
| NCT00381615 | Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study | COMPLETED | PHASE2 | 2006-09 | 2008-08 | 2007-07 |
| NCT00383578 | Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-09 | | 2008-05 |
| NCT00387634 | Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults | COMPLETED | PHASE4 | 2006-09 | 2011-10 | 2011-10 |
| NCT00664742 | The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome | COMPLETED | PHASE4 | 2006-09 | 2007-10 | 2007-10 |
| NCT00368277 | A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly | COMPLETED | PHASE3 | 2006-09 | 2008-02 | 2008-02 |
| NCT00390520 | Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-09 | 2007-09 | 2007-09 |
| NCT00422552 | Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol | COMPLETED | PHASE1, PHASE2 | 2006-09 | | |
| NCT00419887 | Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers | COMPLETED | PHASE1 | 2006-09 | | |
| NCT00414752 | Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking | COMPLETED | PHASE1 | 2006-09 | | |
| NCT00385658 | Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome | COMPLETED | PHASE4 | 2006-08 | 2007-03 | 2007-03 |
| NCT00392262 | A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients | COMPLETED | PHASE3 | 2006-08 | 2007-02 | 2007-02 |
| NCT00967213 | Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration | COMPLETED | PHASE3 | 2006-08 | | 2008-02 |
| NCT00378014 | Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy | COMPLETED | PHASE3 | 2006-08 | 2013-01 | 2013-01 |
| NCT00395629 | Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis | COMPLETED | PHASE1, PHASE2 | 2006-08 | 2009-03 | 2007-12 |
| NCT00426582 | Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2006-08 | | 2010-08 |
| NCT00412789 | Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan | COMPLETED | PHASE1 | 2006-08 | | 2008-01 |
| NCT00426140 | Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. | COMPLETED | PHASE1 | 2006-08 | | 2006-11 |
| NCT00386763 | Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria. | COMPLETED | PHASE3 | 2006-08 | 2007-03 | |
| NCT00847678 | Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS | TERMINATED | PHASE2 | 2006-08 | | 2007-11 |
| NCT00400777 | Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension | COMPLETED | PHASE4 | 2006-08 | 2008-06 | 2007-11 |
| NCT00333567 | Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery | COMPLETED | PHASE4 | 2006-08 | | |
| NCT00416962 | Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine | COMPLETED | PHASE1 | 2006-08 | 2006-12 | |
| NCT00368134 | To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-08 | | |
| NCT00414856 | Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux | COMPLETED | PHASE1 | 2006-08 | | |
| NCT00411125 | Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women | COMPLETED | PHASE1 | 2006-08 | 2006-11 | |
| NCT00400647 | Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil | COMPLETED | PHASE4 | 2006-07 | 2008-09 | 2008-09 |
| NCT00360178 | Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide | COMPLETED | PHASE3 | 2006-07 | 2006-12 | 2006-12 |
| NCT00348634 | Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients | TERMINATED | PHASE4 | 2006-07 | 2007-04 | 2007-04 |
| NCT00365820 | Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain | TERMINATED | PHASE2, PHASE3 | 2006-07 | 2007-04 | 2007-04 |
| NCT00426452 | A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers | COMPLETED | PHASE1 | 2006-07 | | |
| NCT00427505 | Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam | COMPLETED | PHASE1 | 2006-07 | | |
| NCT00503022 | Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration | COMPLETED | PHASE1 | 2006-07 | | |
| NCT00415922 | Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers | COMPLETED | PHASE1 | 2006-07 | | |
| NCT00411567 | A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma | COMPLETED | PHASE1, PHASE2 | 2006-07 | | |
| NCT00415883 | To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers | COMPLETED | PHASE1 | 2006-07 | | |
| NCT00367094 | Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension | COMPLETED | PHASE3 | 2006-07 | | |
| NCT00354016 | Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects | COMPLETED | PHASE3 | 2006-07 | | |
| NCT00387205 | Study To Assess Long Term Safety Of Pazopanib | COMPLETED | PHASE1 | 2006-06-20 | 2018-03-08 | 2013-02-13 |
| NCT00375752 | Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer | TERMINATED | PHASE4 | 2006-06-01 | 2010-12-16 | 2010-12-16 |
| NCT00351468 | EXTEND (Eltrombopag Extended Dosing Study) | COMPLETED | PHASE3 | 2006-06 | 2015-07 | 2015-07 |
| NCT00369161 | A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients | COMPLETED | PHASE4 | 2006-06 | 2008-12 | 2008-12 |
| NCT00351130 | Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy | COMPLETED | PHASE4 | 2006-06 | 2007-03 | 2007-03 |
| NCT00372476 | Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer | COMPLETED | PHASE4 | 2006-06 | 2012-07 | 2012-07 |
| NCT00446082 | Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease | COMPLETED | PHASE1 | 2006-06 | 2013-11 | 2013-11 |
| NCT00353912 | Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension | COMPLETED | PHASE3 | 2006-06 | 2007-04 | 2007-04 |
| NCT00344110 | Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension | COMPLETED | PHASE3 | 2006-06 | 2007-04 | 2007-04 |
| NCT00350168 | Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension | COMPLETED | PHASE3 | 2006-06 | 2007-04 | 2007-04 |
| NCT00413426 | Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects | COMPLETED | PHASE1 | 2006-06 | 2007-09 | |
| NCT00422825 | Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib | COMPLETED | PHASE1 | 2006-06 | 2006-09 | 2006-09 |
| NCT00363051 | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | COMPLETED | PHASE2 | 2006-06 | 2012-04 | 2008-01 |
| NCT00410358 | A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor. | COMPLETED | PHASE1 | 2006-06 | | 2008-02 |
| NCT00355134 | Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE3 | 2006-06 | 2011-08 | 2011-06 |
| NCT00418769 | Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers | COMPLETED | PHASE1 | 2006-06 | | 2006-08 |
| NCT00351377 | Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate | COMPLETED | PHASE3 | 2006-06 | 2009-06 | 2009-06 |
| NCT00369278 | Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients | COMPLETED | PHASE3 | 2006-06 | 2008-12 | 2008-12 |
| NCT00409929 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071 | COMPLETED | PHASE1 | 2006-06 | | 2006-07 |
| NCT00366002 | Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder | COMPLETED | PHASE4 | 2006-06 | 2007-09 | |
| NCT00426036 | Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine | COMPLETED | PHASE1 | 2006-06 | | |
| NCT00415844 | Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers | COMPLETED | PHASE1 | 2006-06 | | |
| NCT00410228 | Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects | COMPLETED | PHASE1 | 2006-06 | | |
| NCT00415831 | Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers | COMPLETED | PHASE1 | 2006-06 | | |
| NCT00351832 | A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-06 | | |
| NCT00389948 | Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn | COMPLETED | PHASE3 | 2006-06 | 2007-01 | |
| NCT00390390 | Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn | COMPLETED | PHASE3 | 2006-06 | 2007-01 | |
| NCT00329966 | Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older | COMPLETED | PHASE2 | 2006-06 | | |
| NCT00329927 | Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects | COMPLETED | PHASE2 | 2006-06 | | |
| NCT00329849 | Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age | COMPLETED | PHASE3 | 2006-05 | 2007-03 | 2007-03 |
| NCT00340834 | Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase | COMPLETED | PHASE3 | 2006-05 | 2011-07 | 2011-07 |
| NCT00334139 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | COMPLETED | PHASE4 | 2006-05 | 2009-07 | 2009-07 |
| NCT00343551 | Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension. | COMPLETED | PHASE3 | 2006-05 | | 2007-01 |
| NCT00537862 | Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients | COMPLETED | PHASE4 | 2006-05 | | 2007-02 |
| NCT00351884 | Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-05 | | 2007-11 |
| NCT00493766 | Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone | TERMINATED | PHASE1 | 2006-05 | | 2008-07 |
| NCT00264160 | Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy | COMPLETED | PHASE2, PHASE3 | 2006-05 | 2009-08 | 2008-11 |
| NCT00427583 | Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors | TERMINATED | PHASE2, PHASE3 | 2006-05 | | 2009-04 |
| NCT00421044 | A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function | COMPLETED | PHASE1 | 2006-05 | | 2008-02 |
| NCT00406016 | Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI | COMPLETED | PHASE1 | 2006-05 | 2011-09 | 2011-09 |
| NCT00338936 | Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study) | COMPLETED | PHASE3 | 2006-05 | 2007-09 | 2007-09 |
| NCT00327587 | 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension | COMPLETED | PHASE3 | 2006-05 | 2007-08 | 2007-08 |
| NCT00438360 | Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis | COMPLETED | PHASE3 | 2006-05 | 2007-11 | 2007-11 |
| NCT01276457 | Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients | COMPLETED | PHASE3 | 2006-05 | 2009-02 | 2009-02 |
| NCT00332462 | A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients | COMPLETED | PHASE4 | 2006-05 | 2009-01 | 2008-04 |
| NCT00258765 | Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. | TERMINATED | PHASE2 | 2006-05 | | 2006-11 |
| NCT00419536 | Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone | TERMINATED | PHASE1 | 2006-05 | | |
| NCT00350155 | Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel | COMPLETED | PHASE4 | 2006-05 | | |
| NCT00418002 | Safety and Tolerability of AQW051 in Elderly Healthy Volunteers. | COMPLETED | PHASE1 | 2006-05 | | |
| NCT00415740 | Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers | COMPLETED | PHASE1 | 2006-05 | | |
| NCT00399945 | Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study | COMPLETED | PHASE1 | 2006-05 | | |
| NCT00304525 | A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma | COMPLETED | PHASE1, PHASE2 | 2006-04 | 2013-11 | 2013-11 |
| NCT00299832 | SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction | COMPLETED | PHASE3 | 2006-04 | 2007-05 | 2007-05 |
| NCT00299806 | SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension | COMPLETED | PHASE3 | 2006-04 | 2006-11 | 2006-11 |
| NCT00477269 | Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension | COMPLETED | PHASE2, PHASE3 | 2006-04 | 2014-01 | 2014-01 |
| NCT00310713 | Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine | COMPLETED | PHASE4 | 2006-04 | 2006-08 | 2006-08 |
| NCT00329901 | Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years | COMPLETED | PHASE3 | 2006-04 | 2007-12 | 2007-05 |
| NCT00303251 | Safety of TKI258 in Advanced/Metastatic Melanoma Subjects | COMPLETED | PHASE1, PHASE2 | 2006-04 | | 2009-09 |
| NCT00430937 | Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections | TERMINATED | PHASE3 | 2006-04 | | 2008-03 |
| NCT00331864 | SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration | COMPLETED | PHASE3 | 2006-04 | 2008-04 | 2008-04 |
| NCT00325429 | Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-04 | | |
| NCT00325117 | To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy | COMPLETED | PHASE3 | 2006-04 | | |
| NCT00420836 | Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study | COMPLETED | PHASE1 | 2006-04 | | |
| NCT00311740 | A Study of VAH631 in Patients With Essential Hypertension (Factorial Study) | COMPLETED | PHASE3 | 2006-03 | 2006-09 | 2006-09 |
| NCT00332852 | Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer | COMPLETED | PHASE3 | 2006-03 | | 2010-07 |
| NCT00367393 | Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis | COMPLETED | PHASE4 | 2006-03 | 2007-12 | 2007-12 |
| NCT00327145 | A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy | COMPLETED | PHASE3 | 2006-03 | 2007-01 | 2007-01 |
| NCT00333229 | A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss | TERMINATED | PHASE4 | 2006-03 | 2013-12 | 2013-12 |
| NCT00371826 | SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus | COMPLETED | PHASE4 | 2006-03 | 2012-06 | 2012-06 |
| NCT00420485 | Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2006-03 | 2010-11 | 2010-11 |
| NCT00345319 | Purified Rabies Vaccine for Human Use (Chick-embryo Cell) | COMPLETED | PHASE3 | 2006-03 | 2006-05 | 2006-05 |
| NCT00376064 | Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly | COMPLETED | PHASE4 | 2006-03 | | 2010-01 |
| NCT00306787 | Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes | COMPLETED | PHASE3 | 2006-03 | 2008-02 | 2008-02 |
| NCT00305903 | Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease | COMPLETED | PHASE4 | 2006-03 | 2007-08 | |
| NCT00311480 | Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects | COMPLETED | PHASE2 | 2006-03 | | |
| NCT00300287 | A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia | COMPLETED | PHASE3 | 2006-02-20 | 2007-06-26 | 2007-06-26 |
| NCT00447694 | Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment | COMPLETED | PHASE2 | 2006-02 | 2009-11 | 2009-11 |
| NCT00311753 | Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients | COMPLETED | PHASE3 | 2006-02 | | 2007-12 |
| NCT00330317 | Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer | COMPLETED | PHASE3 | 2006-02 | 2010-11-16 | 2010-03 |
| NCT00396409 | Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis | COMPLETED | PHASE3 | 2006-02 | 2008-08 | 2008-08 |
| NCT00348491 | Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib | COMPLETED | PHASE4 | 2006-02 | | 2006-05 |
| NCT00304226 | Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy | COMPLETED | PHASE4 | 2006-02 | 2007-01 | 2007-01 |
| NCT00391690 | Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer | COMPLETED | PHASE4 | 2006-02 | | 2010-12 |
| NCT00320710 | Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer | COMPLETED | PHASE3 | 2006-02 | 2013-07 | 2013-07 |
| NCT00388505 | Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis | COMPLETED | PHASE3 | 2006-02 | 2009-03 | 2009-03 |
| NCT00297817 | Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents | COMPLETED | PHASE2 | 2006-02 | 2007-04 | 2007-04 |
| NCT00375427 | Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions | COMPLETED | PHASE3 | 2006-02 | | 2010-02 |
| NCT00290771 | Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM) | TERMINATED | PHASE2 | 2006-02 | 2008-08 | 2008-08 |
| NCT00301236 | Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder | COMPLETED | PHASE3 | 2006-02 | 2006-11 | |
| NCT00311493 | Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults | COMPLETED | PHASE4 | 2006-02 | | |
| NCT00281658 | Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 | COMPLETED | PHASE3 | 2006-01-02 | 2021-11-23 | 2010-06-18 |
| NCT00284947 | Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids | COMPLETED | PHASE4 | 2006-01 | 2008-12 | 2008-12 |
| NCT00380445 | Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2006-01 | 2007-04 | 2007-04 |
| NCT00273312 | Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma | COMPLETED | PHASE2 | 2006-01 | | 2006-10 |
| NCT00380380 | A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes. | COMPLETED | PHASE3 | 2006-01 | 2006-11 | 2006-11 |
| NCT00300274 | Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection | COMPLETED | PHASE3 | 2006-01 | 2011-07 | 2011-07 |
| NCT00289978 | Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE3 | 2006-01 | 2009-07 | 2009-07 |
| NCT00260208 | Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus | TERMINATED | PHASE4 | 2006-01 | | 2010-09 |
| NCT00420524 | A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function | COMPLETED | PHASE1 | 2006-01 | | 2010-07 |
| NCT00332709 | Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer | COMPLETED | PHASE3 | 2006-01 | 2010-08 | 2010-08 |
| NCT00310648 | Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years) | COMPLETED | PHASE3 | 2006-01 | | |
| NCT00272987 | ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib | TERMINATED | PHASE3 | 2005-12-13 | 2019-10-21 | 2009-07-31 |
| NCT00263588 | Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer | COMPLETED | PHASE2 | 2005-12-02 | 2018-03-15 | 2007-09-25 |
| NCT00377962 | Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation | COMPLETED | PHASE4 | 2005-12 | 2010-02 | 2010-02 |
| NCT00367939 | Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine | COMPLETED | PHASE3 | 2005-12 | 2006-07 | 2006-07 |
| NCT00248170 | Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer | COMPLETED | PHASE3 | 2005-12 | 2014-09 | 2014-09 |
| NCT00669942 | Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients | COMPLETED | PHASE1, PHASE2 | 2005-12 | 2008-11 | 2008-11 |
| NCT00242567 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | COMPLETED | PHASE3 | 2005-12 | 2012-01 | 2012-01 |
| NCT00267202 | Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma | COMPLETED | PHASE4 | 2005-12 | 2008-04 | 2008-01 |
| NCT00294086 | A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure | COMPLETED | PHASE2 | 2005-12 | 2007-01 | 2007-01 |
| NCT00396656 | Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients | COMPLETED | PHASE3 | 2005-12 | 2007-12 | 2007-12 |
| NCT00372697 | Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly | COMPLETED | PHASE3 | 2005-12 | 2007-10 | 2007-10 |
| NCT00284934 | Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients | COMPLETED | PHASE3 | 2005-12 | 2008-06 | 2008-06 |
| NCT00275821 | Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) | COMPLETED | PHASE3 | 2005-12 | 2008-01 | 2008-01 |
| NCT00280540 | Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension | COMPLETED | PHASE4 | 2005-12 | | 2006-08 |
| NCT00275925 | Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures | COMPLETED | PHASE4 | 2005-12 | 2007-03 | |
| NCT00219297 | Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer | COMPLETED | PHASE2 | 2005-11-16 | 2010-06-24 | 2010-06-24 |
| NCT00264849 | Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma | COMPLETED | PHASE4 | 2005-11 | 2008-09 | 2008-09 |
| NCT00394823 | VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients | COMPLETED | PHASE3 | 2005-11 | 2007-06 | 2007-06 |
| NCT00394745 | Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome | COMPLETED | PHASE3 | 2005-11 | 2007-06 | 2007-06 |
| NCT00329940 | Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer | COMPLETED | PHASE3 | 2005-11 | | 2008-01 |
| NCT00267176 | Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension | COMPLETED | PHASE4 | 2005-11 | | 2006-09 |
| NCT00262236 | Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension | COMPLETED | PHASE3 | 2005-11 | 2006-08 | 2006-08 |
| NCT00250575 | A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia | COMPLETED | PHASE3 | 2005-11 | | 2009-12 |
| NCT00332839 | Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients. | TERMINATED | PHASE4 | 2005-11 | 2013-03 | 2013-03 |
| NCT00254475 | A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia | COMPLETED | PHASE3 | 2005-11 | 2006-09 | 2006-09 |
| NCT00259103 | Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor | COMPLETED | PHASE2 | 2005-11 | 2006-10 | 2006-10 |
| NCT00260156 | A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-11 | 2008-12 | 2008-12 |
| NCT00262990 | Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer | COMPLETED | PHASE3 | 2005-11 | | 2010-02 |
| NCT00248157 | Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy | TERMINATED | PHASE3 | 2005-11 | 2006-05 | 2006-05 |
| NCT00248131 | Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy | TERMINATED | PHASE3 | 2005-11 | 2006-07 | 2006-07 |
| NCT00260923 | A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure | COMPLETED | PHASE3 | 2005-11 | 2006-11 | 2006-11 |
| NCT00273299 | Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension | COMPLETED | PHASE3 | 2005-11 | 2006-07 | 2006-07 |
| NCT00267150 | Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants | COMPLETED | PHASE3 | 2005-11 | 2008-01 | 2008-01 |
| NCT00267189 | RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency | COMPLETED | PHASE3 | 2005-11 | 2007-11 | 2007-11 |
| NCT00259116 | A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure | COMPLETED | PHASE2 | 2005-11 | | |
| NCT00277472 | Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension | COMPLETED | PHASE4 | 2005-11 | | 2005-11 |
| NCT00237237 | Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-10 | | 2007-02 |
| NCT00219193 | A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients | COMPLETED | PHASE3 | 2005-10 | 2007-01 | 2007-01 |
| NCT00250562 | A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan. | COMPLETED | PHASE3 | 2005-10 | 2006-06 | 2006-06 |
| NCT00375505 | The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss | COMPLETED | PHASE3 | 2005-10 | 2014-05 | 2014-05 |
| NCT00264576 | Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults | COMPLETED | PHASE2 | 2005-10 | 2006-05 | 2005-12 |
| NCT00237250 | Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance | COMPLETED | PHASE3 | 2005-10 | 2006-07 | 2006-07 |
| NCT00311415 | Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children | COMPLETED | PHASE3 | 2005-10 | 2008-04 | 2008-04 |
| NCT00235391 | Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload | COMPLETED | PHASE3 | 2005-10 | 2008-10 | 2008-10 |
| NCT00219141 | Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension | COMPLETED | PHASE3 | 2005-10 | 2007-11 | 2007-11 |
| NCT00251004 | Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients | COMPLETED | PHASE3 | 2005-10 | 2009-10 | 2009-08 |
| NCT00464776 | Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy | COMPLETED | PHASE1, PHASE2 | 2005-10 | | 2008-04 |
| NCT00284050 | Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement | COMPLETED | PHASE2 | 2005-10 | 2008-06 | 2008-06 |
| NCT00518765 | Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet | COMPLETED | PHASE3 | 2005-10 | | 2007-08 |
| NCT00254878 | Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14 | COMPLETED | PHASE3 | 2005-10 | 2006-02 | |
| NCT00311428 | Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months | COMPLETED | PHASE4 | 2005-10 | | |
| NCT00251433 | GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer | TERMINATED | PHASE1 | 2005-09-26 | 2022-06-22 | 2010-06-10 |
| NCT00117507 | Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients | COMPLETED | PHASE4 | 2005-09 | 2008-01 | 2008-01 |
| NCT00310804 | Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60) | COMPLETED | PHASE3 | 2005-09 | 2006-04 | 2005-10 |
| NCT00306527 | Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly | COMPLETED | PHASE3 | 2005-09 | 2006-04 | 2005-12 |
| NCT00231166 | Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma | COMPLETED | PHASE1 | 2005-09 | 2009-05 | 2009-05 |
| NCT00229138 | Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients | COMPLETED | PHASE4 | 2005-09 | 2007-03 | 2007-03 |
| NCT00239005 | Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation | COMPLETED | PHASE4 | 2005-09 | | 2008-03 |
| NCT00242580 | A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib | COMPLETED | PHASE3 | 2005-09 | | 2008-01 |
| NCT00332969 | Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma | COMPLETED | PHASE2 | 2005-09 | | 2010-10 |
| NCT00125346 | Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects | TERMINATED | PHASE3 | 2005-09 | 2007-02 | 2007-02 |
| NCT00332696 | Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | COMPLETED | PHASE2 | 2005-09 | 2008-09 | 2008-09 |
| NCT00247650 | Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy | COMPLETED | PHASE2 | 2005-09 | | 2007-03 |
| NCT00138632 | Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) | COMPLETED | PHASE1, PHASE2 | 2005-09 | | 2007-11 |
| NCT00232115 | Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis | COMPLETED | PHASE3 | 2005-09 | 2006-07 | |
| NCT00464880 | Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy | COMPLETED | PHASE1, PHASE2 | 2005-09 | 2007-11 | |
| NCT00134966 | A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa | COMPLETED | PHASE3 | 2005-08 | 2007-09 | 2007-09 |
| NCT00434317 | Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases | COMPLETED | PHASE4 | 2005-08 | | 2008-04 |
| NCT00461136 | Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes | COMPLETED | PHASE1, PHASE2 | 2005-08 | 2006-11 | 2006-11 |
| NCT00135005 | Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST) | COMPLETED | PHASE1 | 2005-08 | 2006-11 | 2006-11 |
| NCT01279473 | Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study) | COMPLETED | PHASE1, PHASE2 | 2005-08 | | 2009-12 |
| NCT00417807 | Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors | COMPLETED | PHASE1, PHASE2 | 2005-08 | | 2009-06 |
| NCT00130364 | Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis | COMPLETED | PHASE4 | 2005-08 | 2006-08 | |
| NCT00110266 | Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients | COMPLETED | PHASE2 | 2005-07-25 | 2008-03-28 | 2008-03-28 |
| NCT00154284 | Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients | COMPLETED | PHASE3 | 2005-07 | 2008-07 | 2008-07 |
| NCT00143026 | Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States | COMPLETED | PHASE4 | 2005-07 | 2006-06 | 2006-06 |
| NCT00821574 | Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome | COMPLETED | PHASE4 | 2005-07 | 2007-03 | 2007-03 |
| NCT00124280 | Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) | COMPLETED | PHASE2 | 2005-07 | | 2007-10 |
| NCT00171600 | Antialbuminuric Effects of Valsartan and Lisinopril | TERMINATED | PHASE4 | 2005-07 | 2007-01 | 2007-01 |
| NCT00130351 | A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma | COMPLETED | PHASE3 | 2005-07 | 2005-08 | 2005-08 |
| NCT00219258 | Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma | COMPLETED | PHASE3 | 2005-07 | | |
| NCT00098046 | Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection | COMPLETED | PHASE3 | 2005-07 | 2007-07 | |
| NCT00310856 | Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) | COMPLETED | PHASE2 | 2005-06 | 2006-11 | 2006-11 |
| NCT00375648 | Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer | COMPLETED | PHASE3 | 2005-06 | | 2007-07 |
| NCT00120536 | Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-06 | 2006-07 | 2006-07 |
| NCT00219180 | Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure | COMPLETED | PHASE3 | 2005-06 | 2006-09 | 2006-09 |
| NCT00136799 | Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia | COMPLETED | PHASE3 | 2005-06 | 2006-04 | 2006-04 |
| NCT00171405 | A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg | COMPLETED | PHASE3 | 2005-06 | 2006-02 | 2006-02 |
| NCT00154310 | Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients | COMPLETED | PHASE4 | 2005-06 | 2008-09 | 2008-09 |
| NCT00411580 | Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) | COMPLETED | PHASE1 | 2005-06 | 2008-12 | 2008-12 |
| NCT00386750 | Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function | TERMINATED | PHASE4 | 2005-06 | 2005-11 | 2005-11 |
| NCT00456833 | Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy | COMPLETED | PHASE1 | 2005-06 | | 2011-03 |
| NCT00124748 | Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) | TERMINATED | PHASE3 | 2005-06 | 2010-11 | 2010-11 |
| NCT00171301 | Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) | COMPLETED | PHASE4 | 2005-06 | 2008-05 | 2008-05 |
| NCT00154297 | Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients | COMPLETED | PHASE4 | 2005-06 | | 2008-06 |
| NCT00219102 | A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients | COMPLETED | PHASE3 | 2005-06 | 2007-05 | 2007-05 |
| NCT00141063 | Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD | COMPLETED | PHASE3 | 2005-06 | 2005-08 | |
| NCT00310635 | Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age | COMPLETED | PHASE4 | 2005-06 | | |
| NCT00316628 | Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over. | COMPLETED | PHASE2 | 2005-06 | | |
| NCT00316615 | Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects. | COMPLETED | PHASE2 | 2005-06 | | |
| NCT00170781 | Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout | COMPLETED | PHASE4 | 2005-06 | | |
| NCT00128544 | Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B | COMPLETED | PHASE2 | 2005-05 | 2007-05 | 2007-05 |
| NCT00125125 | Fluvastatin in Adults With Dislipidemia With History of Muscle Problems | COMPLETED | PHASE4 | 2005-05 | 2005-12 | 2005-12 |
| NCT00219011 | "ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure | COMPLETED | PHASE3 | 2005-05 | 2007-02 | 2007-02 |
| NCT00170885 | Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients | COMPLETED | PHASE4 | 2005-05 | 2007-07 | 2007-07 |
| NCT00171522 | Preference of Tegaserod vs. PEG 3350 in Patients With Constipation | COMPLETED | PHASE4 | 2005-05 | 2005-09 | |
| NCT00171665 | Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis | COMPLETED | PHASE3 | 2005-05 | 2005-12 | |
| NCT00310700 | Kinetics of B Cell Response in Infants Menjugate Vaccination | COMPLETED | PHASE4 | 2005-05 | 2005-11 | 2005-11 |
| NCT00351507 | A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-05 | 2006-02 | 2006-02 |
| NCT00384228 | A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL | COMPLETED | PHASE1, PHASE2 | 2005-05 | | 2007-01 |
| NCT00239876 | Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients | COMPLETED | PHASE3 | 2005-05 | | 2005-12 |
| NCT00145327 | Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis) | COMPLETED | PHASE3 | 2005-05 | 2009-11 | 2009-11 |
| NCT00110617 | Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients | COMPLETED | PHASE2 | 2005-05 | 2008-04 | 2008-04 |
| NCT00127270 | Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder | COMPLETED | PHASE4 | 2005-05 | 2006-02 | |
| NCT00121381 | Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis | COMPLETED | PHASE4 | 2005-05 | 2007-01 | |
| NCT00141050 | Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD | COMPLETED | PHASE3 | 2005-05 | 2005-07 | |
| NCT00171652 | Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis | COMPLETED | PHASE3 | 2005-05 | 2005-10 | |
| NCT00109707 | A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies | COMPLETED | PHASE1, PHASE2 | 2005-04 | 2012-09 | 2012-09 |
| NCT00509990 | Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting | COMPLETED | PHASE4 | 2005-04 | | 2007-09 |
| NCT00171184 | Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder | COMPLETED | PHASE4 | 2005-04 | 2006-06 | |
| NCT00171899 | Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) | COMPLETED | PHASE4 | 2005-04 | 2007-06 | 2007-06 |
| NCT00171769 | Atrial Fibrillation Feasibility Certoparin Trial - AFFECT | COMPLETED | PHASE3 | 2005-04 | | 2006-08 |
| NCT00312130 | A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes | COMPLETED | PHASE3 | 2005-04 | 2006-11 | 2006-11 |
| NCT00219167 | A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure | COMPLETED | PHASE3 | 2005-04 | 2006-02 | 2006-02 |
| NCT00171808 | Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer | COMPLETED | PHASE2 | 2005-04 | | 2010-05 |
| NCT00262028 | Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children | COMPLETED | PHASE2 | 2005-04 | 2006-11 | 2006-11 |
| NCT00171821 | A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload | COMPLETED | PHASE3 | 2005-04 | 2010-07 | 2009-05 |
| NCT00108108 | Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy | TERMINATED | PHASE1 | 2005-04 | 2008-06 | 2008-06 |
| NCT00171704 | A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer | COMPLETED | PHASE3 | 2005-04 | 2011-03 | 2011-03 |
| NCT00110240 | Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-04 | 2006-10 | 2006-10 |
| NCT00133627 | Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis | COMPLETED | PHASE4 | 2005-04 | 2005-10 | 2005-10 |
| NCT00284089 | Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration | COMPLETED | PHASE1, PHASE2 | 2005-04 | 2009-01 | 2007-03 |
| NCT00149968 | Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife) | COMPLETED | PHASE4 | 2005-04 | 2007-01 | 2007-01 |
| NCT00171470 | The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn. | COMPLETED | PHASE3 | 2005-04 | 2006-08 | |
| NCT00171457 | The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia. | COMPLETED | PHASE3 | 2005-04 | 2006-09 | |
| NCT00142298 | Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies | COMPLETED | PHASE3 | 2005-03 | 2009-11 | 2009-11 |
| NCT00310817 | Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months. | COMPLETED | PHASE2 | 2005-03 | 2006-05 | 2006-05 |
| NCT00172042 | A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) | COMPLETED | PHASE3 | 2005-03 | 2010-06 | 2010-05 |
| NCT00107016 | Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women | COMPLETED | PHASE2 | 2005-03 | 2007-04 | 2007-04 |
| NCT00646542 | Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency | COMPLETED | PHASE3 | 2005-03 | | 2010-10 |
| NCT00106340 | Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-03 | 2008-05-20 | 2008-05 |
| NCT00170911 | Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis. | COMPLETED | PHASE2 | 2005-03 | | 2005-12 |
| NCT00219154 | A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine | COMPLETED | PHASE3 | 2005-03 | 2006-01 | 2006-01 |
| NCT00294710 | A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine | COMPLETED | PHASE3 | 2005-03 | 2006-07 | 2006-07 |
| NCT00311441 | Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children | COMPLETED | PHASE4 | 2005-03 | | |
| NCT00120302 | Quality of Life Study in Adults With Facial Eczema | COMPLETED | PHASE4 | 2005-03 | 2006-01 | |
| NCT00108836 | Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder | COMPLETED | PHASE2 | 2005-03 | 2006-05 | |
| NCT00316654 | Persistence of Antibody Response to N. Meningitidis Group C in Children | COMPLETED | PHASE4 | 2005-02 | 2005-10 | 2005-10 |
| NCT00219063 | A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal. | COMPLETED | PHASE3 | 2005-02 | 2006-03 | 2006-03 |
| NCT00219076 | A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients | COMPLETED | PHASE3 | 2005-02 | | 2005-10 |
| NCT00170820 | Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen | COMPLETED | PHASE4 | 2005-02 | | 2006-03 |
| NCT00238953 | Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients | COMPLETED | PHASE4 | 2005-02 | 2006-06 | 2006-06 |
| NCT00132652 | Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B | COMPLETED | PHASE3 | 2005-02 | 2006-12 | 2006-12 |
| NCT00098059 | Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection | COMPLETED | PHASE3 | 2005-02 | 2007-12 | 2007-12 |
| NCT00351546 | A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes | COMPLETED | PHASE3 | 2005-02 | 2005-12 | 2005-11 |
| NCT00171613 | A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients | COMPLETED | PHASE4 | 2005-02 | | 2005-10 |
| NCT00170846 | ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients | COMPLETED | PHASE4 | 2005-02 | 2009-10 | 2009-10 |
| NCT00219050 | A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension | COMPLETED | PHASE3 | 2005-02 | 2005-11 | 2005-11 |
| NCT00139568 | An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation | COMPLETED | PHASE3 | 2005-02 | 2005-10 | |
| NCT00170768 | Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over | COMPLETED | PHASE2 | 2005-02 | 2005-05 | |
| NCT00099801 | Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant | COMPLETED | PHASE3 | 2005-01 | 2006-03 | 2006-03 |
| NCT00101803 | Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-01 | 2006-01 | 2006-01 |
| NCT00102466 | Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-01 | 2009-01 | 2009-01 |
| NCT00238485 | An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder | COMPLETED | PHASE3 | 2005-01 | 2007-07 | 2007-07 |
| NCT00239083 | Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients | COMPLETED | PHASE4 | 2005-01 | 2006-08 | 2006-08 |
| NCT00219115 | A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg | COMPLETED | PHASE3 | 2005-01 | 2006-03 | 2006-03 |
| NCT00219284 | Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease | COMPLETED | PHASE4 | 2005-01 | 2008-07 | 2008-07 |
| NCT00228059 | An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder. | COMPLETED | PHASE3 | 2005-01 | 2007-07 | 2007-07 |
| NCT00149903 | Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients | COMPLETED | PHASE3 | 2005-01 | | 2006-06 |
| NCT00102388 | Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-01 | | 2008-03 |
| NCT00138606 | Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-01 | 2006-01 | 2006-01 |
| NCT00138567 | Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2005-01 | 2006-08 | 2006-08 |
| NCT00639691 | A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy | COMPLETED | PHASE4 | 2005-01 | 2011-12 | 2011-12 |
| NCT00487708 | Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms | COMPLETED | PHASE2 | 2005-01 | 2008-07 | 2008-07 |
| NCT00171015 | VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil | COMPLETED | PHASE3 | 2004-12 | 2005-04 | 2005-04 |
| NCT00139594 | Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder | COMPLETED | PHASE4 | 2004-12 | 2007-07 | 2007-07 |
| NCT00172055 | Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy | COMPLETED | PHASE3 | 2004-12 | 2009-07 | 2009-07 |
| NCT00371670 | Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee | COMPLETED | PHASE2 | 2004-12 | | 2006-07 |
| NCT00510003 | Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old | COMPLETED | PHASE4 | 2004-12 | | 2006-01 |
| NCT00145275 | To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women | COMPLETED | PHASE3 | 2004-12 | 2005-10 | 2005-10 |
| NCT00150046 | Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients | COMPLETED | PHASE3 | 2004-12 | | 2007-05 |
| NCT00150059 | Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis | COMPLETED | PHASE4 | 2004-12 | 2005-12 | |
| NCT00136851 | Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension | COMPLETED | PHASE4 | 2004-12 | 2005-07 | 2005-07 |
| NCT00171002 | Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone | COMPLETED | PHASE3 | 2004-11 | 2005-06 | 2005-06 |
| NCT00219089 | A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients. | COMPLETED | PHASE3 | 2004-11 | 2005-08 | 2005-08 |
| NCT00107939 | Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder | COMPLETED | PHASE3 | 2004-11 | 2007-04 | 2007-04 |
| NCT00138554 | Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-11 | 2006-07 | 2006-07 |
| NCT00138515 | Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-11 | 2006-05 | 2006-05 |
| NCT00239798 | Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients | COMPLETED | PHASE2 | 2004-11 | | 2006-11 |
| NCT00171574 | Antiproteinuric Effect of Valsartan and Lisinopril | COMPLETED | PHASE4 | 2004-11 | 2006-07 | 2006-07 |
| NCT00138580 | Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-11 | 2006-04 | 2006-04 |
| NCT00099229 | Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder | COMPLETED | PHASE3 | 2004-11 | 2006-08 | 2006-08 |
| NCT00170937 | A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome | COMPLETED | PHASE4 | 2004-11 | | 2006-03 |
| NCT00115245 | Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B | COMPLETED | PHASE3 | 2004-11 | 2006-08 | 2006-08 |
| NCT00138619 | Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-11 | 2007-04 | 2007-04 |
| NCT00170872 | 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis | COMPLETED | PHASE3 | 2004-11 | | 2005-07 |
| NCT00154219 | Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis | COMPLETED | PHASE3 | 2004-11 | | 2006-10 |
| NCT00171431 | The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) | TERMINATED | PHASE3 | 2004-11 | 2006-05 | 2006-05 |
| NCT00230074 | A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS) | COMPLETED | PHASE2 | 2004-11 | 2005-02 | 2005-02 |
| NCT00099541 | Non-small Cell Lung Cancer Registry | COMPLETED | PHASE4 | 2004-11 | 2007-11 | |
| NCT00288561 | Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration | COMPLETED | PHASE2 | 2004-11 | 2007-07 | |
| NCT00219128 | A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure. | COMPLETED | PHASE3 | 2004-11 | 2005-06 | 2005-06 |
| NCT00170898 | Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain | COMPLETED | PHASE4 | 2004-11 | | |
| NCT00262041 | Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents | COMPLETED | PHASE2 | 2004-10 | 2006-03 | 2006-03 |
| NCT00097955 | Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria | COMPLETED | PHASE2 | 2004-10 | 2007-04 | 2007-04 |
| NCT00170963 | Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone | COMPLETED | PHASE3 | 2004-10 | 2005-06 | 2005-06 |
| NCT00107926 | Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder | COMPLETED | PHASE3 | 2004-10 | 2007-08 | 2007-08 |
| NCT00138541 | Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-10 | 2006-04 | 2006-04 |
| NCT00138528 | Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome | COMPLETED | PHASE4 | 2004-10 | 2006-02 | 2006-02 |
| NCT00150072 | Efficacy and Safety of Imatinib in Chordoma | COMPLETED | PHASE2 | 2004-10 | 2008-04 | 2008-04 |
| NCT00149942 | Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy | COMPLETED | PHASE4 | 2004-10 | 2006-08 | 2006-08 |
| NCT00310687 | Persistence of Immune Response After Vaccination With MCC | COMPLETED | PHASE4 | 2004-10 | 2005-12 | 2005-12 |
| NCT00101712 | Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia | COMPLETED | PHASE3 | 2004-10 | 2006-05 | 2006-05 |
| NCT00171678 | Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis | COMPLETED | PHASE3 | 2004-10 | 2005-08 | 2005-08 |
| NCT00171691 | Safety of Diclofenac Sodium Gel in Knee Osteoarthritis | COMPLETED | PHASE3 | 2004-10 | 2006-06 | 2006-06 |
| NCT00134979 | Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 | 2004-10 | 2005-11 | 2005-11 |
| NCT00104104 | A Multiple Myeloma Trial in Patients With Bone Metastases | COMPLETED | PHASE4 | 2004-10 | 2007-10 | 2007-10 |
| NCT00171210 | An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload | COMPLETED | PHASE3 | 2004-10 | | 2008-04 |
| NCT00154375 | Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma | COMPLETED | PHASE3 | 2004-10 | | 2008-08 |
| NCT00484003 | A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis | COMPLETED | PHASE4 | 2004-10 | 2004-12 | |
| NCT00121316 | Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients | COMPLETED | PHASE4 | 2004-10 | 2005-07 | |
| NCT00150020 | Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance | COMPLETED | PHASE4 | 2004-10 | | 2006-02 |
| NCT00246584 | A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US) | COMPLETED | PHASE2 | 2004-10 | | |
| NCT00171535 | Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension | COMPLETED | PHASE3 | 2004-10 | 2005-04 | 2005-04 |
| NCT00154206 | Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients | COMPLETED | PHASE4 | 2004-09 | | 2007-01 |
| NCT00171093 | A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia | COMPLETED | PHASE3 | 2004-09 | | 2006-01 |
| NCT00171912 | Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes | COMPLETED | PHASE2 | 2004-09 | 2012-01 | 2012-01 |
| NCT00170794 | Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients. | COMPLETED | PHASE3 | 2004-09 | | 2006-07 |
| NCT00172003 | Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis | COMPLETED | PHASE4 | 2004-09 | 2009-07 | 2009-07 |
| NCT00492063 | Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly | COMPLETED | PHASE3 | 2004-09 | 2005-05 | 2004-12 |
| NCT00262002 | Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants | COMPLETED | PHASE2 | 2004-09 | 2006-10 | 2005-07 |
| NCT00128245 | Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca | COMPLETED | PHASE2 | 2004-09 | 2006-12 | 2006-12 |
| NCT00145301 | 52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine | COMPLETED | PHASE3 | 2004-09 | | 2005-11 |
| NCT00099268 | Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy | COMPLETED | PHASE3 | 2004-09 | 2008-11 | 2008-11 |
| NCT00129831 | Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2004-09 | 2005-09 | 2005-09 |
| NCT00279773 | Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia | TERMINATED | PHASE1 | 2004-09 | | 2007-10 |
| NCT00139581 | Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects | COMPLETED | PHASE4 | 2004-09 | 2005-09 | |
| NCT00232102 | Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia | COMPLETED | PHASE3 | 2004-09 | 2006-08 | |
| NCT00232037 | Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia | COMPLETED | PHASE3 | 2004-09 | 2006-08 | |
| NCT00310674 | Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age | COMPLETED | PHASE3 | 2004-09 | | |
| NCT00170989 | Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone | COMPLETED | PHASE3 | 2004-09 | 2005-07 | 2005-07 |
| NCT00171730 | An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly | COMPLETED | PHASE2 | 2004-08-24 | 2013-12-06 | 2013-12-06 |
| NCT00170729 | A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery | COMPLETED | PHASE4 | 2004-08-17 | 2005-02-28 | 2005-02-28 |
| NCT00171951 | Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease | COMPLETED | PHASE2 | 2004-08-13 | 2013-07-08 | 2013-07-08 |
| NCT00098007 | A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients | COMPLETED | PHASE3 | 2004-08-09 | 2007-01-08 | 2007-01-08 |
| NCT00219024 | Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension. | COMPLETED | PHASE3 | 2004-08 | 2005-06 | 2005-06 |
| NCT00171132 | VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women | COMPLETED | PHASE4 | 2004-08 | 2007-08 | 2007-08 |
| NCT00171262 | Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers | COMPLETED | PHASE4 | 2004-08 | 2007-06 | 2007-06 |
| NCT00170859 | Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients | COMPLETED | PHASE4 | 2004-08 | 2006-12 | 2006-11 |
| NCT00093639 | Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate | COMPLETED | PHASE1, PHASE2 | 2004-08 | 2006-08 | 2006-08 |
| NCT00171626 | Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis | COMPLETED | PHASE3 | 2004-08 | 2005-06 | 2005-06 |
| NCT00170924 | To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure. | COMPLETED | PHASE4 | 2004-08 | 2006-06 | 2006-06 |
| NCT00097968 | Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy | COMPLETED | PHASE3 | 2004-08 | | 2005-04 |
| NCT00311012 | SPP100 Dose Finding Study in Japan | COMPLETED | PHASE2 | 2004-08 | 2005-03 | 2005-03 |
| NCT00134992 | A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers | COMPLETED | PHASE4 | 2004-08 | | |
| NCT00171067 | VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria | COMPLETED | PHASE3 | 2004-07 | 2007-05 | 2007-05 |
| NCT00154336 | A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis. | COMPLETED | PHASE2 | 2004-07 | 2005-08 | 2005-08 |
| NCT00138593 | Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11% | COMPLETED | PHASE3 | 2004-07 | 2006-07 | 2006-07 |
| NCT00139555 | Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension | COMPLETED | PHASE4 | 2004-07 | 2006-11 | 2006-11 |
| NCT00131118 | Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta | COMPLETED | PHASE2 | 2004-07 | 2007-05 | 2007-05 |
| NCT00132808 | Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older | COMPLETED | PHASE3 | 2004-07 | 2008-02 | 2008-02 |
| NCT00171366 | A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril. | COMPLETED | PHASE3 | 2004-07 | 2005-07 | 2005-07 |
| NCT00131742 | Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B | COMPLETED | PHASE3 | 2004-07 | 2007-01 | 2007-01 |
| NCT00171977 | Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) | COMPLETED | PHASE4 | 2004-07 | | 2009-04 |
| NCT00351585 | A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-07 | 2005-09 | 2005-09 |
| NCT00238498 | A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes | COMPLETED | PHASE2 | 2004-07 | 2005-06 | 2005-06 |
| NCT00129818 | A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding | COMPLETED | PHASE4 | 2004-07 | 2005-10 | 2005-10 |
| NCT00171327 | Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction | COMPLETED | PHASE4 | 2004-07 | 2005-09 | 2005-09 |
| NCT00171353 | A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure | COMPLETED | PHASE4 | 2004-07 | 2005-09 | 2005-09 |
| NCT00098228 | Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2004-07 | 2004-12 | 2004-12 |
| NCT01090323 | Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). | COMPLETED | PHASE2 | 2004-07 | | 2009-07 |
| NCT00226707 | Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis | COMPLETED | PHASE3 | 2004-07 | 2005-03 | |
| NCT00117754 | Terbinafine Compared to Griseofulvin in Children With Tinea Capitis | COMPLETED | PHASE3 | 2004-07 | 2006-04 | |
| NCT00117767 | Terbinafine Compared to Griseofulvin in Children With Tinea Capitis | COMPLETED | PHASE3 | 2004-06 | | 2006-03 |
| NCT00100620 | Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis | COMPLETED | PHASE3 | 2004-06 | 2007-04 | 2007-04 |
| NCT00171639 | The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis | COMPLETED | PHASE3 | 2004-06 | 2007-03 | 2007-03 |
| NCT00171756 | Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients. | COMPLETED | PHASE4 | 2004-06 | 2006-03 | 2006-03 |
| NCT00154193 | Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels | COMPLETED | PHASE4 | 2004-06 | | 2007-11 |
| NCT00100555 | A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate | COMPLETED | PHASE3 | 2004-06 | 2005-06 | 2005-06 |
| NCT00154232 | Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF) | COMPLETED | PHASE4 | 2004-06 | | 2005-03 |
| NCT00150007 | Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS) | COMPLETED | PHASE4 | 2004-06 | | 2005-06 |
| NCT00219037 | Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension | COMPLETED | PHASE3 | 2004-06 | 2005-10 | 2005-10 |
| NCT00171444 | Comparison of Two Treatment Strategies in Hypertensive Patients | COMPLETED | PHASE4 | 2004-06 | 2005-05 | 2005-05 |
| NCT00099892 | Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-05 | 2005-09 | 2005-09 |
| NCT00099918 | Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-05 | 2005-09 | 2005-09 |
| NCT00239863 | Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients | COMPLETED | PHASE3 | 2004-05 | | 2006-05 |
| NCT00171171 | A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis | COMPLETED | PHASE3 | 2004-05 | | 2006-11 |
| NCT00232089 | Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia | COMPLETED | PHASE3 | 2004-05 | 2006-06 | 2006-06 |
| NCT00099853 | Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-05 | 2008-01 | 2008-01 |
| NCT00084071 | Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia | COMPLETED | PHASE3 | 2004-05 | 2008-07 | 2008-07 |
| NCT00099931 | Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-05 | 2005-06 | 2005-06 |
| NCT00099944 | Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-05 | 2005-10 | 2005-10 |
| NCT00097812 | Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid | COMPLETED | PHASE3 | 2004-05 | 2005-12 | 2005-12 |
| NCT00142974 | Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy | TERMINATED | PHASE2 | 2004-05 | 2005-04 | 2005-04 |
| NCT00232063 | Long-term Study of Ciclosporin for Atopic Dermatitis | COMPLETED | PHASE3 | 2004-05 | | 2005-11 |
| NCT00232076 | Verification Study of Ciclosporin for Atopic Dermatitis | COMPLETED | PHASE3 | 2004-05 | | 2005-03 |
| NCT00171509 | Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients | COMPLETED | PHASE4 | 2004-05 | 2005-10 | 2005-10 |
| NCT01197287 | Safety, Tolerability and Pharmacokinetics of QAK423A in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients | COMPLETED | PHASE1 | 2004-05 | | 2005-02 |
| NCT00231998 | Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis | COMPLETED | PHASE3 | 2004-05 | 2005-06 | |
| NCT00232011 | Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis | COMPLETED | PHASE3 | 2004-05 | 2005-05 | |
| NCT00170976 | A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension | COMPLETED | PHASE3 | 2004-04 | 2005-06 | 2005-06 |
| NCT00086268 | Non-small Cell Lung Cancer Study US75 (Z-PACT) | COMPLETED | PHASE3 | 2004-04 | 2007-10 | 2007-10 |
| NCT00171743 | Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients | COMPLETED | PHASE4 | 2004-04 | 2006-01 | 2006-01 |
| NCT00171080 | VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis | COMPLETED | PHASE3 | 2004-04 | 2006-03 | 2006-03 |
| NCT00088608 | A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease | COMPLETED | PHASE2 | 2004-04 | | 2006-06 |
| NCT00098735 | Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation | COMPLETED | PHASE3 | 2004-04 | | 2006-04 |
| NCT00242528 | Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma. | WITHDRAWN | PHASE4 | 2004-04 | | |
| NCT00099905 | A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-04 | 2005-10 | 2005-10 |
| NCT00097825 | Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men | COMPLETED | PHASE3 | 2004-04 | 2007-08 | 2007-08 |
| NCT00079937 | Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma | COMPLETED | PHASE3 | 2004-04 | 2008-03 | 2008-03 |
| NCT00241124 | Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes | COMPLETED | PHASE4 | 2004-04 | 2005-06 | 2005-06 |
| NCT00284921 | MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive | TERMINATED | PHASE3 | 2004-04 | | 2006-08 |
| NCT00239811 | Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients | COMPLETED | PHASE3 | 2004-04 | | 2006-05 |
| NCT00171938 | Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors) | TERMINATED | PHASE2 | 2004-04 | 2006-06 | 2006-06 |
| NCT00699166 | Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) | COMPLETED | PHASE2 | 2004-04 | 2005-09 | 2005-09 |
| NCT00142987 | Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS | COMPLETED | PHASE4 | 2004-04 | 2005-06 | |
| NCT00171145 | A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder. | COMPLETED | PHASE3 | 2004-04 | 2004-12 | |
| NCT00149877 | Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation | COMPLETED | PHASE4 | 2004-04 | 2006-02 | |
| NCT00117377 | Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis | COMPLETED | PHASE4 | 2004-04 | 2005-06 | |
| NCT00237198 | Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment | COMPLETED | PHASE2 | 2004-03 | | 2006-07 |
| NCT00240955 | Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients | COMPLETED | PHASE4 | 2004-03 | 2006-05 | 2006-05 |
| NCT00925730 | Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion | COMPLETED | PHASE4 | 2004-03 | | 2006-01 |
| NCT00088582 | Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients | COMPLETED | PHASE2 | 2004-03 | | 2005-10 |
| NCT00101673 | Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11% | COMPLETED | PHASE3 | 2004-03 | 2005-06 | 2005-06 |
| NCT00346242 | Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events | COMPLETED | PHASE4 | 2004-03 | | 2006-03 |
| NCT00171314 | The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer | COMPLETED | PHASE3 | 2004-03 | | 2010-11 |
| NCT00135824 | Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers | COMPLETED | PHASE4 | 2004-03 | 2004-05 | 2004-05 |
| NCT00076362 | Pediatric Hypothalamic Obesity | COMPLETED | PHASE4 | 2004-03 | | 2005-07 |
| NCT00149890 | Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids | COMPLETED | PHASE3 | 2004-03 | 2009-03 | 2009-03 |
| NCT00303329 | Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients | COMPLETED | PHASE2 | 2004-03 | 2008-10 | 2008-10 |
| NCT00171379 | Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant | COMPLETED | PHASE3 | 2004-03 | 2005-06 | 2005-06 |
| NCT00171392 | Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus | COMPLETED | PHASE3 | 2004-03 | 2005-06 | 2005-06 |
| NCT00141089 | Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation. | COMPLETED | PHASE3 | 2004-03 | 2005-02 | |
| NCT00333489 | Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension | COMPLETED | PHASE4 | 2004-03 | 2005-04 | 2005-04 |
| NCT00171782 | Hypertension and Cardiovascular Risk Factors | COMPLETED | PHASE4 | 2004-02 | 2004-12 | 2004-12 |
| NCT00093600 | PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | COMPLETED | PHASE1 | 2004-02 | 2011-06 | 2011-06 |
| NCT00100607 | Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE2 | 2004-02 | 2005-09 | 2005-09 |
| NCT00312143 | Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients | COMPLETED | PHASE4 | 2004-02 | 2005-10 | 2005-10 |
| NCT00150085 | Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion | TERMINATED | PHASE4 | 2004-02 | 2005-10 | 2005-10 |
| NCT00171717 | Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant | COMPLETED | PHASE4 | 2004-02 | 2005-12 | 2005-12 |
| NCT00166725 | Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients | COMPLETED | PHASE2 | 2004-02 | | |
| NCT00154245 | A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients. | COMPLETED | PHASE4 | 2004-01 | 2006-03 | 2006-03 |
| NCT00116376 | Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM) | COMPLETED | PHASE1, PHASE2 | 2004-01 | 2005-11 | 2005-11 |
| NCT00088595 | Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors | COMPLETED | PHASE2 | 2004-01 | 2008-07 | 2008-07 |
| NCT00099866 | Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes | COMPLETED | PHASE3 | 2004-01 | 2005-08 | 2005-08 |
| NCT00475800 | Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA) | COMPLETED | PHASE3 | 2004-01 | | 2004-12 |
| NCT00172016 | A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates | COMPLETED | PHASE4 | 2004-01 | | 2005-04 |
| NCT00409643 | Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients | COMPLETED | PHASE3 | 2004-01 | 2004-07 | 2004-07 |
| NCT00171119 | A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril | TERMINATED | PHASE4 | 2004-01 | | 2005-03 |
| NCT00232024 | Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia | COMPLETED | PHASE3 | 2004-01 | 2006-05 | |
| NCT00149851 | A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD) | COMPLETED | PHASE2 | 2004-01 | 2005-06 | 2005-06 |
| NCT00171483 | Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). | COMPLETED | PHASE3 | 2004-01 | 2005-04 | |
| NCT00154271 | Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP) | COMPLETED | PHASE4 | 2004-01 | 2005-06 | 2005-06 |
| NCT00073528 | Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer | COMPLETED | PHASE3 | 2003-12-09 | 2018-03-22 | 2008-06-03 |
| NCT00476034 | Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA) | COMPLETED | PHASE3 | 2003-12 | | 2004-11 |
| NCT00076336 | Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis | COMPLETED | PHASE3 | 2003-12 | | 2009-12 |
| NCT01270906 | Safety of CHIR-258 (TKI258) in Advanced Solid Tumors | TERMINATED | PHASE1 | 2003-12 | | 2006-10 |
| NCT00087659 | A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy | COMPLETED | NA | 2003-12 | 2007-05 | |
| NCT00170742 | Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. | TERMINATED | PHASE3 | 2003-12 | | 2006-05 |
| NCT00619905 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate | COMPLETED | PHASE1, PHASE2 | 2003-12 | 2005-08 | 2005-08 |
| NCT00171028 | A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension | COMPLETED | PHASE3 | 2003-12 | 2006-11 | 2006-11 |
| NCT00241007 | A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension | COMPLETED | PHASE3 | 2003-12 | 2005-03 | 2005-03 |
| NCT00099242 | Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease | COMPLETED | PHASE3 | 2003-11 | 2006-01 | |
| NCT00099749 | Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant | COMPLETED | PHASE2, PHASE3 | 2003-11 | | 2006-04 |
| NCT00237146 | Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy | COMPLETED | PHASE4 | 2003-11 | 2008-03 | 2008-03 |
| NCT00969046 | Dose-Escalation Study in Advanced Colon Cancer Patients | COMPLETED | PHASE1 | 2003-11 | 2006-11 | 2006-11 |
| NCT00170833 | Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients | COMPLETED | PHASE3 | 2003-11 | | 2005-11 |
| NCT00234637 | Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment | COMPLETED | PHASE4 | 2003-11 | 2005-06 | 2005-06 |
| NCT00219323 | Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma. | COMPLETED | PHASE3 | 2003-11 | 2006-03 | 2006-03 |
| NCT00391976 | Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis | COMPLETED | PHASE3 | 2003-11 | 2008-01 | 2008-01 |
| NCT00171275 | Fluvastatin in the Therapy of Acute Coronary Syndrome | COMPLETED | PHASE4 | 2003-11 | | 2007-02 |
| NCT00170950 | Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension | TERMINATED | PHASE3 | 2003-10 | 2008-05 | 2008-01 |
| NCT00154349 | Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia | COMPLETED | PHASE2 | 2003-10 | 2007-02 | 2007-02 |
| NCT00171496 | Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients | COMPLETED | PHASE4 | 2003-10 | 2006-03 | 2006-03 |
| NCT00107237 | AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme | COMPLETED | PHASE1, PHASE2 | 2003-10 | 2006-06 | 2006-06 |
| NCT00124709 | Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification | TERMINATED | PHASE4 | 2003-10 | 2008-11 | 2008-01 |
| NCT00081926 | Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | COMPLETED | PHASE4 | 2003-10 | 2007-03 | |
| NCT00104442 | Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease | COMPLETED | PHASE4 | 2003-10 | 2006-04 | |
| NCT00248144 | A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis | COMPLETED | PHASE4 | 2003-10 | 2007-07 | |
| NCT00219271 | Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer | COMPLETED | PHASE4 | 2003-09 | 2009-09 | 2009-09 |
| NCT00390858 | A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload. | COMPLETED | PHASE2 | 2003-09 | 2008-02 | 2008-02 |
| NCT00219219 | Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases | COMPLETED | PHASE4 | 2003-09 | 2006-10 | |
| NCT00099957 | A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes | COMPLETED | PHASE2 | 2003-09 | 2005-06 | 2005-06 |
| NCT00366938 | Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA). | COMPLETED | PHASE3 | 2003-09 | | 2004-03 |
| NCT00367315 | Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA) | COMPLETED | PHASE3 | 2003-09 | | 2004-02 |
| NCT00072709 | Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) | COMPLETED | PHASE2 | 2003-09 | 2004-12 | 2004-12 |
| NCT00171054 | Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension | COMPLETED | PHASE4 | 2003-09 | 2007-10 | 2007-10 |
| NCT01287325 | Efficacy of DNK333 in Patients With COPD and Cough | COMPLETED | PHASE1, PHASE2 | 2003-09 | | 2004-04 |
| NCT00241111 | Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis | COMPLETED | PHASE4 | 2003-09 | | 2006-01 |
| NCT00241137 | A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg | COMPLETED | PHASE3 | 2003-09 | 2005-01 | 2005-01 |
| NCT00171834 | Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer | COMPLETED | PHASE1, PHASE2 | 2003-08 | 2008-09 | 2008-09 |
| NCT00171288 | Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone | COMPLETED | PHASE3 | 2003-08 | 2005-08 | 2005-08 |
| NCT00118456 | Study of Oral AEE788 in Adults With Advanced Cancer | COMPLETED | PHASE1 | 2003-07 | | 2008-01 |
| NCT00063479 | Bisphosphonate Treatment of Osteogenesis Imperfecta | COMPLETED | PHASE2 | 2003-06 | 2007-05 | 2007-05 |
| NCT01044186 | A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity | COMPLETED | PHASE2 | 2003-06 | | 2007-12 |
| NCT00482248 | Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma | COMPLETED | PHASE3 | 2003-06 | 2006-06 | 2006-06 |
| NCT00219310 | RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir | COMPLETED | PHASE4 | 2003-06 | 2005-06 | 2005-06 |
| NCT01316458 | Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy | COMPLETED | PHASE2 | 2003-06 | | 2010-07 |
| NCT00171418 | Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). | COMPLETED | PHASE3 | 2003-06 | 2005-02 | |
| NCT00135837 | Photodynamic Therapy in Occult-Only Lesions (POOL) | COMPLETED | PHASE4 | 2003-06 | | |
| NCT00099736 | Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant | COMPLETED | PHASE3 | 2003-05-07 | 2005-09-19 | 2005-09-19 |
| NCT00241098 | The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure | COMPLETED | PHASE4 | 2003-05 | 2005-06 | 2005-06 |
| NCT00333138 | Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis | COMPLETED | PHASE2 | 2003-05 | 2011-04 | 2011-04 |
| NCT00067080 | Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions | COMPLETED | PHASE2 | 2003-05 | | 2007-07 |
| NCT00061763 | Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias | COMPLETED | PHASE2 | 2003-05 | | 2004-11 |
| NCT00238472 | A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion | COMPLETED | PHASE4 | 2003-05 | 2005-06 | 2005-06 |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | COMPLETED | PHASE3 | 2003-05 | 2010-02 | 2010-02 |
| NCT00061750 | Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions | COMPLETED | PHASE3 | 2003-05 | | 2004-11 |
| NCT00482508 | Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients | COMPLETED | PHASE3 | 2003-05 | 2005-10 | 2005-10 |
| NCT00172029 | Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid | COMPLETED | PHASE4 | 2003-04 | | 2005-09 |
| NCT00063609 | The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy | COMPLETED | PHASE4 | 2003-04 | 2005-04 | |
| NCT00239785 | Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients | COMPLETED | PHASE3 | 2003-04 | | 2005-04 |
| NCT00238446 | Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients | COMPLETED | PHASE3 | 2003-04 | | 2006-06 |
| NCT00409851 | One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension | COMPLETED | PHASE3 | 2003-04 | 2005-03 | 2005-03 |
| NCT00154362 | The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States. | COMPLETED | PHASE4 | 2003-04 | 2004-10 | 2004-10 |
| NCT00239018 | Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients | COMPLETED | PHASE4 | 2003-04 | 2005-07 | 2005-07 |
| NCT00239070 | Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients | COMPLETED | PHASE3 | 2003-04 | 2006-05 | 2006-05 |
| NCT00136773 | Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2003-04 | 2005-11 | 2005-10 |
| NCT00621244 | A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies | COMPLETED | PHASE1, PHASE2 | 2003-03-01 | 2009-12-03 | 2009-12-03 |
| NCT00237133 | Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women | COMPLETED | PHASE4 | 2003-03 | 2009-01-21 | 2009-01 |
| NCT00242541 | Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas | TERMINATED | PHASE4 | 2003-03 | | 2005-08 |
| NCT00171561 | Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria. | COMPLETED | PHASE4 | 2003-03 | 2006-09 | 2006-09 |
| NCT00101738 | Freedom Study: Myfortic in Kidney Transplant Patients | COMPLETED | PHASE3 | 2003-03 | 2005-05 | 2005-05 |
| NCT00171847 | Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer | TERMINATED | PHASE4 | 2003-03 | | 2008-10 |
| NCT00237263 | An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States | COMPLETED | PHASE2 | 2003-02 | 2007-07 | 2007-07 |
| NCT00056459 | Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. | COMPLETED | PHASE3 | 2003-02 | | 2007-01 |
| NCT00219232 | An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease | COMPLETED | PHASE3 | 2003-02 | 2006-07 | 2006-07 |
| NCT00057265 | A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B | COMPLETED | PHASE3 | 2003-02 | | 2006-04 |
| NCT01033747 | Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study | COMPLETED | PHASE2, PHASE3 | 2003-02 | 2008-01 | 2008-01 |
| NCT00052013 | Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 | COMPLETED | PHASE2 | 2003-02 | | 2006-06 |
| NCT00238940 | Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants | COMPLETED | PHASE3 | 2003-02 | 2005-09 | 2005-09 |
| NCT00237224 | Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole | COMPLETED | PHASE4 | 2003-02 | | 2007-02 |
| NCT00154323 | The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States. | COMPLETED | PHASE4 | 2003-01 | 2006-01 | 2006-01 |
| NCT00409760 | Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension. | COMPLETED | PHASE3 | 2003-01 | 2004-02 | 2004-02 |
| NCT00056446 | Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer | COMPLETED | PHASE3 | 2003-01 | 2007-01 | 2007-01 |
| NCT00171990 | Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes | COMPLETED | PHASE3 | 2003-01 | 2006-02 | |
| NCT00238979 | A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) | COMPLETED | PHASE4 | 2003-01 | | 2005-02 |
| NCT00377806 | Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins | COMPLETED | PHASE4 | 2003-01 | 2006-09 | |
| NCT00134953 | Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment | TERMINATED | PHASE3 | 2003-01 | 2004-05 | |
| NCT00171106 | Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure | COMPLETED | PHASE4 | 2002-12 | 2008-02 | 2007-08 |
| NCT00171041 | A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age | COMPLETED | PHASE3 | 2002-12 | 2006-03 | 2006-03 |
| NCT00128232 | Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients | COMPLETED | PHASE3 | 2002-12 | | 2004-08 |
| NCT00238992 | Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients. | COMPLETED | PHASE3 | 2002-12 | | 2005-07 |
| NCT00239044 | An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients | COMPLETED | PHASE3 | 2002-12 | | 2005-07 |
| NCT00149994 | Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients | COMPLETED | PHASE4 | 2002-12 | 2007-12 | 2007-12 |
| NCT00238901 | Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation | COMPLETED | PHASE3 | 2002-12 | | 2005-07 |
| NCT00050635 | STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea | COMPLETED | PHASE4 | 2002-12 | 2003-07 | |
| NCT01275222 | Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors | COMPLETED | PHASE1, PHASE2 | 2002-11-13 | 2008-09-03 | 2008-09-03 |
| NCT00225979 | Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly | COMPLETED | PHASE3 | 2002-11 | 2005-03 | 2005-03 |
| NCT00219245 | An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits | COMPLETED | PHASE4 | 2002-11 | 2005-01 | 2005-01 |
| NCT00171795 | Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment | COMPLETED | PHASE3 | 2002-11 | 2005-05 | 2005-05 |
| NCT00238966 | Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil | COMPLETED | PHASE4 | 2002-11 | 2005-04 | 2005-04 |
| NCT00237120 | Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase) | COMPLETED | PHASE3 | 2002-11 | 2007-06 | |
| NCT00241150 | Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome | COMPLETED | PHASE4 | 2002-11 | 2005-01 | 2005-01 |
| NCT00241085 | Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus | COMPLETED | PHASE4 | 2002-11 | 2005-08 | 2005-08 |
| NCT00242554 | Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases | COMPLETED | PHASE4 | 2002-10 | | 2007-07 |
| NCT00240942 | Letrozole in the Treatment of Severe and Recurrent Endometriosis | COMPLETED | PHASE2 | 2002-10 | 2006-06 | 2006-06 |
| NCT00232050 | Study of Omalizumab in Moderate to Severe Bronchial Asthma | COMPLETED | PHASE3 | 2002-10 | 2005-05 | 2005-05 |
| NCT00237159 | Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis | COMPLETED | PHASE4 | 2002-10 | | 2005-12 |
| NCT00308425 | Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS | COMPLETED | PHASE3 | 2002-10 | 2005-06 | 2005-06 |
| NCT00050011 | Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy | COMPLETED | PHASE3 | 2002-09 | 2009-01 | 2009-01 |
| NCT00241072 | Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance | COMPLETED | PHASE4 | 2002-09 | 2005-07 | 2005-07 |
| NCT00237172 | Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) | COMPLETED | PHASE2 | 2002-09 | | 2005-07 |
| NCT00171860 | A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome | TERMINATED | PHASE2 | 2002-09 | | 2007-07 |
| NCT00241059 | Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients | COMPLETED | PHASE4 | 2002-08 | 2005-01 | 2005-01 |
| NCT00372710 | Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions | TERMINATED | PHASE3 | 2002-08 | | |
| NCT00694460 | Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers | COMPLETED | PHASE2 | 2002-08 | 2004-09 | 2004-08 |
| NCT00379483 | Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload | COMPLETED | PHASE2 | 2002-07 | 2003-04 | 2003-04 |
| NCT00050349 | EPO906 in Carcinoid and Other Neuroendocrine Tumors | COMPLETED | PHASE2 | 2002-07 | 2007-04 | 2007-04 |
| NCT00050947 | Pediatric Epilepsy Study | COMPLETED | PHASE3 | 2002-07 | 2004-02 | 2004-02 |
| NCT00171886 | Octreotide Efficacy and Safety in First-line Acromegalic Patients | COMPLETED | PHASE4 | 2002-07 | 2006-05 | 2006-05 |
| NCT00333047 | Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy | COMPLETED | PHASE2, PHASE3 | 2002-07 | | |
| NCT00709969 | Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria | COMPLETED | PHASE3 | 2002-07 | 2003-02 | |
| NCT00241020 | Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma | COMPLETED | PHASE3 | 2002-06 | 2005-10 | 2005-10 |
| NCT00050934 | Pediatric Epilepsy Study | COMPLETED | PHASE3 | 2002-06 | 2004-06 | 2004-06 |
| NCT00035087 | EPO906 Therapy in Patients With Advanced Colorectal Cancer | COMPLETED | PHASE2 | 2002-05 | 2003-03 | 2003-03 |
| NCT00171964 | Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions | COMPLETED | PHASE4 | 2002-05 | 2008-12 | 2008-12 |
| NCT00239902 | Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients | COMPLETED | PHASE2 | 2002-05 | | 2004-11 |
| NCT00239057 | Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids, | COMPLETED | PHASE3 | 2002-05 | 2005-01 | 2005-01 |
| NCT00343226 | An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. | COMPLETED | PHASE4 | 2002-05 | | 2005-04 |
| NCT00171587 | Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer | COMPLETED | PHASE1, PHASE2 | 2002-05 | 2007-03 | 2007-03 |
| NCT00103740 | Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period | COMPLETED | PHASE3 | 2002-04 | 2011-04 | 2003-12 |
| NCT00241046 | Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment | TERMINATED | PHASE4 | 2002-04 | | 2005-03 |
| NCT00035243 | EPO906 Therapy in Patients With Advanced Kidney Cancer | COMPLETED | PHASE2 | 2002-04 | | 2003-08 |
| NCT00035997 | Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis | COMPLETED | PHASE4 | 2002-04 | 2004-01 | 2004-01 |
| NCT00170755 | A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder | COMPLETED | PHASE3 | 2002-04 | 2005-01 | |
| NCT00035165 | EPO906 Therapy in Patients With Advanced Melanoma | COMPLETED | PHASE2 | 2002-03 | | 2003-05 |
| NCT00940563 | A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors | COMPLETED | PHASE2 | 2002-03 | | 2004-08 |
| NCT00239031 | Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids | COMPLETED | PHASE3 | 2002-03 | 2005-07 | 2005-07 |
| NCT00239889 | Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women | COMPLETED | PHASE4 | 2002-03 | | |
| NCT00130338 | Rivastigmine Capsules in Patients With Probable Vascular Dementia | COMPLETED | PHASE3 | 2002-02 | 2006-05 | 2006-05 |
| NCT00046254 | Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture | COMPLETED | PHASE3 | 2002-02 | 2007-02 | 2007-02 |
| NCT00045942 | PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2) | COMPLETED | PHASE1, PHASE2 | 2002-01-30 | 2008-03-27 | 2008-03-27 |
| NCT00385931 | Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin | COMPLETED | PHASE3 | 2002-01 | 2003-04 | 2003-04 |
| NCT00097786 | Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications | COMPLETED | PHASE3 | 2002-01 | 2009-10 | 2009-10 |
| NCT00035113 | EPO906 Therapy in Patients With Prostate Cancer | COMPLETED | PHASE2 | 2002-01 | 2004-01 | 2004-01 |
| NCT00035126 | EPO906 Therapy in Patients With Advanced Breast Cancer | COMPLETED | PHASE2 | 2002-01 | 2003-11 | 2003-11 |
| NCT00574743 | Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients | COMPLETED | PHASE4 | 2002-01 | | 2004-04 |
| NCT00036413 | A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis | COMPLETED | PHASE2 | 2002-01 | 2002-10 | 2002-10 |
| NCT00407212 | A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy | COMPLETED | PHASE1, PHASE2 | 2002-01 | 2003-11 | 2003-11 |
| NCT00049829 | HORIZON-PFT: Pivotal Fracture Trial | COMPLETED | PHASE3 | 2002-01 | | 2006-06 |
| NCT00172068 | Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow | TERMINATED | PHASE2 | 2002-01 | | 2008-11 |
| NCT00094146 | Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity | COMPLETED | PHASE2 | 2002-01 | 2002-12 | |
| NCT00046748 | Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma | COMPLETED | PHASE3 | 2001-12 | 2004-04 | 2004-04 |
| NCT00351052 | Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis | COMPLETED | PHASE3 | 2001-12 | 2004-09 | |
| NCT00367978 | Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus | COMPLETED | PHASE4 | 2001-12 | 2003-09 | 2003-09 |
| NCT00531063 | This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus | COMPLETED | PHASE3 | 2001-11 | | 2005-08 |
| NCT00531440 | This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307. | COMPLETED | PHASE3 | 2001-11 | | 2005-08 |
| NCT00029224 | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions | COMPLETED | PHASE4 | 2001-10 | 2002-11 | 2002-11 |
| NCT00171236 | Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia | COMPLETED | PHASE3 | 2001-10 | 2005-03 | 2005-03 |
| NCT00565474 | Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant | COMPLETED | PHASE4 | 2001-09 | | 2007-10 |
| NCT00035100 | EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer | COMPLETED | PHASE2 | 2001-09 | | 2003-06 |
| NCT00099216 | Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia | COMPLETED | PHASE3 | 2001-08 | 2005-11 | 2005-11 |
| NCT00237211 | Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | COMPLETED | PHASE2 | 2001-06 | 2006-10 | 2006-10 |
| NCT00233337 | Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers | COMPLETED | PHASE4 | 2001-05 | 2005-08 | 2005-08 |
| NCT00228020 | Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients | COMPLETED | PHASE3 | 2001-05 | | 2006-01 |
| NCT00154258 | A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia | COMPLETED | PHASE2 | 2001-04 | 2009-12 | 2009-12 |
| NCT00154388 | Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases | COMPLETED | PHASE2 | 2001-02 | 2007-01 | 2007-01 |
| NCT00613665 | Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults | COMPLETED | PHASE1 | 2001-02 | 2002-04 | 2001-12 |
| NCT00014638 | Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer | COMPLETED | PHASE4 | 2001-01 | 2002-03 | 2002-03 |
| NCT00051636 | Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period | COMPLETED | PHASE3 | 2001-01 | 2011-04 | 2004-03 |
| NCT00637949 | Safety of Lumiracoxib in Patients With Osteoarthritis | COMPLETED | PHASE3 | 2000-12 | 2001-03 | 2001-03 |
| NCT00267215 | Efficacy and Safety of Lumiracoxib | COMPLETED | PHASE3 | 2000-11 | | 2001-02 |
| NCT00006475 | STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis | COMPLETED | PHASE2 | 2000-09 | 2002-12 | 2002-12 |
| NCT00171925 | Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I | TERMINATED | PHASE3 | 2000-08 | 2008-11 | 2008-11 |
| NCT00006370 | Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer | COMPLETED | PHASE2 | 2000-07 | 2004-06 | 2004-06 |
| NCT00535418 | Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers | COMPLETED | PHASE2, PHASE3 | 2000-06 | | 2002-07 |
| NCT00098241 | Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients | COMPLETED | PHASE3 | 2000-06 | 2007-03 | 2007-03 |
| NCT00237185 | A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene | COMPLETED | PHASE2 | 2000-06 | 2013-06 | 2013-06 |
| NCT00006052 | STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia | COMPLETED | PHASE2 | 2000-06 | | 2003-06 |
| NCT00333840 | Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | COMPLETED | PHASE3 | 2000-06 | 2012-03 | 2012-03 |
| NCT00006053 | STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa | COMPLETED | PHASE2 | 2000-06 | 2003-03 | 2003-03 |
| NCT00006343 | STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | COMPLETED | PHASE3 | 2000-06 | 2007-03 | 2007-03 |
| NCT00738257 | A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients. | COMPLETED | PHASE4 | 2000-06 | | 2004-12 |
| NCT00149916 | Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107 | COMPLETED | PHASE3 | 2000-04 | | 2004-04 |
| NCT00130845 | Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy | COMPLETED | PHASE3 | 2000-02 | 2005-12 | 2005-12 |
| NCT00149864 | Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302 | COMPLETED | PHASE3 | 2000-02 | 2003-12 | 2003-12 |
| NCT00333086 | A Study of Letrozole in the Treatment of Endometrial Cancer | COMPLETED | PHASE2 | 2000-01 | | 2006-06 |
| NCT00171223 | An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha | COMPLETED | PHASE2 | 1999-12-06 | 2013-11-29 | 2013-11-29 |
| NCT00006269 | Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | TERMINATED | PHASE3 | 1999-12 | | 1999-12 |
| NCT00247663 | Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | COMPLETED | PHASE2 | 1999-12 | | 2005-12 |
| NCT00149929 | Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301 | COMPLETED | PHASE3 | 1999-12 | 2003-04 | 2003-04 |
| NCT00131144 | Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy | COMPLETED | PHASE3 | 1999-11 | 2005-12 | 2005-12 |
| NCT00005073 | Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms | TERMINATED | PHASE3 | 1999-09 | 2003-03 | 2003-03 |
| NCT00171249 | An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia | COMPLETED | PHASE2 | 1999-08-09 | 2013-09-23 | 2013-09-23 |
| NCT00171158 | An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis | COMPLETED | PHASE2 | 1999-07-26 | 2013-04-22 | 2013-04 |
| NCT00003884 | Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone | COMPLETED | PHASE3 | 1998-08 | 2001-01 | 2001-01 |
| NCT00006368 | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | COMPLETED | PHASE1 | 1998-01 | 2003-11 | 2003-11 |
| NCT03070691 | Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | WITHDRAWN | PHASE2, PHASE3 | | | |
| NCT00277550 | The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia | WITHDRAWN | PHASE4 | | | |
| NCT00124241 | An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B | COMPLETED | PHASE2 | | 2005-11 | 2003-02 |
| NCT00409019 | Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy | WITHDRAWN | PHASE4 | | | 2011-03 |
| NCT01451450 | Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy | WITHDRAWN | PHASE2 | | | |
| NCT00243763 | TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma | TERMINATED | PHASE1 | | | |
| NCT00487123 | Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months | COMPLETED | PHASE4 | | 2007-09 | 2007-09 |
| NCT00002394 | Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment | COMPLETED | NA | | | |